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Since the tragedy of the drug Thalidomide® in the late 1950 to early 1960’s, 
chirality has been recognized as an important aspect that must be controlled in the drug 
development process in the pharmaceutical industry. Since then, there has been a 
considerable movement towards single enantiomer drugs. This demand has presented 
many challenges for the synthetic organic chemist. Chiral catalysts offer one solution to 
this problem, as they afford the unique ability to preferentially synthesize one 
enantiomer. Unfortunately, the design of new chiral catalysts is often empirical, with luck 
and trial and error necessary due to factors that govern enantioselectivity. Therefore, it 
would be highly beneficial to develop a method that is capable of screening multiple 
chiral catalysts early in the catalyst development cycle.  
 
 
 
 Using a modified ion-trap mass spectrometer, the chiral environment of various 
chiral catalysts may be examined, free from solvent and ion-pairing affects. Thus, the 
catalyst’s inherent asymmetric environment (enantioselectivity) may be probed using 
simple chiral molecules, including alcohols, ethers, and epoxides of various steric 
demands. Using these probes, various C2-symmetric bis-oxazolines and di-imines 
catalysts were examined. Use of the binaphthyl-based diamine, BINAM, condensed with 
various 3,5-disubstituted benzaldehydes, provided selectivity close to the privileged 
catalyst, bis-oxazoline. In general, the chiral probes 1-phenyl-2-propanol, 1-
mehtoxyethylbenzene, and styrene oxide offer the best look at the catalyst’s 
enantioselectivity potential. With the use of the ion-trap mass spectrometer as a mass 
filter, the purity of the catalyst is not paramount, thus, multiple catalysts may be 
screened simultaneously, with the constraint that the catalysts must be of different m/z.  
This thesis presents results found during the exploration of various C2 and C1-symmetric 
chiral catalysts, in the development of the new chiral screening method utilizing various 
chiral probes. 
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Chapter 1 – Chirality and Asymmetric Catalysis 
 
 
 
1.1 – Chirality 
 
 
Chirality, or the spatial arrangement of atoms in space, prompted Louis Pasteur, 
the father of modern stereochemistry due to his pioneering work with tartaric acid, to 
write:  “L’  univers  est  dissymétrique.” 1 His separation of tartaric acid salts in 1848, with a 
pair of tweezers and a microscope, gave birth to the field of stereochemistry,2 and is a 
landmark in the history of organic chemistry. His keen insight into the three-dimensional 
aspects of Nature served him well later in life, when, in 1857, he discovered the 
enantioselective fermentation of tartaric acid.3 He thus discovered the significance 
chirality imparts in biological systems, as many of the molecules necessary for life, 
carbohydrates, amino acids, DNA, etc., are inherently dissymétrique, the origin of which 
is an interesting and much debated topic (homochirality).4,5 
 
 A chiral molecule may be defined by a stereocenter, usually an asymmetric 
carbon with four different atoms attached. A molecule with an asymmetric carbon forms 
non-superimposable mirror images, which form a pair of enantiomers, (a) in Figure 1. 
Axial chirality also exists in Nature and is unique in that an asymmetric carbon is 
absent, instead replaced by an axis of chirality. Examples include allenes and biphenyl 
or binapthyl-based molecules such as BINOL, BINAP, and BINAM see (b) in Figure 1, 
2 
 
and the right-hand turn of a DNA helix (c).6 Enantiomers have the same physical 
properties, such as melting/boiling points, molecular weight, etc., differing only in the 
atom’s  3D  arrangement   in space. Diastereomers are stereoisomers that are not mirror 
images of one another, possessing at least two stereocenters, at least one of which 
differs from the other (Figure 1).  
 
 The pervasiveness of chirality in biological systems imparts significant 
importance to its control in the synthesis of pharmaceutical-based medicines, as 
individual enantiomers may exhibit stark differences in 
pharmacological, and toxicological activities/effects, as 
well as differences in efficacy/potency (i.e., 
pharmacodynamics and pharmacokinetics). The 
pharmacodynamics may be innocuous, as is the case for 
limonene, where (S)-limonene invokes the smell of lemon, 
while the (R) enantiomer triggers the smell of orange 
Figure 1. Examples of chiral molecules. (a) displays a pair of enantiomers (2-butanol). (b) displays an 
example of axial chirality (axis in red). (c) example of axial chirality in DNA (taken from Dickerson et al.)6 
(d) diastereomers (tartaric acid). 
      (a)            (b)                      (c)               (d) 
X = OH (BINOL) 
X = PPh2 (BINAP) 
X = NH2 (BINAM) 
Figure 2. R/S-limonene. 
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(Figure 2).7 Unfortunately, the pharmacological differences may also be tragic, as was 
the case for the drug thalidomide.  
Thalidomide was prescribed for pregnancy-related nausea in the late 1950s and 
early 1960s in Europe, Australia, Japan, and Canada. Sold in its racemic form, it was 
later found to cause severe birth 
defects. Specifically, it was found the 
S enantiomer was responsible for the 
teratogenicity, while the R enantiomer 
conferred the desired sedative effect 
(Figure 3). It was also later found to 
racemize in vivo, thus, preventing the sale of the desired pure enantiomer, and muting 
the argument whether the single-enantiomer form would have prevented the tragedy. 
 
 Prior to this, enantiomeric forms were not a consideration in drug formulation, 
due in part to the difficulty in separation,8 and synthesis.9 Since thalidomide, however, 
the industry has become aware the need to consider enantiomers as separate drug 
candidates. This became mandated in 1992, when the FDA issued guidelines on drug 
development and stereoisomeric drugs, changing the landscape of drug discovery and 
development for the industry.10 Figure 4 displays the percentage of drugs approved by 
the FDA from 1999-2008 by enantiomeric formulation. The trend towards single-
enantiomer drugs over the racemic version is discernible and unequivocal,11 especially 
when considering the fact in the early 1990s, 90% of chiral drugs were still racemic.9 
Figure 3. Thalidomide enantiomers. 
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 The reasons for the shift are two-fold: therapeutic and financial. The therapeutic 
benefits of single-enantiomer drug formulations, according to Hutt & Valentová, include 
the following: 
 
x increased efficacy (potentially);  
x less complex, more selective pharmacodynamics profile;  
x less complex pharmacokinetic profile; 
x less complex relationship between plasma concentration and effect; and 
x less potential for complex drug interactions.12  
 
The financial impacts are also large and palatable. From a drug development 
perspective, it is usually much cheaper to develop an asymmetric process (via synthesis 
or separation), than spend money on characterizing the toxicological and 
pharmacokinetic profile of the undesired enantiomer and racemate.13  
Figure 4. Enantiomeric composition of drugs approved by the FDA by 
year.11 
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 Patent protection/extension, however, is the main driver for single-enantiomer 
drugs. It is estimated a new drug costs between $92-883 million to bring to market.14 
Couple this to the low percentage of drugs passing clinical trials, 32% for large molecule 
and 13% for small molecules,15 and it becomes clear – companies must protect their 
investment and extend patent life as long as possible. Developing the single-enantiomer 
form increases the complexity and associated costs, increasing capital requirements, 
both monetary and human, required for generic companies to enter the market. Since 
they run on razor-thin margins, this is seen as a competitive advantage.  
 
  A racemic version may also allow a competitor to skirt patent laws and gain 
access to the market. If one of the enantiomers is inactive, a competitor may synthesize 
the enantio-active form, patent it as a new chemical entity, and market it. This   “chiral  
switch”   also   allows  patent   holders   the  ability   to   extend   the   life   of   their patents and is 
actively pursued by patent holders, and smaller companies, as an alternative strategy to 
the time-consuming and expensive drug discovery process (for example, the company 
Sepracor who’s   business  model   is   built   around   the   chiral   switch).16 Figure 5 displays 
three examples of common drugs that have undergone the chiral switch strategy.12 
Figure 5. Example of drugs that have undergone the chiral switch. 
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Chiral molecules are a multi-billion dollar-a-year business. The market for single-
enantiomer fine chemicals (agricultural, flavor, fragrances, etc.) was expected to be $16 
billion in 2007, a 13.2% growth rate.17 In 2011, seven of the top-ten best-selling drugs 
were single enantiomers,18 with sales of pharmaceutical-based single enantiomers at 
$225 billion in 2005,19 with projected sales of $5.1 billion for chiral technologies 
(methodology, separations etc.) by 2017.20 This huge market for chiral molecules has 
presented many challenges for chemists. The cost, and more so the speed of drug 
development, with the need to get to market as fast as possible, places enormous 
pressure on the synthetic organic chemist to derive fast, efficient asymmetric 
methodologies, as well as the analytical chemist to develop methodologies to separate 
and quantitate chiral molecules.  
 
From an atom economy point of view, asymmetric catalysis affords an excellent 
opportunity to introduce asymmetry into the molecule. Unfortunately, this is complicated 
due to the fact that many chiral catalysts are patented, requiring royalties and freedom 
to operate agreements, limiting industrial use.21 Rather, other methods and/or in-house 
development of catalysts/ligands are pursued. It would therefore be highly beneficial to 
develop a rapid chiral catalyst screening method to aid in the discovery of new catalyst 
systems in pursuit of cheaper, faster, and more efficient asymmetric synthetic 
routes/methodologies.  
 
1.2 – Methods for Achieving Enantiopurity 
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 Enantiopurity may be attained through numerous methods, (Figure 6). Each 
method has its merits and faults, discussed briefly in the proceeding paragraphs; thus, 
the method selected depends on many factors, such as chemistry, time, money, 
commercial availability, “elegance”, and simplicity.   
 
 
 
 
 
 
 
 
 
 
 
 
 Farina et al. performed a brief survey of single-enantiomer drugs released from 
1992 – 2003 and deduced the chiral method of induction through patents.13 Based on 
the data in Figure 7 the chiral pool method was by far the most popular method used in 
industry to induce chirality. 
prochiral 
substrates 
biocatalysis organometallic catalysts 
chiral 
auxiliary 
Enantiopure compound synthesis chiral pool 
chromatography kinetic  resolution 
direct 
crystallization 
classical 
resolution 
racemates 
Figure 6. Different routes to enantiopurity. 
 8 
 1.2.1 – Resolution 
  
Resolution requires the use of a stoichiometric quantity of an enantiomerically 
pure resolving agent with a racemic mixture to form a diastereomer, where differences 
in physical properties of the two may be exploited, such as solubility (crystallization), 
boiling points (distillation), and polarity (chromatography), etc. A requirement of the 
diastereomer is reversibility; hence, acid-base chemistry is preferred. In 1853, Pasteur 
first reported the first classical resolution, via formation of a diastereomeric salt with 
subsequent crystallization. He found a racemic mixture of tartaric acid mixed with the 
basic resolving agent, (+)-quinotoxine, precipitated the enriched (d)-tartaric acid/(d)-
quinotoxine, shown in Scheme 1.22,23 This method remains popular today, with little 
dddd 
0!
1!
2!
3!
4!
5!
6!
7!
1992! 1993! 1994! 1995! 1996! 1997! 1998! 1999! 2000! 2001! 2002! 2003!
Methods for Chiral Induction for Single-Enantiomer Drugs by Year!
chiral pool! resolution! enantioselective synthesis! not available!
Figure 7. Method of chiral induction for single-enantiomer drugs released from 1992 – 2003.13 
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modification, due to the scalability, ranging from mg to kg, reproducibility, ease of 
implementation (i.e., no equipment modifications), and historical knowledge. However, 
not every compound forms a salt and the maximum yield is 50%, with the other 
enantiomer a waste product, if there is no commercial application/market.24 
 
1.2.2 – Kinetic Resolution 
 
 Kinetic resolutions are based upon differential rates of reaction between the two 
enantiomers. Marckwald and McKenzie first discovered the principle in 1899 with the 
preferential esterification for the R enantiomer when a racemic mix of mandelic acid was 
reacted with (-)-menthol (Scheme 2).25 This  method   confers   extremely   high   ee’s,   but  
usually at a cost of yield (driven by the ''G of the two transition states), which itself is 
limited to a maximum of 50%. This again produces waste from the other enantiomer 
and is thus viewed as inelegant.  
Scheme 1. Classical resolution of tartaric acid via enantiopure (d)-quinotoxine. 
10 
 
 
A variation on the kinetic method is found when the enantiomers are able to 
racemize on a time scale faster than the reaction, and is called a dynamic kinetic 
resolution. It was first reported by Noyori in 1989, with the stereoselective 
hydrogenation of E-ketoesters.26 Figure 8 displays the free energy diagram of the 
reaction, clearly demonstrating the thermodynamic preference for the faster-forming 
anti-epimer. Since the enantiomers racemize, the theoretical yield can be 100%, 
however, for good ee, the kA/kB should be at least 20 and kinv should be faster than kA, 
hence kinv > kA >> kB.27 
Scheme 2. First example of kinetic resolution by Marckwald & MaKenzie.25 
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1.2.3 – Chromatography and Direct Crystallization 
 
Two other methods for separation of racemates include chromatography and direct 
crystallization. Separation of racemates utilizing a column requires conversion to 
diastereomers either directly by derivatization, or through interaction with a chiral 
stationary phase,  forming  a  “transient”  diastereomer. In 1952, Dalgliesh introduced the 
three-point model of interaction to explain the separation of enantiomers, an extension 
of the biological enzyme-substrate mechanism of Easson and Stedman.28,29 The three-
a 
b 
c 
d 
e 
Figure 8. Free energy diagram of the dynamic kinetic resolution of the stereoselective hydrogenation of a 
E-keto-ester.27 
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point model postulates three points of contact are necessary for enantiomeric 
separation. This can only be met in an asymmetric environment with only one of the 
enantiomers in the correct 3D configuration (Figure 9).   
 
 Chromatography is inherently difficult to translate to larger scales, and is 
therefore regulated more towards the smaller scales of academia. However, newer 
technology, designated simulated moving bed (SMB), has been used to resolve the 
intermediate tetralone in the synthesis of sertraline, an antidepressant, by Pfizer.30 The 
SMB is a series of valves and switches that allow for multiple columns to be placed in 
series with appropriate inlets and outlets. This set-up also (Figure 10)31 allows for the 
undesired enantiomer to be racemized with NaOH and acetonitrile, and recycled 
through the process, increasing yield to theoretically 100%, but requiring significant 
capital investment, and most likely a dedicated reactor train. 
Figure 9. Three-point model of chiral separation. Note the S enantiomer (left) has three points of 
contact, while the R enantiomer (right) only has one point of contact. 
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 Direct crystallizations are much less common due to the fact the enantiomers 
must crystallize as two separate mirror image (enantiomorphous) crystals or 
conglomerates. The number of racemates that meet this criteria was estimated to be 
between 5-10%.32 Fortuitously, the tartaric acid crystals Pasteur separated manually 
meet this definition. In 1882, Jungfleish seeded a supersaturated solution of sodium 
ammonium tartrate with one enantiomer on one side of a vessel, and the other 
enantiomer on the other side. He found each enantiomer to selectively crystallize on the 
respective side on the vessel in which it was seeded.33 This method was successfully 
used to separate a racemic mixture of d/l-Methadone,34 but again, a maximum of 50% 
yield is achieved.  
 
 A second method of crystallization is called resolution by entrainment, or 
preferential crystallization. This technique seeds a racemic mix with one of the 
Figure 10. SMB set-up for industrial chiral chromatographic separation of the intermediate tetralone, 
which is processed to the antidepressant Sertraline. Adapted from US patent 6,444,854 and Hawkins et 
al.31 
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enantiomers and is heated to dissolve. Upon cooling to the supersaturation point, the 
enriched enantiomer will start to crystallize, after which it is filtered, leaving the other 
enantiomer enriched in the mother liquor. Afterwards, additional racemate is added to 
adjust to the starting point concentration. The contents are heated, allowed to cool, and 
the other enantiomer will preferentially crystallize. After filtration, more of the racemic 
mix is added and the process is repeated. The purity attained for this method can be 
quite high, for example, after 15 cycles, a 97% optical purity was obtained for the 
preferential crystallization of the (-)-hydrobenzoin enantiomer.35 However, impurities that 
become enriched after each cycle may begin to interfere with the crystallization process. 
 
1.2.4 – Chiral Pool 
 
 The simplest method for introducing chirality into a target molecule is to start with 
enantiopure starting material that may be transformed to the target molecule with the 
chirality preserved during the course of the synthetic process. This method is called 
chiral pool synthesis and was used in the synthesis of the t-Bu bis-oxazoline (1, 1a) 
used in this work (Scheme 3).36 Upon inspection of Figure 7, it becomes obvious most 
process  chemists’  prefer   to  draw   from   the  chiral  pool  when   introducing  chirality   into  a  
desired molecule. This is most likely a matter of convenience, as time is critical in the 
drug discovery/development stage. Nature serves as the provider of the pool, as the 
15 
 
majorities of synthons are of natural origin, and as such, are relatively cheap. These 
include alkaloids, amino acids, carbohydrates, hydroxy acids, and terpenes (Figure 11). 
 
 
 
Scheme 3. Synthesis of bis-oxazoline (tBOX) via the chiral pool method. 
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The chiral pool method has represented the only source of chiral materials for years; 
therefore, the methodology has been proven through time. The disadvantage of the 
chiral pool method is the limited availability of both natural enantiomers, and the 
potential extra steps in the synthesis, assuming the starting material can even be 
transformed to the desired product.  
 
Figure 11. Selection of chiral molecules comprising the chiral pool. 
17 
 
1.2.5 – Chiral Auxiliary 
 
Alternatively, the chiral center(s) may be introduced during the synthesis by 
introducing a chiral auxiliary (which itself is derived from the chiral pool) that directs 
enantioselectivity via intramolecular asymmetric induction. The auxiliary is then 
removed afterwards and potentially recycled.37 Oxazolidinones are common chiral 
auxiliaries, and were pioneered by David Evans in enantioselective aldol condensations 
via a boron enolates (Scheme 4).38 The oxazolidinone (4) was used in the first 
enantioselective synthesis of methylphenidate (Ritalin), used for the treatment of 
attention deficient hyperactive disorder (ADHD) (Scheme 5).39 
 
 
Scheme 4. Oxazolidinone and common oxazolidinones used as chiral auxiliaries (top). Example of 
Evan’s  oxazolidinone for use as a chiral auxiliary in an aldol addition.38 
   2            3     4 
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 The method of removing the oxazolidinone allows for the generation of different 
functionalities for the new aldol. For example, reductive conditions yield a primary 
alcohol40 while oxidative conditions yield a carboxylic acid.41 Weinweb amides may 
even be synthesized for later use as ketones by employing N,O-
dimethylhydroxylamine.42 The   Evan’s   oxazolidinone, as well as others, direct 
asymmetry in other transformations including alkylations, conjugate additions, 
cycloadditions, and nucleophilic addition reactions.13 
 
In the case of alkylations, the chiral auxiliary directs chiral induction due to the 
resulting 3D conformation of the molecule. Due to metal chelation to the carbonyl and 
enolate, the conformation is more rigid, forming a six membered ring between the N-C-
CO portion of the oxazolidinone and the enolate. The chiral moiety at the 4-position of 
Scheme 5. First enantioselective synthesis of Methlphenidate via Evan's oxazolidinone and a chiral 
auxiliary. 
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the oxazolidinone directs the incoming electrophile, effectively blocking its path from the 
bottom, and forcing attack from the top, as shown in Figure 12.43 
The disadvantage of using chiral auxiliaries is the stoichiometric amount of 
material that is required to induce chirality.  The fact that the auxiliaries are usually 
cheap somewhat negates this fact; however, the method requires two extra steps in the 
synthesis, introduction and cleavage of the auxiliary, thereby reducing atom economy 
and cycle time.44 There may also be complications removing the product from the 
stoichiometric amount of auxiliary, which itself is a highly desired commodity, to be 
isolated and reused later, reducing costs and waste, and increasing efficiency. 
 
1.3 – Catalysis 
 
Due to the inefficiencies or limitations of the previous methods, it would be ideal 
to develop methodologies that incorporate sub-stoichiometric amounts of chiral material, 
i.e. catalysis, into the synthesis. In 1835, Baron J. J. Berzelius defined a catalyst as any 
substance that facilitates chemical reactions without being consumed in the process.45 
Figure 12. Chiral induction via blockage from the bottom. 
20 
 
Catalysts   “facilitate”   reactions   by   reducing   the   energy   of   activation   required   for   a  
reaction to take place. Figure 13 
displays the free energy diagram for a 
generic reaction with and without a 
catalyst. Many of the biochemical 
processes required for life are catalyst-
driven via enzymes. It is also crucial 
for our economy and our way-of-life, 
as an estimated 90% of all chemical 
processes currently in use are catalytic 
in nature.46 Catalysts are divided into three categories, homogeneous (same phase), 
heterogeneous (different phase), and enzymatic (biocatalysis). Heterogeneous catalysis 
is by far the most prevalent in use today, with an estimated 80% of the global market 
share, followed by 17% for homogeneous, and 3% for enzymatic.46  
 
 
1.3.1 – Organometallic Catalysis  
 
Organometallic catalysts (OMC) bridge the fields of organic and inorganic 
chemistry, and have become an indispensable tool for the modern synthetic chemist, as 
they provide unique solutions to enantioselectivity and CH bond activation. The d-
orbitals of metals allow access to energetically favorable alternative pathways to CH 
bond activation. This lower energy of activation allows for much greater selectivity, 
because alternate higher energy pathways are not accessible. In recognition of the 
Figure 13. Free energy diagram for a catalyst vs. non-
catalyst reaction. Taken from 
http://www.uic.edu/classes/bios/bios100/lectures/energy
hump01.jpg 
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importance of OMC to chemistry, The Royal Swedish Academy of Sciences has 
awarded ten Nobel Prizes to Chemists whose work pioneered/advanced the field of 
OMC,47 with the most recent (2010) recipients, Akira Suzuki, Ei-ichi Negishi, and 
Richard Heck, for their contributions in the field of Pd cross-couplings.48   
 
The mechanisms of a transformation utilizing OMC can range from complex to 
nuanced, but they all generally go through some oxidative addition to the metal, 
transmetallation, followed by reductive 
elimination leading to the product and 
the regenerated catalyst, shown in 
Scheme 6. OMC have also found use 
in asymmetric synthesis, where the 
ligand coordinates to the catalyst, 
forming a rigid, three-dimensional 
template, necessary to differentiate the 
enantiomers or direct a group to the 
prochiral face. Due to the regeneration of the catalyst, catalysis is ideally suited for 
asymmetric synthesis, since the chiral portion is usually the most expensive and hardest 
molecule to obtain. 
 
1.3.2 – Biocatalysis 
 
Scheme 6. General Catalytic Cycle. 
22 
 
Biocatalysis utilizes enzymes to transfer chirality, yielding an extremely selective 
(chemo, regio, and enantio) process, due in part to the very specific nature of the 
enzyme-substrate complex.49 The enzyme, tyrosine phenol-lyase (Tpl), is used to 
produce L-DOPA, the precursor of the neurotransmitter dopamine, norepinephrine, and 
epinephrine (adrenaline). Erwinia herbicola cells, previously treated in L-tyrosine 
medium to induce Tpl and subsequently isolated by centrifugation, were added to 
catechol, pyruvic acid, and ammonia to produce (S)-3,4-dihydroxyphenylalanine, or L-
DOPA, shown in Scheme 7.50 Of note is the high regioselectivity of the new aryl-C bond 
formation, in addition to the high enantioselectivity of the hydrogenation. The only 
impurities observed were from the L-tyrosine, a product of the medium used to cultivate 
the cells, and a natural byproduct of the Tpl. This process is used to produce 
approximately half of the 250 tons of L-DOPA produced annually (as of 2005).50 
 
The previous example highlighted the advantages conferred by biocatalysis – the 
high selectivity. However, this is tempered by the limited reaction conditions that 
enzymes can tolerate, such as aqueous solvents, and limited pH and temperature 
ranges, oxidation, as well as substrate and product inhibition.51 In addition, some people 
may suffer from allergic reactions to proteins, particularly if they manage to get into the 
Scheme 7. Enzymatic synthesis of L-DOPA. 
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bloodstream.52 All these factors contribute to a high inertia for adopting/developing an 
enzymatic process; therefore, OMC are more commonly embraced. 
 
1.3.3 – Enantioselective Catalysis 
 
 
  Enantioselective catalysis utilizes catalytic amounts of a chiral substance to 
induce chirality in a molecule. The catalyst may comprise a metal, coordinated to chiral 
ligands, as with Cu bis-oxazolines, or consist 
solely of a chiral molecule, usually derived 
from nature, for example, proline. One of the 
first examples of an asymmetric synthesis 
was reported in 1904 by Willy Marckwald 
when he enantioselectively (10% ee) 
decarboxylated 2-ethyl-2-methylmalonic acid 
with the alkaloid brucine (Scheme 8).53 Since 
then, numerous chiral ligands have been developed for enantioselective synthesis, 
particularly for asymmetric hydrogenations, due to historical reasons (Figure 14).  
Scheme 8. Enantioselective decarboxylation 
with brucine. 
Figure 14. Historically significant chiral catalysts. 
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 The first asymmetric organometallic procedures were developed by Noyori in 
1966 for the cyclopropanation of styrene with ethyldiazoacetate and a 
(salicyladiminato)-copper complex (Scheme 9).54 This was followed by the rise 
phosphines for use in asymmetric hydrogenation, where much of the early work was 
concentrated. In 1986, Knowles and Horner modified Wilkinson’s  catalyst, RhCl(PPh)3, 
used in hydrogenation of alkenes, with a chiral bisphosphine (5) to produce an 
asymmetric hydrogenation, albeit at low optical purity (15).55,56  
A few years later, Kagan reported the highest optical yields, 72%, to date (1971) 
for an asymmetric homogeneous catalyst using the C2-symmetric DIOP (8) for an 
alkene hydrogenation.57 Knowles also continued to make progress, increasing ee to 
87% with the CAMP ligand (7) and Rh in 1972.58 By 1974, the ee’s were high enough 
for commercially viability. Knowles, while working with Monsanto, was the first to 
develop an industrial-scale enantioselective hydrogenation process for the production of 
L-DOPA using DIPAMP (6), shown below in Scheme 10.59  
 
 
 
Scheme 10. First commercial use of an asymmetric catalyst. 
Scheme 9. First enantioselective cyclopropanation by Noyori in 1966.54 
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 By 1980, Noyori and Takaya discovered the usefulness of atropisomerism in 
asymmetric synthesis and used the Rh(I)-based BINAP (9) for an asymmetric 
hydrogenation of D-(acylamino)acrylic acids (Scheme 11).60 In 1986, Noyori used Ru(II) 
with BINAP in the asymmetric hydrogenation of isoquinoline alkaloids,61 and in the 
process significantly increased the scope of the catalyst.  
 
 In 1980, Sharpless introduced the first asymmetric epoxidation shown in Scheme 
12.62 For their pioneering efforts into asymmetric catalysis, Knowles, Noyori and 
Sharpless, shared the 2003 Nobel Prize in Chemistry.63,9,59 Since then, numerous 
enantioselective catalysis have been employed on an industrial scale (Table 1).64  
 
Scheme 12. Sharpless epoxidation. 
Scheme 11. Asymmetric hydrogenation using BINAP and Rh. 
9 
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Table 1. Metal coordinated chiral catalyst in industrial use.64 
 
Company Metal Reaction Type Final Product 
Monsanto Rh Hydrogenation L-Dopa 
Sumitomo Cu Cyclopropanation Cilastatin 
Anic. Enichem Rh Hydrogenation L-Phenylalanine 
J. T. Baker Ti Epoxidation Disparture 
ARCO Ti Epoxidation Glycidols 
Takasago Rh Rearrangement L-Menthol 
Merck B C=O reduction MK-417 (ophthalmic)* 
E. Merck Mn Epoxidation Antihypertensive* 
Takasago Ru Hydrogenation Carbapenem 
*Developmental quantities for safety assessment and clinical trials 
 
There are many factors that one must consider when selecting an asymmetric 
catalyst, such as the turnover number (TON = mol product/mol catalyst), turnover 
frequency (TOF = TON hr-1), catalyst loading, and patents and associated legalities; 
however, these are subsumed by the choice of the metal and ligand. 
 
1.3.3.1 – Metal 
 
 
 The choice of metal is an important aspect to consider for asymmetric induction, 
with the noble and transition-based metals by far the most popular.65 Different metals 
possess different coordination spheres, which affect geometry and steric crowding, a 
major driving force for enantioselectivity. Additionally, the ability to adopt multiple 
oxidation states is crucial for catalytic activity.  
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While Pd is extremely popular on an industrial scale, due in no small part to the 
popularity of the C-C bond coupling reactions, such as the Suzuki, Negishi, Heck, Stille, 
Buchwald-Hartwig, etc.66 For asymmetric catalysis, Ru, Rh, and Ti are the most 
prevalent.65 This is no doubt related to the pioneering asymmetric work of Noyori, 
Knowles, and Sharpless. A final consideration is the price of the metal. Although it is 
used in catalytic amounts, the 
price may fluctuate drastically, as 
shown with Pd in Figure 15.67 In 
some cases, the metal may be 
recycled, but most lose catalytic 
activity with each cycle and may 
need to be regenerated via an acid 
or base wash. Many are air and 
moisture sensitive as well, which 
are other factors that must be considered. 
 
1.3.3.2 – Ligands 
 
 
 The choice of ligand is the most important aspect of asymmetric synthesis since 
it forms the template that will dictate the direction of approach a reagent will take, and 
hence the enantioselectivity. Electronics of the ligand can affect the electron density on 
the metal and hence accelerate or decelerate the rate of the catalysis (ligand 
activation/deactivation).68 The ideal class of ligand is stable in air and water, 
 
Figure 15. Price of Pd ($US/gram) since 1986. Taken from 
infomine.com 
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inexpensive and easy to prepare in both enantiomeric forms.69 The catalyst should also 
be highly tunable, offering the ability to easily modify the ligand with various functional 
groups. Even small differences in ligand structure can have a drastic effect on 
selectivity.70 This has been termed a modular approach and is critical since 
performance of a new catalyst/ligand is more empirical than theoretical.  
  
The diphosphines are the most widely used class of ligands on the industrial 
scale, again due to Noyori and historical precedence of the asymmetric 
hydrogenations.65 C1-symmetric ligands, such as those shown in Figure 16 have been 
shown to induce modest to excellent enatioselectivities.71 Unsymmetrical, with two 
different substituents, or mono substituted ligands have also been employed, resulting 
in   generally   lower   ee’s   than   the   corresponding   C2-symmetric catalysts.  Analog C2-
symmetric catalysts have been synthesized bearing two different groups 
(unsymmetrical) substituents, as well as mono substituted catalyst, all displaying 
generally lower   ee’s   than   the   corresponding   C2-symmetric originals,72,73 but in some 
cases offering better selectivity.71 
Figure 16. Common C1-symmetric catalysts. 
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Of all the ligands, a certain class has stood out and become common in 
asymmetric   synthesis   due   to   their   high   ee’s   and,   perhaps   more   importantly,   their  
success over a wide range of transformations. As such, they have been termed 
“privileged   structures.”74 This generality hints at a common template inherent to all 
privileged structures. A common feature of this class, aside from the generality, is a C2-
symmetric framework. 
 
1.4 – C2-Symmetric Ligands 
 
 
 
C2-symmetry in catalysts was first developed by Kagan in   the   70’s   with   the  
introduction of the diop ligand (5).75 These ligands contain an axis of symmetry, such 
that a 180° rotation will return the original molecule, i.e., it will be indistinguishable from 
the original upon a 180° rotation. Examples of this class are shown in Figure 17. 
Common transformations catalyzed by theses ligands include the Diels-Alder reaction 
(1, 2, 10, 12), the Mukaiyama aldol reaction (1, 2, 11), conjugate additions (1, 1a, 2), 
cyclopropanations and aziridinations (1, 1a, 2), and epoxidations (2), among others.36  
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This generality is crucial since predicting the behavior/performance of a new 
catalyst based on mechanistic or electronic/steric nature is not always possible due to 
the  potential  complexities  of  the  catalyst’s  mechanism  (if  known). A chemist may select 
one of these C2-symmetric catalysts and, with a high degree of confidence, be assured 
a decent ee, regardless of functionalization or reaction/mechanism.  
 
Inherent to all C2-symmetric catalysts is a reduction in the number of competing 
transition states due to the intrinsic symmetry.76 If one takes a generic C2-symmetric 
ligand and divides it into four equal quadrants, it becomes clear: two quadrants are 
equal upon rotation. Figure 18 displays the equivalency of quadrants I and IV, and II 
and III. The   framework   provided  by   the   symmetry   provides   a   “fence”   surrounding   the  
Figure 17. Examples C2-Symmetric Ligands. 
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reaction site (metal center) and effectively blocks one side of the molecule for 
reaction.77  
 
1.4.1 – Bis-Oxazolines (BOX) 
 
The bis-oxazoline class of ligands has become popular due to their synthetic 
ease, being derived from the chiral pool (chiral amino alcohols), and excellent ee over a 
wide range of transformations. Figure 19 displays some of the transformations yielding 
over 50% ee, with copper proving to be the best metal.  
 
 
Figure 18. Left – Generic C2-symmetric catalyst with quadrants. Right - Schematic of a C2-symmetric 
quadrant and the chiral fence produced by the substituents. Modified from Nishiyama et al.77 
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 BOX ligands are derived from the chiral pool, retaining the natural chirality 
derived from nature. Scheme 13 displays the common routes to the synthesis of the 
Scheme 13. Different synthetic routes to BOX ligands.36 
14 
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18 
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1a 1 
Figure 19. The range of enantioselective reactions catalyzed by 1 and 1a yielding at least 50% ee (left).  
Different metals used with 1 and 1a as a percentage of transformations with at least 50% ee (right).36 
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BOX ligand. The bridge of the molecule is provided by a symmetrical di-substituted 
malonic acid derivative (14), while two equivalents a chiral E-amino alcohol (16) 
provides the asymmetric inducer. This E-amino alcohol is usually prepared as in 
Scheme 3, page 15, from a chiral amino acid, which is subsequently reduced to the 
alcohol. Coupling of the E-amino alcohol and malonic acid produces the bis-amide (16), 
with the final cyclization step a matter of converting the alcohol to a better leaving 
group.   
 
Method A1 in Scheme 13, used by Corey et al.78 converted the alcohol to an acid 
chloride via thionyl chloride, followed by basic conditions for cyclization. Conversion to a 
tosylate (or mesylate) followed by basic conditions was also utilized to produce BOX 
ligands (A2).79 Less conventional methods have been used to cyclize bis-amides with 
Bu2SnCl2 (A3),80 Ph3P (A4),81 and with dehydrating conditions/reagents (A5).36  
 
Alternatively, a di-substituted malononitrile may also be used to couple two 
equivalents of a E-amino alcohol (A6), or a 1,2-diol (A7). Other routes have been 
developed to synthesize more exotic BOX-like ligand. As of 2006 there were over 140 
different BOX ligands synthesized.36 
Scheme 14. Alternate synthesis of BOX ligand. 
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1.4.2 – C2-Symmetric Di-Imines 
 
 Di-imines, or Schiff bases,82 are also excellent ligands for enantioselective 
transformations, such as epoxidations,83,84,85 enantioselective epoxide ring openings,86, 
87 aziridinations,84 cyclopropanations,88 and Diels-Alder reactions.89,90,71 Among di-
imines, the salen ligand is frequently involved in the most popular and well-studied 
reactions.  Salen’s  derive   their  name  from   the  starting  materials  used   in   the  synthesis,  
saliclaldehyde and ethylenediamine (Scheme 15).91  
 
 
The synthesis of di-imines is straightforward – a condensation between a chiral 
diamine and an aromatic aldehyde to produce the mono-imine and loss of water. The 
process is repeated for the second amine. As the reaction is in equilibrium, any method 
that removes the water will drive the reaction forward (Scheme 16). Heating to reflux or 
4Å molecule sieves (sometimes with ZnCl2, or MgSO4)92 are the two most popular 
additives for removing water; alternatively, a Dean-Stark apparatus may be used.93, 
Reaction times vary greatly from hours to days, depending on the dehydrating method 
and temperature.94,95,96  
Scheme 15. Synthesis of a salen ligand. 
+ 2 H2O 
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A variety of aromatic aldehydes are readily available from commercial sources. 
Chiral di-imines are less prevalent, with 1,2-cyclohexanediamine and 1,2-
diphenylethylenediamine, used for the Jacobsen and Katsuki catalysts, commercially 
available. Di-imines may also be engineered to take advantage of the axial chirality that 
has proven successful with the BINAP catalysts, via BINAM (b) in Figure 1. The ease in 
which they are synthesized, and the breadth of commercially-available sources for the 
aromatic aldehyde, makes them an attractive target for combinatorial synthesis.97 
 
 Noyori utilized a salen ligand in the first enantioselective synthesis of a 
cyclopropane (Scheme 9, page 24). Salen ligands further gained popularity due to thier 
use in enantioselective epoxidations with Mn(III) as described by Jacobsen et al, and 
Scheme 16. Generic synthesis of di-imine ligands. 
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Katsuki et al in 1990, who modified the ligand to  achieve  high  ee’s  in  excess  of  90%.98,99  
Scheme 17 displays the Jacobsen and Katsuki catalysts. Both ligands, as well as 
BINAM-based ligands have been used in cyclopropanations and aziridinations, utilizing 
wide variety of metals, Cr, Mn, Ru, Co, and Cu, and generally gave ee lower than the 
bis-oxazolines.100 Di-imine use with copper is predominately salen-based, as the 
oxygens provide a tetra-coordinate chelation sphere, favorable conditions for stabilizing 
the catalyst. Thus, 2,6 diCl substitution of the aryl ring is the next most popular di-imine. 
It  was  used  with  Cu(II)  producing  ee’s >86% for asymmetric aldol reactions of pyruvate 
esters.101  
 
A secondary use for these ligands is as chiral activators; ligands that are added 
to a catalyst to further enhance selectivity, particularly with diethyl zinc. For example, 
when (R)-Ph2-BINOL only was used in the production of (S)-phenyl-1-propanol from 
benzaldehyde and diethylzinc, the ee was only 8%; however, when a chiral activator 
was added, ee up to 99% were obtained (Scheme 18).102 
Scheme 17. Epoxidation using Jacobsen or Katsuki catalyst. 
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1.5 – Enantioselective Catalysis and the Transition State 
 
 In the simplest case, forming diastereomers, either real or transient, creates 
enantioselectivity. This creates small energy differences between the two transition 
states (TS). Understanding the TS is crucial for chiral catalysis: to quote Ian Williams, 
“catalysis is a transition-state molecular  recognition  event.”103 The following sections will 
explore this quote in more detail.  
 
1.5.1 – Gibbs Free Energy  
 
In the absence of a chiral catalyst, a simple, sp2-hybridized prochiral substrate 
will produce a racemic mix upon addition of a fourth group. If, however, a chiral catalyst 
is utilized, an excess of one enantiomer will be represented in the product mix (ideally). 
Scheme 18. Di-imine used as a chiral activator in the synthesis of (S)-phenyl-1-propanol. 
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This is represented in the illustration in Figure 20. At the top left (a), in the absence of a 
chiral catalyst, the incoming reactant may approach from either side. Alternatively, if a 
chiral catalyst is used (b), it blocks access to one side of the prochiral substrate, hence, 
preferentially forming one enantiomer.  
 
 
 
The corresponding free energy diagrams for these cases are represented in (c) 
and (d). In the absence of a chiral influence, as in (c), there is no difference in TS 
energy between the enantiomers, 'G equals zero, and hence no difference in the 
enantiomer ratio. However, when a chiral catalyst is used, as in (d), the chiral catalyst 
increases the transition state energy for one of the enantiomers. This in turn favors 
(d) 
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Figure 20. Top left (a) – generic reaction upon a prochiral substrate with out a chiral catalyst. Bottom left 
(c) – resultant Gibbs free energy diagram with equal transition states. Top right (b) – same reaction with 
a chiral catalyst. Bottom right (d) – resultant Gibbs free energy diagram with unequal transition states. 
The transition state with the lowest EA (left) will be the dominant product.  
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formation of the enantiomer with the lowest TS energy, and is manifested in the product 
distribution with an excess of one enantiomer.  
 
 An alternative synthesis to Scheme 18, developed by Noyori, et al.,104 is given 
below (Figure 21) for the asymmetric alkylation of benzaldehyde, and serves as an 
excellent example of the TS energies driving selectivity, albeit greatly simplified. 
Benzaldehyde, when subjected to DAIB, (2S)-(-)-exo-(dimethylamino)isoborneol, and 
diethyl zinc, produces the (S ) enantiomer in 98% ee. The (S ) enantiomer is favored due 
to the lower energy of activation, i.e., the TS is stabilized by 2.7 kcal mol-1 relative to the 
(R ) enantiomer (Figure 19).   
    
 As a point of reference, the energy for a ring flip from equatorial to axial for 
methylcyclohexane is ~ 1.7 kcal mol-1, shown in Figure 22.105 Therefore, small 
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''G≠ ≈  2.7  kcal/mol 
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(R ) (S ) 
98% ee 
Figure 21. DAIB catalyzed alkylation of benzaldehyde producing (S )-phenyl-propanol in 98% ee. The 
''G≠ ('GTSR – 'GTSS) for the reaction only ~ 2.7 kcal mol-1.104 
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differences in energy are the crux of enantioselectivity – 
any interaction that stabilizes (or destabilizes) a 
transition state relative to the other, can result in large 
differences in product distribution (ee). This relationship is shown in the graph in Figure 
23. The Gibbs free energy was calculated from the following equation: 
 
'G≠ = -RT lnk1/k2 
 
when k1/k2 is the ratio of rates of forming the enantiomeric products. 
   
The preceding examples displayed reactions under kinetic control, the category 
in which the majority of all reactions fall.24 The alternative is thermodynamic control, 
where the products are in equilibrium. Figure 24 displays free energy diagrams for 
reactions under kinetic and thermodynamic control. For a newly formed pair of 
enantiomers, the isoenergetic nature of the two excludes thermodynamic control, i.e., 
k1/k2 Enantiomeric Excess % 
''G≠ (kcal 
mol-1) 
1.0 0.0 0.00 
3.0 50.0 0.65 
9.0 80.0 1.30 
19.0 90.0 1.74 
99.0 98.0 2.72 
99.9 99.8 4.09 
Figure 23. Differences in free energy of the TS and corresponding selectivities at 25 °C. 
Figure 22. The A value for a methyl 
ring ~ 1.7 kcal mol-1.105 
(1) 
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they occur under kinetic control only. New stereocenters around a diastereotopic face 
may occur by either thermodynamic or kinetic control. 
 
 
1.5.2 – Temperature and Background Effects on Stereoselectivity 
 
  Explicit in the Gibbs free energy equation (1) is the dependence of selectivity 
upon temperature. Lower temperatures allow less energy for competing pathways; More 
importantly, the lower the energy, the less conformational freedom for a molecule in the 
TS and hence, a much more rigid TS – of paramount importance for enantioselectivity.71 
This relationship is illustrated below in tabular106 and graphical form in Figure 25.  
  
 
 
Figure 24. Reactions under kinetic control (a) and thermodynamic control (b). 
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  These data are a generalized/simplified application of equation (1) and assume 
only two diastereomeric pathways, and no shift in the rate-determining step or 
Figure 25. Top - Table of %ee (and er) at different temperatures. Taken from Koskinen.106 Bottom – 
Temperature and effect on ee. 
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mechanism.107 An ideal example of ee and temperature dependence is illustrated in 
Figure 26 with a Mukaiyama aldol reaction catalyzed with BOX (1).101 The slight 
deviation is thought to be a result of free CuOTf2 acting as a Lewis acid. 
 
In other cases, there may be multiple diastereomeric transitions states. For 
example, in the DAIB catalyzed enantioselective alkylation of benzaldehyde in Figure 
21, there are actually eight possible transition states shown in Figure 27. At higher 
temperatures, all are accessible and are represented in the product distribution by the 
relative Gibbs free energies of the transition state. 
Figure 26. Box-catalyzed Mukaiyama aldol reaction displaying ideal temperature dependence. 
60
65
70
75
80
85
90
95
100
-100 -80 -60 -40 -20 0 20 40
En
an
tio
m
er
ic
 E
xc
es
s 
%
Temperature °C
expt calcd
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
An example of competing reactions accessible at higher temperatures is found in 
the asymmetric Michael addition of cyclohexenone and benzyl malonate, catalyzed by a 
BINOL-salen Ni catalyst (21) shown in Figure 28. The deviation from theoretical is due 
to the non-selective background reactions from CsHCO3 and Cs2CO3, accessible at 
Figure 28. Asymmetric Michael addition with deviations from expected ee due to cesium carbonate and 
bicarbonate background reactions. 
> 70% ee (R ) 
Figure 27. Multiple diastereomeric transition states, accessible at different temperatures. 
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higher temperatures.108 These background reactions can have a drastic effect on 
enantioselectivity. The metals themselves may act as Lewis acids (non-selectively), or 
may coordinate to solvent, product, or counter ions resulting in ligand decelerated 
catalysis.107  
 
1.6 – Conclusions 
 
 Chirality is ubiquitous in nature and affects our everyday lives in various and 
subtle ways, for example smell and taste. The inherent chirality in living systems imparts 
important consequences if it is not taken into consideration, as the thalidomide case 
demonstrated. It has brought about significant changes to industries, mainly in the 
pharmaceutical arena, with the need to recognize and control chirality. The result is a 
shift towards producing and marketing single enantiomer drugs, and in the process, 
creating of a market worth billions of dollars annually.  
 
 This in turn has catalyzed a movement to improve methodologies for transferring 
the native chirality found in nature to synthetically made molecules. While many 
methods exist, asymmetric synthesis via chiral catalyst is an attractive option due to the 
small amount of expensive chiral material needed to produce achiral products. The ideal 
chiral catalyst is extremely sensitive to small energy differences in the TS of the 
diastereomeric complexes. The exploitation of these differences results in ee’s  of  90%  
with differences in the transition state energies as low 1.7 kcal mol-1, the same amount 
of energy required for a ring flip in methylcyclohexane. Lowering of the reaction 
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temperature may also further increase selectivity; however, solvent, counter-ions, and 
multiple diastereomeric TS can complicate extrapolation of the results.   
 
Among   chiral   catalysts,   the   “privileged ligand”   class,   comprising many C2-
symmetric ligands, offers excellent enantioselectivity over a wide range of 
transformations and substrates. This suggests a common template inherent within the 
class. Unfortunately, current methodologies for evaluating this template are done in the 
condensed   phase,   measuring   ee’s   from   isolated   reaction   products   where   various  
substrates and catalyst were varied. This is a time-consuming and inefficient process for 
accessing   a   catalyst’s   performance.   It would be highly advantageous to develop a 
method that could rapidly determine the chiral environment induced by a metal and 
ligand, explicitly measuring   the   catalyst’s   intrinsic   discriminatory potential, 
unencumbered by solvent and counter-ion/aggregate phenomena. The next chapter will 
present a brief survey of current methods for evaluating chiral catalysis performance. 
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Chapter 2 – Mass Spectrometry  
 
 
 
2.1 – Mass Spectrometers 
 
Mass spectrometry is an analytical technique that determines a gas-phase  ion’s  
mass-to-charge ratio (m/z) via a mass spectrometer (MS) instrument. In 1913, J.J. 
Thompson separated the isotopes 20Ne and 22Ne of neon, and is considered the 
inventor of the technique.109 The historical impact of MS cannot be over-stated; its 
underlying principles played a crucial role in World War II and the invention of the 
atomic bomb, as it was used to separate the isotopes 235U and 238U of uranium.110 It has 
recently crept into popular culture via popular television shows such as CSI and the Big 
Bang Theory. Its utility is recognized from the fact that it in use today on the MARS 
Curiosity rover for analyzing gas and solid samples for evidence of life.111  
 
2.2 – Ion Sources 
 
Since the MS measures a mass per charge ratio, the molecule must be ionized in 
order to be detected. Therefore, ion sources are sine qua non to mass spectrometry. 
Electron impact or ionization (EI), invented by Dempster in 1918, is the oldest method 
still in use today, most often coupled to a GC.112 The 70eV electron energy used in EI 
produces a de Broglie wavelength close to that of an organic bond (0.14nm). This 
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causes many fragmentations and is thus referred   to  as   a   “hard”   ionization   technique.  
Alternatively, chemical ionization is a soft ionization technique and was created in 1966 
by Munson and Field as an alternative to EI.113 It is an ion molecule reaction, a result of 
high impact electrons ionizing a reagent gas, typically methane, ammonia, or isobutene, 
ultimately forming a plasma medium conducive for proton transfer to the neutral 
molecule. As a soft ionization technique, the parent ion peaks are usually visible. 
 
2.3 – Electrospray Ionization (ESI) 
 
The technique, electrospray ionization (ESI), was invented by Fenn in 1984 and 
subsequently won him the Nobel Prize in Chemistry in 2002.114,115 It is the most 
common and popular ionization technique due its ease of coupling with other 
techniques (such as LC-MS),  its  “soft”  ionization  nature,  high  sensitivity,  and  access  to  
multiple charge states, effectively extending the mass range of the instrument.116,117,118  
 
2.3.1 – Charged Droplet Formation 
 
In essence, ESI transfers ions formed in solution to the gas-phase, intact. The 
exact mechanism of how it achieves this remains controversial.117 The first step is 
production of charged droplets (with the use of nitrogen to aid in the nebulization) by 
applying a potential difference of 2-6 kV between the capillary and a counter electrode 
to produce an electric field. The field, when in positive mode, induces the positive 
charges to migrate towards the tip of the needle and meniscus of the droplet, while the 
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negative charges drift away from the surface. The Coulombic repulsion eventually 
overcomes the surface tension of the liquid, forming the Taylor cone and a fine mist of 
small, charged droplets.114 The droplet continues evaporation via the sheath gas 
(nitrogen) and a heated capillary, shown in Figure 29, until the gas-phase ion exists.  
 
 
 
 
 
 
 
 
 
The process from parent droplet produced from the Taylor cone to the precursor  
of the gas-phase ion including the time between fissions, droplet size, and number of 
charges is shown in Figure 30. The parent droplets, when produced at low flow rates 
(<5PL/min), yield an average droplet size of 1.5 Pm, with approximately 60,000 singly 
charged ions.119 The Coulombic repulsion of the charged particles, trying to maximize 
the distance between charges, is countered by the attractive force of the solvent surface 
tension. As evaporation continues, the charge density becomes greater, until a 
Coulombic explosion/fission occurs, producing smaller droplets. These daughter 
droplets contain 2% of the mass and 15% of the charge of the original parent droplet, 
hence they have much more charge density than before fission.120 This process is 
Figure 29. Schematic of the ESI source.119 
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repeated until a small charged droplet is left, i.e., the precursor of the gas-phase ion 
(Figure 30).119 
 
2.3.2 – Charged Residue Model 
 
The exact mechanism of how the charged droplets ultimately become gas-phase 
molecules is a matter of controversy.121 Dole proposed the charged residue model 
Figure 30. The process from large, parent ion, to the smaller charged droplets, which are precursors to 
the gas-phase ions. Only the first three fissions are shown. The time between fissions, droplet radii, and 
the number of estimated charge ions are given. The onset displays the shape of the droplet as fission 
occurs.119  
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(CRM) where Coulombic repulsions and Rayleigh instabilities are the dominating force 
producing gas-phase ions.122 As the parent droplet forms and is released from the 
Taylor cone, solvent evaporation, continues, decreasing the radius of the droplet in the 
process. At some radius, the Coulombic repulsions of the surface charges will equal the 
force from the surface tension of the liquid. This is termed the Rayleigh limit and may be 
calculated from equation (2). 
 
 
𝑞 = 8𝜋(𝜀଴γ𝑅ଷ)ଵ/ଶ 
 
 
where H0 is the permittivity of vacuum, R is the radius of the droplet, and Jis the surface 
tension of the liquid.123 These daughter droplets then repeat the process and decluster 
until a charged droplet 
with a single analyte is 
left.  Final desolvation 
transfers the charge to 
the analyte. 124 Figure 31 
illustrates the CRM 
schematically.125 
Evidence suggests the 
CRM dominates with larger molecules.126,124  
 
2.3.3 – Ion Evaporation Model 
 
(1) 
Figure 31. Schematic of the Charged Reside Model.125 
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 The second theory was developed by Iribarne and Thompson and is called the 
ion evaporation method (IEM).127,128 The authors theorize after a number of Coulombic 
fissions, droplets of the correct radii (10-20 nm) possess enough energy to overcome 
the surface tension and are ejected from the droplet. Thus, unlike the CRM, the droplets 
do not reach a point where containment of a single ion is necessary. The authors 
suggest a rate constant for ion emission may be calculated from the following formula: 
 
𝑘ଵ =
௞್்
௛   𝑒   ቀ−
∆ீ∓
ோ் ቁ   
 
 
where kb is the Boltzmann constant, T is the temperature of the droplet, h is  Planck’s  
constant, and 'G≠ is free energy of activation. Figure 32 displays the IEM 
schematically.125 Evidence suggests that the ionization of small molecules are 
dominated by the IEM process.129,130  
 
 
 
Figure 32. Ion Evaporation Model.125 
(2) 
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2.4 – Mass Analyzers 
 
 
The mass analyzer is the heart of the MS, as it separates the ions based on the 
m/z. There are a number of methods to separate the ions and various instruments have 
been built to do so, each with a its advantages and disadvantages, as shown in Table 
2.131,132 
 
Of all the analyzers, the quadrupole MS is the most popular due to the small footprint, 
low maintenance, general robustness, and low cost.133 Many of the analyzers are 
combined for enhanced functionality. For example, coupling of two quadrupoles and an 
RF quadrupole only forms a triple quad (TQ), and allows for MS/MS and specialized 
experiments, such as neutral ion loss, and product and precursor ion scan, as well as 
increased sensitivity with selected (single) ion monitoring.134,133 More recently, the TQ 
has in turn been coupled to a 2D linear ion trap, which itself has been coupled to time-
of-flight (TOF), and an Fourier transform ion cyclotron resonance (FT-ICR),135 each of 
which can access different features of the technique. For gas-phase ion-molecule 
Table 2. Mass spectrometer types.131, 132 
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reactions, however, ion-trap MS analyzers is the instrument of choice since they can 
trap an ion for enough time to allow reactions to occur.    
 
 
 
2.4.1 – Quadrupole Ion Trap (QIT) Mass Analyzers 
 
 
 
 
The quadrupole ion trap (QIT), also known as a 3D ion trap, was first conceived 
by Wolfgang Paul and H. Steinwedel in the 1950s,136,137 a conception that won Paul the 
Nobel Prize for Physics in 1989, along with Hans Dehmelt.138 Its advantages, aside from 
the ability to monitor ion-molecule reactions, include a small footprint, high sensitivity, 
high resolution (at slow scan speeds), and perhaps most popular, the ability to perform 
multiple stages of MS (MSn).132  
 
2.4.1.1 – Mass Selection Detection and Storage 
 
 
The initial use of the trap was rather limited, mainly as an ion storage device, 
using the mass-selective mode of detection, where the ions of stable trajectory increase 
the inductive load of the system. The ions may then be detected by monitoring the 
power requirements. Fischer used the instrument as a mass spectrometer to obtain a 
crude mass spectra of krypton,139 while Dehmelt and Major used the instrument as an 
ion storage device for spectroscopy.140 
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In the late 1960s, the mass-selective storage mode was invented by Dawson and 
Whetten.141 This mode operates similar to a quadrupole MS, operating in a stability 
region where single ions only are stable, with all other falling into the sides of the ion 
trap. The ion may be ejected and detected by an external detector, greatly enhancing 
the performance of the instrument. 
 
2.4.1.2 – Mass Selective Ejection 
 
 
In the early 1980s, two watershed moments in the history of ion traps occurred 
that brought them out of the niche market of academia and into the mainstream. The 
first was invention of the mass-selective ejection mode by Stafford and others at 
Finnigan.142 This allowed the instrument to act as an ion trap and trap a large range of 
ions then sequentially eject them out of the trap to an external detector. The second 
was the serendipitous discovery that He gas at approximately 1 mtorr increases 
instrument performance (resolution and sensitivity).143 This was discovered when trying 
to interface an ion trap to a GC. Figure 33 displays the effect of helium on the resolution 
and sensitivity. Since then, many 
advances have been made in the 
field, including extension of the 
mass range via axial 
modulation,144 high resolution 
(30,000 FWHM) by decreasing 
the scan speed,145 and multi-
Figure 33. Effect of He on resolution and sensitivity.143 
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stage MSn.146 A new linear ion-trap has also recently been developed that increases the 
ion capacity and trapping efficiency relative to the 3D ion trap.147  
 
2.5 – Ion Trap Theory 
 
QIT are dynamic mass analyzers as opposed to static analyzers such as the 
sectors. QITs use dynamic fields via radio frequency (RF) and direct current (DC) 
potentials to create a quadrupole field and a potential well to trap ions. The following 
sections briefly describe the theory of operation. 
 
 
2.5.1 – Ion Trap Construction 
 
An ion trap mass analyzer consists of a hyperboloidal ring electrode surrounded 
by two hyperboloidal-shaped end caps (Figure 34), and 
is roughly the size of a tennis ball.148,149 One of the end 
caps contains a hole that allows ions to pass through, 
while the other end cap contains multiple holes forming 
a circle to allow the ions to pass out of the trap and to 
the detector. This axis is defined as z-axis. Application 
of an rf voltage to the ring electrode, called the 
fundamental rf, usually in the MHz range, produces a 
quadrupole field, which confines the ions inside the Figure 34. Ion trap with ring and end cap electrodes148 
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trap.  
 
2.5.2 – Motion of Ions in a Quadrupole Field 
 
 
The quadrupole field is defined by the geometry of the trap, specifically the ratio 
of r0 to z0 as shown in Figure 35. The ideal ratio is given by the following formula: 
 
r02 = 2z02 
 
where r0 to z0 are defined in Figure 35. The majority 
of ion traps on the market employ a r0 of 1.00 or 
0.707 cm.150 Knight suggested that the ideal ratio 
did not have to be 2,151 and in fact, manufacturers 
have  been  utilizing  a   “stretch”   design.  The  Thermo  
LCQ used in this work is built with r0 = 0.707 cm and 
z0 = 0.785 cm, a 57% increase.150   
 
Ions in a quadrupole field are guided to the center of the trap due to a strong, 
linear restoring force as the ions deviate from the 
center. Application of an rf potential to the ring 
electrode and a dc potential applied to the 
endcaps produces the quadrupole field, shown in 
Figure 36. An ion will be focused to the center of 
Figure 35. Cross section ideal trap150 
Figure 36. Example of a pure 
quadrupole field.150 
(4) 
58 
 
the trap where it will fall towards the y-axis. Rotation of the field about the z-axis at the 
correct frequency will refocus the ion to the center. Helium gas acts as a buffer gas to 
focus the ions towards the center of the trap and helps to thermalize the ions. The 
equation for the strength of the field is given by the following formula: 
 
Φ(𝑟, 𝑧) =    ௎ି௏ ୡ୭ୱఠ௧ଶ   ቀ
௥మିଶ௭మ
௥బమ
ቁ +  ௎ି௏ ୡ୭ୱఠ௧ଶ  
 
where U is the amplitude of the dc potential, V is the amplitude of the rf, Zis the angular 
frequency of the rf potential, and r0 is the radius of the ring electrode.149 The quadrupole 
field creates a pseudo-potential well in which the ions are trapped. The deeper the 
depth of the well, the more efficient the trapping and the more kinetic energy required to 
force an ion out of the well. Ions with the lowest m/z are trapped deeper in the well. 
 
Accounting for the stretched geometry, the motion of the ions in a quadrupole 
field are governed by solutions to the Mathieu equations: 
  
 
 
where 𝑎௭  and   𝑞௭  are stability parameters, : is the angular frequency in rad s-1, 𝑒 is the 
electric charge, and 𝑚  is the mass of the ion.150 Plotting solutions to the Mathieu 
equations, one obtains a stability diagram shown in Figure 37. 
(5) 
(6) 
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The portion in blue represents the region where the ions are stable in the axial (z) 
direction (the axis in which the ions are injected and ejected). The portion in orange 
represents the stable region in the radial (r) direction. Where the regions overlap, the 
portion in green, is where ions are stable in the trap. There are other stability regions 
not displayed in Figure 37, which is an area of on-going research.152 
 
The trapped ions oscillate at a characteristic frequency for each ion of a given 
m/z, known as the secular frequency, in both the axial and radial direction. The 
frequencies are given by140 
Zr = Er:/2  Zz = Ez:/2 
where E is: 
Figure 37. Stability diagram with az as the y-axis and qz as the x-axis.143 
(7) 
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𝛽   ≈   ට𝑎௭ +  
௤೥మ
ଶ  
 
Simulations were run on ion trajectories and graphed with the results shown in Figure 
38, along with a photomicrograph of an aluminum ion in orbit of an ion trap. The ion 
motion is typically described as/by a Lissajous curve. It has similar topology to the 
quadrupole field. Ions with a smaller m/z are more focused towards the center of the 
trap, followed by successively larger ions of m/z, much like a layer of onions.  
 
2.6 – Ion Ejection  
 
The mass-selection ejection mode was an important discovery in the history of 
the ion trap, second only to its discovery. It allowed a wide range of ions to be trapped, 
then ejected sequentially and detected. In essence, it allowed an ion trap to function as 
its namesake.  
Figure 38. Simulated ion motion in an ion trap (left),140 photomicrograph of single charged ion of Al.140  
(8) 
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2.6.1 – Mass-Selective Instability 
 
 
Most modern spectrometers operate with an rf potential applied to the ring 
electrode only and no dc potential applied to the electrodes, which reduces the 𝑎௭ term 
to 0. From Figure 37 it can be seen that stability in the axial direction is obtained only to 
where qz equals 0.908. After this value, ions are not stable along the z-axis and are thus 
ejected from the trap through the holes in the endcap. This value is known as qeject.  
 
To obtain a mass spectrum of a range of ions, the amplitude of the rf potential is 
increased,  which   in  turn,   increases  each  ion’s  qz value until it reaches 0.908, at which 
point the ion is ejected from the trap, with ions of smaller m/z ejected first, followed by 
the larger m/z ions. This technique is often referred to as the mass-selective instability 
mode (or scan). Figure 39 displays an example of three ions of different m/z and the 
effect of increasing the amplitude of the rf on the position on the stability line. 
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The exclusion limit in Figure 39 is a drawback of the trap technology as the ion 
trap has a low mass cut off (LMCO), below which no ions will be retained in the trap. 
The LMCO is given by the following formula: 
 
𝑚 𝑧௠௜௡ൗ =   4.44𝑉/(𝑟଴
ଶΩଶ) 
 
where V is the amplitude of the rf potential applied to the ring electrode, Ω is the angular 
frequency of the rf potential, and 𝑟଴ is the inscribed radius of the ring electrode.153 
 
(9) 
Figure 39. Effect of increasing the amplitude of the rf on three ions of different m/z.149 
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2.6.2 – Resonance Ejection  
 
 Since ions possess a secular frequency in both the axial and radial dimensions, 
application  of  a   “tickle   voltage”,  a   small   potential   (hundreds  mV)   to   the  end  caps  can  
excite the ions and impart more kinetic energy to them. The helium reduces the ions 
kinetic   energy   to   approximately   0.1eV.   Excitation   at   an   ion’s   secular   resonance  
frequency, aided by the trapping field, can increase the kinetic energy of an ion to tens 
of eV.150 When  this  is  applied  to  an  ion’s  axial  secular  frequency,   in conjunction with an 
increase in the amplitude of the rf potential, ions may be ejected axially to the detector. 
This is referred to as resonance ejection or axial modulation, and has the added benefit 
of increasing the mass range of the ion trap. Figure 40 shows the same ions as in 
Figure 39 except with a resonance frequency applied. This creates a hole in the stability 
diagram so ions of higher m/z may be accessed since the qeject is now 0.227, an 
increase of 4 for this mass range. Used in conjunction with other methods and 
modifications, the mass range may be extended by a factor of 960.144 This method also 
greatly enhances the resolution of ions.148 
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2.7 – Resonance Excitation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The previous technique of resonance excitation to impart kinetic energy may be 
utilized to perform a number of other useful applications. For example, ion isolation may 
occur by ejecting unwanted ions from the trap, isolating an ion or range of ions by way 
of applying a broadband set of frequencies;154 the increase in kinetic energy may 
promote endothermic ion-molecule reactions, or bring the ion closer to a detector for an 
image current, thus allowing nondestructive measurements;150 aside from ion ejection, 
the next most popular use of resonance ionization is to impart enough kinetic energy to 
activate the ion to high enough energies to cause fragmentation via collisional induced 
dissociation (CID). 
Figure 40. Effect of resonance ejection to access higher mass range.149 
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2.7.1 – Collision Induced Dissociation (CID) 
 
 Ions may be resonantly activated and induced to fragment providing valuable 
structural information in the process. Different instruments activate ions differently and 
thus confer different advantages and disadvantages. One apparent requirement would 
be a trap or a tandem MS; however, a single quadrupole could be induced to fragment 
ions in-source, in the tube lens region, shown in Figure 41.119 By increasing the capillary 
voltage, the ions will be accelerated through the high-pressure region where they will 
collide with atmospheric molecules and fragment. There is no separation, but coupling 
with an HPLC for the separation followed by in-source fragmentation could provide 
structural information; the caveat – the integrity of the MS data is reliant upon the 
separation of the LC method. Regardless, of the MS used, the ion source conditions 
need to be optimized to prevent in-source fragmentation. 
 
Figure 41. Schematic of an ion trap MS, displaying the tube lens region where ion fragmentation may 
occur.119 
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Collision induced dissociation (CID), also referred to as collision activated 
dissociation (CAD), is the most popular method for ion activation and fragmentation.155 
TQMS and IT both use CID and via a neutral gas to induce fragmentation of an ion, 
usually argon for a TQMS and nitrogen for an IT. For a TQMS, fragmentation occurs in 
space;;   the   “precursor”   ions   are   isolated   in   the   first   quad  and   ejected   into   the   second  
where the ions undergo collisions  with  the  gas  and  fragment,  producing  “daughter”  ions.  
The daughter ions are ejected and guided in the third quadrupole to the detector.  
 
The disadvantage of this method is the lack of control for energy deposition. The 
ions enter the second quadrupole with a narrow range of energies, undergo inelastic 
collisions where some of the kinetic energy is transferred to internal energy 
(predominately vibrational, but others are possible if the energy is high enough)156 and 
upon fragmentation, impart some energy to the fragmented ions where they can 
undergo further fragmentation. Therefore, it may be unclear as to the origin of the peaks 
in the mass spectra, whether they arise from the product peaks, or are fragments of the 
product peaks.  
 
Alternatively, the method in which the IT induces CID imparts a significant 
advantage over activation using the TQMS – more control of the energy imparted to an 
ion, which may be calculated from the following formula: 
 
Eint = Ekin mtarget/(mion + mtarget)  
 
(10) 
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where mion is the mass of the ion and mtarget is the mass of the neutral gas molecule. Ion 
activation  in  an  IT  takes  advantage  of  the  ion’s  secular  frequency  (axial).  A  small  tickle  
voltage,   is   applied   to   the   end   caps.   At   the   correct   frequency,   the   ion’s   secular  
frequency, the ion gains enough kinetic energy to perturb the usual motion from the 
center of the trap. Recall, the restoring effect to an ion as it deviates from the center of 
the quadrupole field.  This force imparts more kinetic energy to the ion whereupon it 
collides with the helium bath gas at 1 mtorr. Continued collision with the gas eventually 
leads to ion fragmentation, at which time the product ions are cooled via the helium gas, 
since the newly formed ions are out of resonance with the applied resonance frequency 
they cannot undergo further fragmentation.  
 
The amount of kinetic energy imparted to the ion may be controlled by varying 
the voltage (< 1V zero-to-peak), or activation time (10-100ms).157 The resonance 
frequency acts as a kick-start for the ion, with the quadrupole field and helium gas 
providing additional energy for fragmentation. The one negative aspect to trapped ion 
fragmentation is the lower limit of trapping, or the low mass cut-off (LMCO, equation 8). 
Adjusting the qz value allows for some flexibility in moving this limit.158 
 
2.8 – Scan Speed 
 
 
Another unique feature of the trapping instruments is the use of variable scan 
speed to access higher resolutions. Mass resolution in trapping instruments is a function 
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of the time an ion spends interacting with the rf field. The resolution may be calculated 
from the following formula: 
 
R = N2/Kk 
 
 
where R is the resolution, N is the number of rf cycles and K1 is 20 for the first stability 
region.159 The theoretical basis for this was originally proposed by Fischer in 1959.160 
He argued to increase resolution, the amplitude of the auxiliary field should be 
minimized, thus maximizing the interaction time between the ions and the rf field; 
alternatively, the scan speed may be varied to achieve the same result. 
 
 Ions are ejected from the trap by ramping up the rf amplitude of the ring electrode 
until the ions have reached enough energy for ejection. If this rate is too fast, the next 
ion will be activated before the previous ion has been ejected, manifesting itself as a 
loss in resolution. Utilizing the techniques of resonance ejection and mass-selective 
instability modes, a slow scan speed (27.8 amu s-1) and the minimization of the auxiliary 
field, a resolution in excess of 30,000 full width half max, (FWHM) was achieved for m/z 
of 502.145 As a point of reference, the normal scan speed, 5500 amu s-1, yields 
resolutions of 4000.118  
 
 When scanning at slow speeds (280 amu s-1), referred to as zoom scan, a 
narrower range of masses must be scanned. Alternatively, the scan speed may be 
increased (55,000 amu s-1), called turbo scan, at a loss of resolution. Normally, this is 
employed to increase the number of scans across a chromatographic peak, but it may 
(11) 
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also be used to decrease the time from the ion trap to the detector, increasing signal of 
weakly coordinated ions.  
 
2.9 – Conclusion  
 
 
 Mass spectrometry is a powerful tool that allows the one to study molecules in 
the gas-phase, deducing structure by the mass to charge ratio. The Nobel-Prize winning 
technique of ESI developed by Fenn, allows the transfer of ions in the solution phase to 
the gas-phase intact. Due to the work of many people, the ion trap mass spectrometer, 
previously a tool mainly for physicists has become indispensible for the modern 
scientist. The techniques of resonance excitation, mass-selective instability mode of ion 
ejection, CID, and many other methods, provide the chemist many tools from which to 
draw upon for their unique interests and research.  
 
 The   QIT’s   ability   to   trap   ions,   offers   the   distinct   ability   to   create   and   monitor  
chemical reactions. The ability to isolate an ion of a desired m/z in the presence of a 
complex matrix, could allow for screening of multiple catalysts present in a crude 
mixture. In addition, the helium gas, necessary for optimal performance of the 
instrument and unique to QIT mass spectrometers, allows for the possibility of 
introducing a neutral reagent to the trap, where upon it may react with the ion 
introduced via ESI. This would allow for the possibility of a rapid, chiral screening 
method.  
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The nature of mass spectrometry, i.e., gas-phase, presents the unique 
opportunity to study inherently unstable or reactive intermediates not possible in the 
condensed phase. The lack of solvent, counter ions, and aggregation phenomena 
enable   the   catalyst’s   native   potential   to   be   probed.   The   true   chiral environment of a 
catalyst may then be accessed and studied, potentially gaining insight into the common 
template that drives C2-symmetric   catalysts   towards   excellent   ee’s   over   a   range   of  
reactions. The next chapter will detail ion-molecule reactions in the gas-phase, 
modifications to the instruments to provide said facility, and methods for determining 
enantioselectivity. 
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Chapter 3 – Gas-Phase Ion-Molecule (IM) Reactions and Enantioselectivity in 
Mass Spectrometry 
 
 
 
3.1 – Gas-Phase Reactions and Mass Spectrometry 
 
 
 MS offers unique abilities to aid in the study of ion-molecule (IM) reactions. Since 
MS operates in the gas phase, it can offer insight into structures, intermediates, and 
mechanisms that are not accessible via traditional condensed phase methods. The low 
pressures required for operation of an MS, desolvates most solvated-catalysts. Hence, 
the  catalyst’s  intrinsic  nature  is  accessible,  free  from  solvent  effects,  as  well  as  any  ion-
pairing/aggregation phenomena.  
 
The low pressure also increases the time between collisions, allowing for the 
study of reactive species/intermediates, assuming a trapping MS is used. According to 
Ottens et al., with a trapping parameter qz of 0.25 (the default), the average velocity of 
an ion is 7m/ms. At a pressure of 7 x 10-6 torr, this corresponds to a mean free path of 
7m, resulting in a collision every ms, allowing for numerous, potential reactions within 
the  instrument’s  time-frame.161 
 
The soft nature of ESI, in conjunction with the pre-formed charge on the metal 
catalyst, allows for the successful transfer of the catalyst from solution to the gas-phase, 
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intact. With the introduction of the ion via ESI, the neutral molecule may be introduced 
into the instrument several of ways, discussed later, or may be present in the 
background. While MS operates at low pressure, there is typically a series of stages of 
differential pressures before the mass analyzer. Thus, the ions are still exposed to 
neutrals/excipients as they transverse through the instrument. This mainly occurs in the 
tube lens region, where the pressure is still relatively high, approximately 1 torr (1.3 torr 
for a Thermo Deca QIT), as ions are still undergoing desolvation on the way to the 
octapole ion guide, and ultimately the mass analyzer.   
  
3.1.1 – History and Instrumentation 
 
 
 Thompson first proposed the idea of gas-phase reactions in a MS in 1913,109 
while Dempster confirmed the existence of ion-molecule (IM) reactions in 1916 involving 
H2+ and H2.162 In 1966, Munson and Field utilized IM reactions in a magnetic deflection 
MS to develop chemical ionization (CI), representing an alternative to EI as a source 
ionization mechanism for molecules.113 It represents the most common application to 
ion-molecule reactions and an area where much of the research was conducted, 
searching for more selective CI reagents.163 
 
Since then, technology and instrumentation has allowed for more controlled and 
refined IM reactions that could be performed with the instruments of the time. With the 
advent of the triple quad (TQ) by Yost in 1978,134 separation in-space was feasible, 
allowing for the study of structures of reactant and product ions,164,165,166,163 and ion-
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molecule reactions inside the collision cell.167,168,169 The flowing-afterglow,170 and its 
closely related sibling, the selected ion flow tube (SIFT),171,172 allowed for the study of 
the rate constants of IM reactions,173,174 bond strengths,175 H/D exchange,176 proton 
affinities,177,163 gas-phase basicity, and clustering equilibria.178,179 Flowing afterglow and 
high-pressure mass spectrometry were among the first instruments used for ion-
molecule experiments, along with the ICR. Newer techniques such as 2D separations 
with ion mobility, has further expanded the abilities of the IM as an analytical tool.180 
However, many of these techniques used direct insertion probes or EI/CI as a means 
for ionization, which are not favorable conditions for fragile organometallic complexes.     
 
3.1.2 – ESI and Organometallic Chemistry 
 
 
Due to John Fenn,114 the ESI method was developed, and it opened up new 
areas of research for organometallic chemists, as the facile nature of transferring the 
metal ion from solution to gas phase by ESI is ideally suited for organometallic studies. 
Previous methods of ionization were not amenable to transition metal complexes due to 
the low volatility, thermal liability and redox nature of the metal complex.181,182 ESI was a 
technique that addressed these obstacles. In 1990, Chait et al, successfully 
electrosprayed a solution of [Ru(II)(bpy)3]Cl2, and performed CID to remove the 
acetonitrile adducts from the complex, thus demonstrating the applicability of ESI and 
CID for studying organometallic complexes (Figure 42).181  
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In 1994, the first proof of an organometallic intermediate for the Suzuki reaction 
was obtained using a TQMS and ESI by Aliprantis and Canary. In order to detect the 
intermediates, pyridine was used in place of the aryl halide substituent, thus, providing a 
means for protonation and detection as the pyridinium salt, [(pyH)Pd(PhP3)2Br]+ in the 
catalytic cycle. Intermediates I and II in Figure 43 were observed in the mass spectrum, 
providing proof of the Sukuzi mechanism.  Although these examples are not true gas-
phase ion molecule reactions, they displayed the potential of ESI for elucidating 
organometallic mechanisms and intermediates, previously limited by ionization 
techniques.  
 
 
 
Figure 42. First electrosprayed transition metal 
organometallic compound, Ru(II)(bpy)3Cl2.181 
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3.2 – Trapping Instruments for Gas-Phase Chemistry 
 
Trapping instruments include the ICR (and FT variants) and the 3D and linear 
(2D) ion traps,147 and the newest MS, the hybrid 2D-orbitrap (orbitrap).183 ICRs were 
used to study kinetics184,185 and were the first instruments used to study 
inorganic/organometallic compounds, Fe(CO)5.186 More recently, the newer orbitraps 
have been modified using the Gronert method, discussed later, to study the Diels 
Alder,187 and Heck reaction.188 
 
The first recorded observation of a gas-phase reaction in an ion trap was by 
Rettinghaus in 1967, when he monitored the formation of COH+ from CO+ and 
Figure 43. Catalytic cycle of the Suzuki mechanism with the pyridine-substituted aryl halide. 
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hydrocarbons present in the background (Figure 44).189 Prior to commercialization 
around 1984, the field of ion traps was 
dominated by the labs of Todd and 
March, where their pioneering work in ion 
ejection methods,190,191,192 ion injection,193 
and ion kinetic/energetics laid the 
groundwork for the ability to study ion-
molecule reactions in the trap.194,195,196  
 
Since the commercialization of ITMS instruments, they have been utilized in 
diverse fields of research, spanning disciplines of organic, inorganic, biochemistry, 
astrochemistry, and quantum mechanics. Typical applications range from ion structure 
elucidation,150,197 mechanistic studies,198,199,200 thermodynamic and kinetic 
studies,201,202,203,204 to  the  common  “omics” – proteomics,205,206,207 metabolomics,208 and 
lipidomics.209 Recently, more exotic applications have been found. For example, NASA 
developed a portable QITMS for analysis of cryogenic leaks prior to space shuttle 
launches.210,161 The ion-trap technology was used to develop an atomic clock accurate 
to the 17th decimal,211 and is currently being investigated for use in quantum 
computers.212 
 
Its popularity stems from its versatility, as it combines many attributes of separate 
mass analyzers into one instrument, i.e., no coupling of analyzers is needed. Together 
with   ESI,   the   QIT   has   been   described   as   a   “complete   gas-phase chemical 
Figure 44. First ion-molecule reaction recorded in an 
an ion trap. From March and Todd.189  
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laboratory,”200 by  O’Hair,  a  modification  of  the  title  of  Beynon’s  book, The Modern Mass 
Spectrometer – A Complete Chemical Laboratory.213 The  “laboratory”  offers   the  ability  
to control the time allowed for the reaction by modifying the trapping time. Similarly, 
using the secular frequency of the ion and resonance excitation, extra energy may be 
deposited to the ion for endothermic reactions,150,214  or fragmentation of ions to access 
unique structures/chemistry.215,216,217 QITs can also isolate an ion of single m/z or a 
range of m/z, alleviating the need for a pure sample, assuming the absence of isobaric 
species. Structure elucidation of resultant products are possible with MSn capabilities, 
and if an FTICR is used, high-resolution is also available as a tool,163 or alternatively, 
variable scan speeds, such as zoom scan, can increase resolution in a 3D trap.132 
Finally, the addition of helium as a bath gas thermalizes the ions, allowing for kinetic 
studies.218  
 
 
3.3 – Neutral Reagent Introduction 
 
With the advent of ESI, a soft introduction of an organometallic compound, such 
as a catalyst, was possible. The ion trap allows a vessel for the reaction to occur, but a 
method is needed to introduce a substrate into the reaction. 
 
3.3.1 – Introduction of Neutral Reagent via Solution Phase 
 
 Introduction of the neutral molecule to the mass analyzer may occur via solution 
or the gas-phase. Solution-phase introduction typically infuses a mix of the ion and 
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neutral molecule directly into the instrument, as was the case for the Suzuki example 
shown in Figure 43. Technically, this could also apply to a solid sample prepared in the 
appropriate matrix. The ion and neutral are then allowed to react in-situ and are 
transferred from the condensed phase to the gas-phase. This has the appeal of 
simplicity, as no instrument modifications are required, and near universal compatibility 
with the majority of ion sources. It may also potentially allow for the study of the ion-
molecule complex as it exists in its native environment – that is, the mass spectrum 
should be representative of the solution-phase complex (assuming single stage MS),219 
although, this remains a controversial topic and an area of intense research.220 
 
The solution introduction method assumes there is no change to the complex 
upon ionization/desolvation to the gas phase. Desolvation is a highly endothermic 
process. The endothermic nature of desolvation is evident in the feeling of a cooled 
flask, and the visual of a frosted receiving flask when rotovapping a solution. The free 
energy of desolvation for a sodium ion is shown below:221 
 
Na+ (aq) Æ Na+ (g) 
-'G°sol = 98 kcal/mol 
 
This is same amount of energy required to break a carbon-hydrogen bond and more 
than what is required to break a carbon-carbon bond (83-85 kcal/mol).222 This fact is 
testimony   to   the   “softness”   of   ESI   as   it   delivers   intact   ions.   Since  many   ion-molecule 
reactions involve weak intermolecular forces, such as S-cation ('H = 19.3 kcal/mol for 
NH4+ - benzene),223 or hydrogen bonds ('G = 1.67 kcal/mol S—H….S, 5.25 kcal/mol O—
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H….O),224 this can call into question the effect of the ionization process on the ion-
molecule complex.  
 
 Many studies have attempted to answer this question, with differing results. 
Wang and Agnes studied the labile equilibrium of strontium with EDTA  
(Sr2+ + EDTA4-           Sr-EDTA2-) and found negligible differences between the 
measured equilibrium via the MS and the solution phase equilibrium.225 Similarly, Leize 
et al. came to the same conclusion using metal alkali cations in competition with 
cryptate 222 and crown ether 18C6.226    
 
 However,  Tureček  and  Gatlin,  provided  contradictory  evidence  when  studying  the  
dissociations of Fe2+(bpy)3 and Ni2+(bpy)3 complexes.227 They found higher dissociation 
equilibrium constants in gas-phase ESI-MS than the expected solution-based 
calculations predicted. The authors attribute this to the ESI process, specifically the 
iterative droplet evaporations with concomitant increase of H3O+ formation from the 
electrostatic field, localized near the surface of the liquid.228 Thus, the gas-phase pH 
with the ion-complex of interest is different than the original bulk solution pH, shifting the 
equilibrium.227  
 
This also highlights the precarious nature of solution-based methods for 
introduction of the complex. As each system is different, the acid/base nature of each 
system may dictate the accuracy of the data, and thus, not be reflective of the inherent 
characteristics of interest. As such, considerations must also be made for matrix 
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components and effects. Linder et al. found evidence of such matrix effects in the 
transfer to the gas-phase when studying diastereomers.229 It is therefore desirable for 
an alternative method for introduction of a neutral molecule to the MS. 
 
3.2.2 – Introduction of Neutral Reagent via Gas-Phase 
 
Introduction of the neutral reagent to the trap via gas-phase (after ion isolation) 
offers significant advantages over the solution-phase alternative. First, the question of 
the  source’s   impact   is   immaterial  (assuming  the  ion  has  not  undergone  transformation  
in the process). Second, ion-isolation followed by multi-stage MS allows for 
manipulation of the ion, allowing access to more possible reactive species (see next 
section). And third, ion-molecule chemistry may be allowed to occur under carefully 
controlled conditions. For example, time, temperature, and pressure, are all variables 
that may be controlled (to a point); however, permanent modification of the instrument is 
required, and trapping MS instruments are typically required. 
 
3.2.2.1 – Introduction via a Valve  
 
The neutral reagent may be pulsed into the trap or introduced at a constant, 
persistent rate. The pulsed introduction method via a pulse valve was first conceived of 
1982,230 and built in 1983 by Freiser and others at Purdue University for use in ICR,231 
and later adapted by Cooks et al. for use in ion traps in 1990.232 Pulsing of the reagent 
utilizes a pulsed valve and necessitates drilling a small hole through the trap for 
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introduction of the reagent. It also requires 
a pulse valve drive controller that 
synchronizes with the ion trap software. 
Figure 45 is a schematic of a Bruker 
Esquire 3000 modified with a pulse valve 
for introduction of a neutral reagent.233 
This set-up offers the advantage that the 
reagent gas is not persistent and thus 
minimizes contamination or interference 
with subsequent operations, but the uncertainty in the pressure does not allow for the 
use in absolute kinetic measurements, although relative measurements of rates can be 
made.198  
 
The alternative to the pulsed methodology is to introduce the reagent at a 
constant flow rate. The advantage over the pulsed methodology is the ability to obtain 
absolute kinetic data, assuming accurate measurements of the pressures are obtained. 
The downside is the constant, persistent presence of the neutral reagent during all 
stages of the experiment, which may introduce complications. For example, if the 
equilibrium between the neutral reagent and ion is on the same time-scale as the ion 
isolation scan, the ion and neutral reagent will coordinate and form a complex with a 
resultant larger m/z than the ion isolation window. Thus, it will be ejected from the trap 
and the signal of the ion of interest will be diminished.  
 
Figure 45. Modified ion trap with pulse valve. Taken 
from Ryzhov.233  
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Alternatively, delivery of the neutral reagent, at a constant flow rate, may utilize a 
leak valve, either directly to the trap,234,235 similar to the pulsed valve set-up previously 
described, or to the ion trap vacuum manifold, with subsequent helium dilution.210,236 
Large errors were initially associated with the pressure determinations, as the pressure 
differential was determined via a manometer and visual inspection before and after the 
leak valve was closed to the trap (evacuated to a pressure of 10-7 torr or less).185 With 
the advent of ion pressure gauges and flow meters, the accuracy has greatly 
improved.237 The use of a calibration reaction with a known rate constant (for example 
CH3I with bromide anion)238 allows for a compensatory factor to be made to allow for 
acquisition of the most accurate data. Figure 46 displays examples of systems utilizing 
leak valves for delivery of a reagent at a constant flow rate.236,210     
 
 
 
 
 
 
 
3.2.2.2 – Introduction via Gas-Phase 
 
 
Figure 46. Schematics for introduction of neutral reagent via leaks valves. Left (a)236 Right (b)210 
a) b) 
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A mass spectrometer must be able to achieve a high vacuum (10-6 – 10-8 torr) 
with this method in order to obtain an accurate determination of the pressure.198 While 
this is not a problem for ICRs that regularly operate at pressures of 10-9-10-10 torr, ITs 
are not capable of meeting this low-pressure requirement. The precision of leak valves 
to deliver small increments of reagent may also bias some kinetic experiments.235 In 
pursuit of addressing these concerns, Gronert developed a method for the constant 
infusion of a reagent to the trap via the in-situ helium line, with a slight modification to 
the internal plumbing.218   
 
This method incorporates a syringe pump (30-300ul/hr) to infuse the neutral 
reagent via a septum port on a custom built manifold, into a helium stream, maintained 
at 1-2 L/min by a mass flow meter. The reagent may be diluted and/or the rate adjusted, 
as needed, to deliver reagent pressures from 10-5 – 10-8 torr. A small portion of the flow 
is directed into the trap, while the majority is diverted to waste. This high dilution is 
necessary due to the low accuracy of the delivery of reagent from syringe pumps at 
lower flow rates.  
 
In order to reduce the lag time of the reagent into the instrument, the internal 
pressure regulator of the instrument is removed. This regulator is used in conjunction 
with a restriction capillary to step the pressure down from the 40 lb/in2 from the helium 
tank to the 3 lb/in2 required of the ion trap. In the absence of the internal regulator, the 3 
psi (above atmospheric pressure ~17.7 psi) is maintained manually via adjustment of 
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the helium tank regulator and a barometer (absolute pressure reader).198 The illustration 
in Figure 47 represents the modified LCQ Deca ion trap. 
 
 
 Ejection of ions from the trap occurs through a series of small pinholes in the end 
cap detector side. These small holes, together with the fact that the mean free path is 
longer than the length of the ion trap, imparts a need to account for the differential 
effusion rates of the gases through the holes; otherwise, the results will be biased 
towards the heavier molecular weight compound. The following equation accounts for 
this differential effusion rate:198 
 
 
Helium 
Barometer 
(3 psi) 
restriction 
capillary to 
LCQ 
Syringe pump 
with 
neutral reagent 
to waste 
heating tape 
 
variac controller 
manifold 
(kept at 150 
mtorr when not 
in use) 
two-way valves 
1 – trap 
2 - vacuum 
Figure 47. Diagram of the modified LCQ ion-trap to allow introduction of a neutral reagent.  
(1) 
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where 1.75 x 10-3 is the pressure inside the trap when 3 psi of helium pressure is 
applied, FR, dR, and MWR are the flow rate, density, and molecular weight of the 
reagent, respectively, and FHe, is the flow rate of the helium (moles/min). 
 
This method of introduction allows for much better control and quantification of 
the neutral reagent than with valve-type methods, offering precisions of ± 5-10%, but 
uncertainties of ± 20-30%.198 This method eliminates the variability associated with ion 
sources and introduction of the neutral through the solution phase. 
 
3.2.2.3 – Laser Desorption 
 
 In some cases, laser desorption may be a suitable option for introduction of 
neutrals into the gas-phase for subsequent reactions. However, this method has not 
been routinely used due to the low yield of neutrals, and, if formed, a short lifetime 
before collisional loss or evacuation via vacuum system.163   
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4 – Mass Spectrometry for Rapid Chiral Recognition 
 
 
 
 The previous chapter discussed mass spectrometry and chiral recognition. This 
section will briefly discuss its use as a rapid chiral screening method.  
 
4.3.1 – Kinetic Resolutions 
 
 
 The majority of rapid mass spectrometry-based methods employ kinetic 
resolution of pseudo-enantiomers, also referred to as quasi-enantiomers (as not to 
offend the crystallographers), to determine enantioselectivity. This method was originally 
developed by Horeau in 1990 to determine the absolute configuration of secondary 
alcohols239 This method incorporates isotopic labeling (Scheme 19).240,241
 
The ee may be calculated by first taking the extent of conversion (c), 
 
𝑐 =
𝑒𝑒௦
𝑒𝑒௦ +  𝑒𝑒௣
 
 
 
Scheme 19. Isotopic labeling of 1-phenylethyl acetate for kinetic resolution in MS. 
(1) 
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where ees is the ee of the substrates and eep is the ee of the products (in this case, 4/5 
/(4/5+ 8/9). The ee (E) may then be calculated:242 
 
𝐸 =   
ln  [(1 − 𝑐)(1 − 𝑒𝑒௦)]
ln  [(1 − 𝑐)൫1 − 𝑒𝑒௣൯]
 
 
 
This method was been adapted to allow for rapid analysis by combining 96-well plates, 
a Water 600 pump, a Gilson 215/889 eight-channel liquid autosampler with a multi-
injector module (20PL loops), eight 
columns (C8 Waters Symmetry 2.1 x 
20mm), and an eight-channel MUX 
ESI system (Figure 48) coupled to a 
Micromass TOF.241 The ESI sprayer is 
control by a rotor, allowing a spectrum 
every 1.2 seconds. One cycle (eight 
samples) takes 70 seconds, thus, a 
96-well plate can be run in 14 
minutes.  
 
 As an alternative to isotopic 
labeling, two different, but closely related, mass-tagged auxiliaries may be 
used.243,244,245  The rates of formation of the diastereomers (quasi-enantiomers) will be 
different and represented in the mass spectra. For example, in the Steglich 
esterification, shown in Scheme 20244 the enantiomer of 1-phenylethanol reacts with the 
acid (A or B). A methyl group, far from the site of reaction, differentiates 
Figure 48. MUX ESI Spray system with eight-channels 
by Micromass.241 
(2) 
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the acids. This allows for discrimination in the MS while not affecting the inherent 
reactivity. Calibrations must be performed to obtain the ionization efficiencies, q, and the 
selectivity factor, s, of the two acids. Preparation of a racemic mix yields the ionization 
efficiencies of the two acids: 
 
q = Imass 1 / Imass 2 
 
Calibration with a known ee for each substrate yields kfast and kslow, from which s may be 
obtained:  
Scheme 20. Kinetic resolution of 1-phenylethanol via the Stiglech reaction utilizing two acids differing in 
mass of 15 (CH3). 
 
(3) 
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s = kfast / kslow 
 
Correcting for the intensity ratio from the formula: 
 
y y q = Imass 1 / Imass 2 
 
where q is derived from the racemic calibration and eq (3), the ee may be calculated 
from the equation:  
 
%𝑒𝑒 =    ൤
(𝑦 − 1)(𝑠 + 1)
(𝑦 + 1)(𝑠 − 1)൨   ×   100 
 
 Thurow et al., adapted HTS, using a HTS-PAL from CTC Analytics AG for liquid-
handling system for a dosing, diluting, injecting and transferring samples from a 96-well 
plate, which the authors state may be adapted to any major LC-MS system, shown in 
Figure 49.243   
 
 
 
 
 
(4) 
(5) 
(6) 
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4.3.2 – Cook’s  Kinetic  Method 
 
 The kinetic method has been used to determine a mixture of amino acids. 
Recalling from last chapter, the rates of the two competing dissociation channels can be 
measured by the fragment ion abundances, reflecting the stability and energy difference 
between the two. The branching ratio for the fragments may be written: 
 
 
𝑅 =    [𝑀
ூூ(𝐴௫)(𝑟𝑒𝑓 ∗) − 𝐻ା]
[𝑀ூூ(𝑟𝑒𝑓∗)ଶ −  𝐻ା]൘  
 
 The degree of chiral recognition may then be written: 
 
𝑅௖௛௜௥௔௟ =
𝑅஽  
𝑅௅
  =   
[𝑀ூூ(𝐴஽)(𝑟𝑒𝑓 ∗) − 𝐻ା]
[𝑀ூூ(𝑟𝑒𝑓∗)ଶ −  𝐻ା]൘
[𝑀ூூ(𝐴௟)(𝑟𝑒𝑓 ∗) − 𝐻ା]
[𝑀ூூ(𝑟𝑒𝑓∗)ଶ −  𝐻ା]൘
 
 
(7) 
(8) 
Figure 49. Setup by Thurow for rapid MS analysis.243 
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The energy difference may be obtained from the following equation: 
 
 
𝑙𝑛𝑅 =   
∆∆𝐺
𝑹𝑇௘௙௙
 
 
 
where R is the gas constant, and Teff is the effective temperature. For a pure 
enantiomer, eq (9) may be used with eq (7) to calculate the energy difference for the 
individual enantiomeric complex:  
 
𝑙𝑛𝑅஽ =   
∆∆𝐺஽
𝑹𝑇௘௙௙
 
 
𝑙𝑛𝑅௅ =   
∆∆𝐺௅
𝑹𝑇௘௙௙
 
 
 For an enantiomeric mixture with an excess of D, the ee may be given as:  
 
∆∆𝐺 =  ∆∆𝐺஽
1 + 𝑒𝑒
2 +  ∆∆𝐺௅
1 − 𝑒𝑒
2  
 
 
=  
[𝐷𝐷𝐺஽ +  ∆∆𝐺௅]
2 +  
[𝐷𝐷𝐺஽ −  ∆∆𝐺௅]
  2   𝑒𝑒 
 
where D and L may be substituted for R and S. By combining equations (8), (9), (10), 
(11), and (12) the ee of the mixture may be delineated from the chiral recognition, R: 
 
𝑙𝑛𝑅 =   
[ln  (𝑅஽) + ln(𝑅௅)]
2 +  ൤
ln  (𝑅௖௛௜௥௔௟)
2 ൨   𝑒𝑒 
 
(9) 
(10) 
(11) 
(12) 
 
(13) 
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With a calibration curve, the ee of unknown samples may be determined. A mixture of 
three amino acids was performed,  resulting  in  ee’s  that  could  be  measured  down  to  2%  
ee with relative errors between 3.0-6.7%.246 While the kinetic method cannot offer the 
HTS that the previous methods could, it does not require expensive specialized 
equipment. Instead, it affords the ability to study multiple samples in one prep 
(assuming equilibrium is achieved), on standard MS equipment. 
 
4.3.3 – Direct Catalyst Screening 
 
 The group of Pfaltz has utilized the kinetic resolution method to screen 
intermediates in the Pd-catalyzed allylic substitution (Tsuji-Trost) and metal-catalyzed 
Diels-Alder reactions utilizing quasi-enantiomeric substrates. The method does not 
require any specialized equipment and is unique among the others methods in that it 
tests the catalysts, not the products. 
   
4.3.3.1 – Pd-Catalyzed Allylic Substitutions 
 
 The mechanism of Pd-catalyzed allylic substitution, the Tsuji-Trost, is shown in 
Scheme 21. Formation of the Pd-intermediate (12 or 13) is fast, while nucleophilic 
addition is rate-limiting, which allows access to the intermediates via MS. In this case, 
16a and 16b (Scheme 22) were used to differentiate the two species in the MS.247  
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Scheme 22. Tsuji-Trost Pd-catalyzed allylic substitution. 
Scheme 21. Allylic ester used in the Pd-catalyzed screening. 
 
 1. ji t t l  ll li  tit ti . 
Scheme 22. Allylic ester used in the Pd-catalyzed screening. 
OBz OBz 
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The selectivity of the catalyst can be determined from the ratio of the rates kA/kB, which 
equals the ratio of the ion abundance 17a/17b. Three catalysts were synthesized and 
screened with the MS. Ligand (20) was found to be the most enantioselective (Scheme 
23).247  
 
 
 
 
The previous methodology was also applied to studying retro-allylic substitution. 
According to the principle of microscopic reversibility, the transition states that govern 
enantioselectivity are the same for the forward and backward reaction. A suitable target 
was found in acetyl acetone, and (21a) and (21b) were used as the quasi-enantiomers 
for the Pd-catalyzed retro-allylic substitution (Scheme 24). 
  
Scheme 23. Mix of ligands to screen Pd catalysts with 16a and 16b, with resultant mass spectrum.247 
 18                              19      20 
18 
19 
20 
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A series of phosphinooxazoline ligands were screened via MS for 
enantioselectivity in the back-reaction. The corresponding condensed phase reactions 
were  performed  and  compared  via  chiral  HPLC;;  the  results  of   the  two  “correlated  very  
well,”248 validating the methodology (Figure 50).247 
 
 
 
 
 
 
 
Scheme 24. Substrates used in the Pd-catalyzed back-reaction study. 
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 An attractive target to further research the back reaction would be the retro-Diels-
Alder, which was pursued by the group of Pfaltz. The retro-Diels Adler reaction is shown 
below in Figure 25, with the quasi-enantiomers (24a) and (24b) chosen for 
discrimination in the MS. Utilizing Lewis acid, Cu(II) Box ligands, the reaction was 
(S )-21b 
(R )-21a 
22a 
22b 
Figure 50. Comparing results from MS via the back reaction, and reaction products via condensed phase 
and chiral HPLC.247 
Scheme 25. Retro-Diels-Alder with the quasi-enantiomers (24a) and (24b). 
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performed at 100 °C, the minimum temperature to induce the retro reaction. After 1 
hour, samples were taken and subjected to MS. Again, excellent agreement was 
obtained between the MS results, and the condensed-phase results based on chiral 
HPLC (Table 3).249 
 
Table 3. Results of ESI-MS screening of BOX Cu(II) catalysts.249 
 
 
ESI-MS 
26a / 26b 
HPLC 
27a / 27b 
Preparative reaction 
endo e.r. 
2-naphthyl 86:14 90:10 88:12 
Ph 80:20 85:15 86:14 
t-Bu 68:32 69:31 64:36 
i-Pro 61:39 58:42 56:44 
benzyl 55:45 51:49 52:48 
 
 
4.4 – Precedence  
 
 
 The method briefly described above has precedence in the literature and is 
based   upon   the   Gronert   group’s   work   with   Mn   Salen   catalysts   with   various   chiral  
alcohols.   As   mentioned   in   Chapter   1,   Mn   Salen   catalysts   (Jacobsen’s   catalyst)   are  
excellent oxygen delivery catalysts, enantioselectivity forming epoxides with olefins. To 
account for the observed stereoselectivity in some conjugated olefins, a radical 
mechanism was theorized (Scheme 26).250 
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 Due to difficulties activating the Mn catalyst in the gas-phase, the radical 
intermediate was not practical. However, using alcohols, the intermediate (28) could be 
mimicked, a hypothesis backed up by DFT calculations. Figure 51 displays the results 
comparing the proposed intermediate (28) in (a) to the ethanol complex.251 The two 
results are remarkably similar, primarily differing in the bond length between the Mn-O, 
where it is longer by 0.4 Å in the ethanol model, implicating weaker bindings and less 
Scheme 26. Radical mechanism for the formation of enantioselective epoxide form olefins. 
(28) 
Figure 51. DFT results comparing the lowest energy conformers for the Mn-salen catalyst complexed 
to (a) yCH2CH2Oy and (b) CH3CH2OH.251 
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steric repulsions in these probes. These results demonstrate the feasibility of probing 
the  catalyst’s  asymmetric environment with simple chiral probes.  
 
Various Mn-salen catalysts were tested for gas-phase enantio-discrimination with 
1-phenylethanol and racemic d5-ring 1-phenylethanol as the chiral probe and internal 
standard, respectively. The results are shown below in Table 4.  
 
Table 4. Results for various Mn-Salen catalysts and their stereoselective preferences for 1-phenylethanol 
in the gas-phase.  
 
 
 
The catalysts displayed a preference for the S enantiomer (Figure 52), which was also 
observed in the condensed-phase kinetic resolution of 1-phenylethanol with  (R,R ) Z = 
t-Bu Mn-salen, however, KBr was necessary as a co-catalyst in the condensed-phase, 
muddying the comparison.252 While the de appears modest compared to the 
condensed-phase, given the lack of an axial ligand, room temperature, and longer Mn-O 
bond length, the de is relatively large.  The larger selectivity observed with the diphenyl 
catalysts (II) was also observed in the condensed-phase epoxidations with styrene,71,251 
lending credence to the hypothesis that these probes can yield information regarding a 
catalysts chiral environment, in a rapid, straightforward manner.   
Ligand KS/R de% 
I (R,R ) Z = C(CH3)3  
R = cyclohexane 1.29 12 
I (R,R ) Z = CH3  
R = cyclohexane 1.29 12 
 II (R,R ) Z = H 
R = diPh 1.45 20 
 II (R,R ) Z = OCH3 
R = diPh 1.48 20 
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4.6 – Conclusion 
 
 Due to the difficulties predicting and engineering a chiral catalyst, the process 
has taken a brute force approach, hoping to overcome the odds of finding a desirable 
catalyst by sheer force and low efficiency. The process is a multi-step process, requiring 
analytical  analysis  at  every  step.  A  catalyst’s  performance  is  based  on  the  ee  for  a  given  
reaction,  for  which  many  methods  have  been  developed  to  assess  the  catalyst’s  chiral  
induction ability, indirectly. 
 
 The methods for testing ee via MS utilize quasi-enantiomers, isotopically-labeled 
substrates, or mass-tagged auxiliaries for differentiation in the MS. Only one method 
directly tests the chiral catalyst through kinetic resolutions or back-reactions. It would be 
much more efficient to develop a method that can directly   test   multiple   catalysts’  
enantioselectivity potential. By employing the modified ion-trap, a series of chiral 
reagents   can   be   introduced   to   the   trap,   where   they   can   probe   the   catalyst’s   chiral  
template. In addition, the MS can act as a filter, so multiple catalysts may be analyzed in 
Figure 52. Example spectra for the Mn-salen catalyst with the 1-phenylethanol system. (a) (R,R ) I (Z = t-
Bu) and (R ) 1-phenylethanol and d-ring 1-phenylethanol as the internal standard in a 1:1 ratio. (b) (R,R ) I 
(Z = t-Bu) and (S ) 1-phenylethanol and d-ring 1-phenylethanol in a 1:1 ratio. Of note is the larger peak 
intensity for the S enantiomer.251 
R S 
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a single experiment, offering a rapid screening tool that may be employed directly after 
synthesis of a catalyst, or a crude mixture of catalysts.   
 
 While  the  rate  of  analysis  cannot  compete  with  the  1000’s  of  sample  analyzed by 
combinatorial means, it significantly reduces time and resources by eliminating 
purification, analysis, and reactions after the crude synthesis, for a modest, one-time 
cost for supplies. This would benefit industry because they could develop and rapidly 
tests novel catalysts, thus skirting patents. Academia could benefit as well, by quickly 
determining the scope of new catalysts. The following chapters present data and 
methodology for probing the chiral space of a series of bis-oxazoline, di-imine, and a 
crude mixture of unsymmetrical di-imine catalysts with a series of chiral alcohols, 
ethers, and epoxides.  
 
 
 
 
 
 
 
102 
 
 
 
 
 
 
5 – Bis-oxazolines and Cyclopropanation 
 
 
 
 The class of bis-oxazolines catalysts presents an excellent starting point for the 
proof of concept and development work for the proposed method: (1) they catalyze a 
wide  range  of  transformations  producing  high  ee’s,  most  notably,  cyclopropanations;;  (2)  
the mechanisms for many of the transformations are understood; and (3) the catalysts 
are commercially available in high ee purity.  Because the copper bis-oxazoline-
catalyzed cyclopropanations are the gold standard for enantioselective 
cyclopropanations, they are briefly discussed in the following pages.  
 
5.1 – Cyclopropanation 
 
 
 Cyclopropane formation represents an important class of organic transformations 
and was one of the first examples of asymmetric synthesis by Noyori in 1968. 
Cyclopropanes are unique due to the internal ring strain imposed by the geometry of the 
molecule. As such, cyclopropanes find immense use as intermediates in many synthetic 
schemes, as well as being found naturally in nature and in many pharmaceuticals and 
agrochemicals.253,254,3,255 The classic cyclopropanation reaction is the Simmons-Smith 
method which employs an alkene, zinc, and diiodomethane (Scheme 27). The 
stereospecificity is a result of the transition structure, often referred to as a butterfly-type 
transition state.256  
103 
 
 
Enantioselective methods for producing cyclopropanes utilize transition metals 
(Ni, Pd, Cu, Fe, Co Ru, and Zn) to catalyze the decomposition of diazoalkanes shown in 
Scheme 28.253 Of the transition metals, Cu, Ru, and Rh have been the most successful, 
with Cu proving to be the most 
selective.257,258 The pioneering work of 
Noyori for the enantioselective 
cyclopropanation utilizing a (salicyladiminato)copper complex with styrene and 
ethyldiazoacetate, paved the way for others, such as Aratani259, Pfaltz260, Masamune,80 
ultimately leading to the modern bis-oxazoline (Scheme 29) as the enantioselective 
standard for cyclopropanations.  
5.2 – Copper Background 
 
 
Scheme 27. Simmons Smith reaction. 
Scheme 29. Ligands used in enantioselective cyclopropanations. 
Scheme 28. General cyclopropanation via 
diazoalkanes. 
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 The late transition metal copper is one of the most recognizable metals in the 
world, where it is found in coins, electrical wiring, metals and statues (Statue of Liberty). 
When mixed with zinc, it forms the alloy brass. When mixed with tin it forms bronze, 
thus it played a crucial role in the cultural development of man during the Bronze Age. 
Copper is also essential for life on earth, and is responsible for a number of critical 
biological processes, such as cellular respiration, regulation of gene expression, and 
free radical scavenging.261,262,263 Due to the nature of its redox reactivity, it is an 
excellent metal for biological systems, particularly enzymes that perform 
oxidative/reductive functions, such as cytochrome-c oxidase264 and superoxide 
dismutase.265  
 
5.2.1 – Physical Properties 
 
 Copper has an atomic weight of 63.55 g/mol, with two stable isotopes, 63 and 65, 
along with 23 radioisotopes.266 63Cu has a natural abundance of 69.09%, with 65Cu 
comprising the remaining 30.91%. It has four oxidation states ranging from 0 to +3, with 
+1 (cuprous) and +2 (cupric) being the most common. In aqueous media the equilibrium 
constant, K, for Cu(II) is extremely large, ~106.267 Cu(I) has a d10 electron configuration 
([Ar]7d10) and a coordination geometry of linear (2), trigonal planar (3), and tetrahedral 
(4).268 Cu(II) has a d9 electron configuration ([Ar]3d9) with a tetragonal coordination 
geometry including tetrahedral, square planar, and trigonal bipyramidal.269 With an 
unpaired electron, Cu (II) is paramagnetic. Cu(II) solutions are readily distinguishable 
from the colorless Cu(I) solutions by a blue or green color.  
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5.3.1 – Copper in Organometallic Synthesis 
 
 
 In organic chemistry, copper is best known for its use in nucleophilic 
organocopper reagents, such as the Gilman reagent (lithium dialkylcuperates) for cross-
coupling and other reactions shown in Scheme 30.270 
 
 
 
 
 
 
 
 
Copper has also been used in aryl-aryl cross couplings. Before Suzuki271 and Stille272 
developed their methodologies, the Ullmann273 and Goldberg274 reactions for cross 
coupling were the standard (Scheme 31). 
 
Scheme 30. Nucleophilic organocopper reactions.270 
Scheme 31. Copper used in cross coupling before Pd. 
106 
 
 The harsh conditions required for the Ullmann and Goldberg reactions (high 
temperatures) meant the reaction(s) fell out of favor for the milder Suzuki, Stille, 
Negishi, and Buchwald, reactions. More recently, copper has found use in click 
chemistry,275 with the coupling of alkynes and azides (Huisgen cycloaddition) to form a 
1,2,3-triazole,276 and the Sonogashira cross coupling of an aryl halide and a terminal 
alkyne.277  
 
5.4 – BOX Cu-Catalyzed Cyclopropanation Mechanism 
 
 
 There are two generally accepted aspects of the copper-catalyzed mechanism. 
First, a copper-carbenoid, formed via the diazoalkane decomposition, is involved in the 
mechanism, shown in Scheme 32,278,81,80,258,279 although recent work by Gronert et al.  
suggests it may be a solvent-stabilized ylide.280 This formation has also been 
determined to be the rate-limiting step.281 Second, copper (I) is the active catalytic 
species, even when Cu(II) is used. It has been found by Kochi et al that Cu (II) species 
are reduced to Cu (I) by diazo compounds.282 Alternatively, Cu(II) has been treated with 
hydrazines to reduce the metal to the active Cu(I) species.278,80  
 Scheme 32. Formation of a copper carbenoid. 
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  There is less agreement as to the formation of the cyclopropane, whether it is a 
concerted, direct insertion,278,283,284 or step-wise process via a metallacyclobutane, 
(Scheme 33).259 Computational investigations into the mechanism have been performed 
by Fraile et al. These studies indicate that the concerted pathway is more favorable by 3 
kcal mol-1. 281  
5.4.1 – Mechanism of Enantioselectivity 
 
 
Pfaltz was the first to rationalize and propose a model for the observed 
enantioselectivites in the diazo-mediated, Cu-catalyzed cyclopropanations.285 Copper 
has a strong affinity for the bis-oxazoline ligands. This, in combination with the 
conformational rigidity and C2-symmetry of the catalyst, reduces the number of 
substrate trajectories and, hence, competing transition states (Figure 53).  
 
 
 
Scheme 33. Proposed mechanism Cu-catalyzed cyclopropanation.259 
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Computational work by Fraile et al, also indicates a slight deviation of the copper 
carbenoid carbon bond relative to the C2 axis, which enhances the enantioselectivity, 
brought about by the steric interaction between the ester of the diazo group and the 
chiral functional group on the BOX ligand. Using a simplified model with methyl groups 
instead of t-Bu at the stereo defining 4-position, a copper carbenoid based on methyl 
diazoacetate, and ethylene, the transition states for the Re and Si approach were 
estimated (Figure 54). After accounting for solvent effects, and single-point energy and 
C2 
identical 
trajectories 
identical 
trajectories 
Figure 54. C2-symmetry and resultant reduction of possible paths and transition states.285 
Figure 53. Proposed transition states for the simplified methyl BOX ligand in the cyclopropanation step 
for ethylene attack for the (a) Re attack with a dihedral angle of 69.8 and 9b) Si approach; dihedral angle 
87.281  
(a) (b) Re        Si 
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frequency calculations, the computational work demonstrated a significant difference in 
transition state energies, with Re face trajectory favored by 1.3 kcal mol-1. These are in 
good agreement with experimental results. Figure 55 displays the two approaches of an 
alkene, with the Si face favored.281  
 
 
 
 
 
 
 
 
The absolute configuration of the C2 carbon (E carbon), where the cis/trans 
diastereoselectivity is defined, is governed by the steric interaction between the carbene 
ester group and the R group of the alkene, shown below in Figure 56. The Si-cis (b) and 
Si-trans (d) both have unfavorable interactions between the ester carbonyl and the 
bulky 4-position of the bis-oxazoline. After accounting for single-point, zero-point, 
solvation energies, and thermal corrections yields an energy difference of 0.2 kcal mol-1 
in favor of the Re-trans (c) configuration. Thus, the trans selectivity is dictated by the 
size of functionality on the olefin; consequently, a desired cis stereochemical 
configuration requires the use of a tris(pyrazolyl)borate Cu(I) or Co(II)salen catalyst.286 
 
Figure 55. Copper carbenoid with alkene attack.281 
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5.5 – Bis-oxazolines Experimental 
  
5.5.1 – ESI  
 
 
 The following bis-oxazolines (Table 5) were commercially purchased. Copper (I) 
triflouromethane sulfonate toluene complex was used as the copper source, purchased 
from Aldrich. Stock solutions of the ligands were prepared with MeOH and were 
refrigerated when not in use. Dilutions were made from the stock ligand solution and 
combined with the copper salt to make final concentrations of approximately 60 PM. The 
catalyst   was   infused   into   the   instrument   via   the   instrument’s   syringe   pump, at rates 
varying from 1-5 mL min-1 using a 500PL Hamilton gas-tight syringe (Hamilton part 
number 81220) adapted with a luer lock fitting (IDEX PN P659), capillary tubing 
      Re-cis          Si-cis           Re-trans            Si-trans (a)       (b)    (c)     (d)  
Figure 56. The four transition state structures for the propylene addition to bis-oxazoline carbenoid. The 
two cis approaches, (b) and (d), have unfavorable interactions between the oxygen of the carbonyl and t-
Bu group of the bis-oxazoline. The Re-trans (c) is favored over the Re-cis (a) approach by 0.2 kcal mol-
1.281 
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(Polymicro Technologies PN 2000021), finger-tight fittings (IDEX PN F120), and 
capillary sleeves (Upchurch PN F-239) to the ESI probe. 
 
 
 
 
 
 
 
 
 
 
5.5.2 – Chiral Probe Introduction 
 
 
Preliminary runs were accessed with different ratios of internal standard and 
analytes. The final ratios for the internal standard and chiral neutral reagents were 
prepared from Table 6: 
 
Table 6. List of chiral reagents and corresponding internal standards and ratios used during testing of the 
bis-oxazolines. 
 
Chiral reagent Internal standard Ratio chiral reagent/int std 
Heat setting / 
external °C 
2-octanol 1-Heptanol 1:3 80 / 165 
1-phenyl-1-
propanol 
Racemic d-ring 1-
phenylethanol 1:1 80 / 165 
1-phenyl-2-
propanol 
Racemic d-ring 1-
phenylethanol 1:3 80 / 165 
1-phenylethanol Racemic d-ring 1-phenylethanol 1:1 80 / 165 
entry abbrev R Z 
 
Enantiomer 
 
3a A Bn Me S, S 
3b B t-Bu Me S, S 
3c C Ph Me S, S 
3d D t-Bu Et S, S 
3e E t-Bu H S, S 
3f F i-pro Me S, S 
3g G Ph Me R, R 
3a-g 
Table 5. Bis-oxazolines utilized in study.  
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styrene oxide (2,3-Epoxypropyl) benzene 1.25:1 25 / 65  
1,2 epoxybutane EtOH 1:2 25 / 65 
propylene oxide 1-octanol 13:1 25 / 65 
2-methoxyoctane 1-heptanol 1:4 80 / 165 
1-methyoxy 
ethylbenzene 
Racemic d-ring 1-
phenylethanol 1:1 80 / 165 
 
 
 
The structures for the chiral probes are shown in (Table 7). 
 
 
Table 7. Table of chiral probes utilized in the bis-oxazoline study. 
 
 
 
  
All chiral reagents and internal standards, except the acyclic ethers, were purchased 
from various vendors. 2-methoxyoctane and 1-methoxyethylbenzene were synthesized 
via the Williamson ether synthesis from the appropriate starting materials (see section 
5.6). Using a small Eppendorf pipet, the neutral reagent was weighed into a pre-tared 
1.5 mL capped-vial. After recording the weight, the balance was re-tared and the 
internal standard was pipetted to the vial and weighed. It was then diluted to 1.25 mL by 
the addition of the appropriate amount of hexanes and mixed. These were prepared 
fresh daily to attain estimates of daily variation. 
 
entry R R1 R2   entry R  entry R R1 
1a OH H H   2a OH  3a Me H 
1b OH H Me   2b OMe  3b Et H 
1c H OH Me      3c Ph H 
1d OMe H H      3d Ph Me 
1e OBn H H         
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The neutral reagent mix was infused into the manifold at a rate between 60-240 
PL hr-1, with a diameter setting of 2.3 mm on the syringe pump. A 250 PL gas-tight 
syringe (Hamilton PN 81130) was used and inserted into the manifold via a septum 
(Supelco part number 20652), such that the metal syringe needle was approximately 
0.9 cm from the metal of the heated manifold. 
 
Heating was required for the introduction of the alcohols and open-chain ethers, 
with the heat settings shown in Table 6. The heat was measured by placing a 
thermocouple between the heating tape and manifold, not to obtain absolute readings, 
but rather as a point of reference for controlling the temperature variability. Using this 
and the Variac controller, temperature variation was reduced to ± 5°C. A flow rate of 
1.25 SLM of helium in the manifold was used for all runs. The pressure was maintained 
around 17.2-17.9 psi in the gas-mixing manifold. When the run was complete, the 
manifold was evacuated, by placing it under vacuum at approximately 150 mtorr. This 
led to evacuation times up to 1 hour for the alcohols.  
 
5.5.3 – Mass Spectrometer Settings 
  
ESI conditions ranged between 3.5-5 kV for the capillary voltage, with a 
temperature range of 100-150 °C. The nitrogen sheath gas flow rate was 10 arbitrary 
units. All conditions  were  optimized  via  the  software’s  auto-tune function. 
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5.5.3.1 – Mass Selection 
 
Since copper has two stable isotopes, 63Cu (69%) and 65Cu (31%), it leads to a 
distinct MS pattern. In earlier work, the whole isotopic range was isolated, but it was 
later decided to isolate only the higher isotope by way of a broadband, notched 
waveform, with a narrow isolation width of 0.8-1.0 m/z. This led to less signal, but 
cleaner spectra, with less interference from impurities (see below).  
 
5.5.3.2 – Scan Activation 
 
 To ensure equilibrium, the scan activation time method was utilized. The reaction 
time was scanned from 2-10 seconds, with 0.5 second step times. An excellent example 
is illustrated in Figure 57. Catalysts C and G are enantiomers, as are R/S 1-phenyl-2-
propanol, thus, two of the four possible plots should be equal, as was the case. The 
plots for the homo-couplings, e.g., R catalyst with R alcohol, are identical, as are the 
hetero-couplings (R catalyst with S alcohol). The plots for the homo/hetero coordinated 
complexes plateau after 4.5 seconds and display significant selectivity.  
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 This scan activation time experiment was performed for all catalysts and chiral 
probes to determine the time required for equilibrium. The concentration or infusion rate 
was typically adjusted to yield equilibration times of around 2-3 seconds.  
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Figure 57. Scan activation time with catalysts C and G (enantiomers) and 1-phenyl-2-propanol. The 
homo-couplings are identical, as are the hetero-couplings. 
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5.5.3.3 – Data Collection and Analysis  
 
The bis-oxazoline ligand and copper solution were mixed and infused into the 
ion-trap via ESI. Figure 58 displays a typical MS of a catalyst system before ion 
isolation.  
 
 
 
 
 
 
 
 
 
To isolate the catalyst ion, a wide isolation window was utilized to capture both 
copper isotopes (5 m/z), with a scan range between 100-1000 m/z, and a q-value of 
0.25. After ion isolation, a clean MS is obtained, as shown in Figure 59. 
Cat B with Cu iso width 4 run 1 #1-15 RT: 0.04-0.79 AV: 15 NL: 1.59E7
T: + p ESI Full ms2 358.00@cid0.00 [300.00-700.00]
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Figure 58. Bis-oxazoline catalyst B before isolation. 
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 The chiral probe and internal standard are allowed to flow into the gas-handling 
manifold and a reaction time is set to reach equilibrium.  Figure 60 provides an example 
of catalyst (B) with (R)-1-phenylethanol and racemic d5-ring 1-phenylethanol at 
equilibrium.  
 
 
 
 
 
 
 
 
Cat B only #1-25 RT: 0.00-0.32 AV: 25 NL: 2.56E6
T: + p ESI Full ms2 357.20@cid0.00 [95.00-1000.00]
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Figure 59. Catalyst B after ion isolation. 
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 Isolation of both copper isotopes affords a complicated spectrum. For reasons to 
be discussed later, the 65Cu isotope bis-oxazoline complex was selected for isolation 
using a narrow isolation width of 0.8-1 m/z. All other controllable conditions remained 
constant. Figure 61 clearly displays a much cleaner spectrum when isolating the higher 
isotope peak.  
 
 
 
 
 
 
S phetoh 30ul per hr #1-25 RT: 0.32-13.22 AV: 25 NL: 7.64E5
T: + p ESI Full ms2 357.20@cid0.00 [95.00-1000.00]
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Figure 60. Catalyst B after equilibrium with the chiral probe (R)-1-phenylethanol and the internal 
standard, d-ring 1-phenylethanol. 
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 For each catalyst and enantiomer, at least 250 scans, usually 500, were 
collected. The results were exported into an excel spreadsheet, where a macro was 
built to automate the process of summing the peaks (peak area) of the desired mass 
range, which included the catalyst, catalyst-probe, and internal standard. The 
equilibrium constant, Kx, was calculated from the following formula: 
 
𝐾௫ =    ൬
𝑝𝑒𝑎𝑘  𝑎𝑟𝑒𝑎  𝑛𝑒𝑢𝑡𝑟𝑎𝑙
𝑝𝑒𝑎𝑘  𝑎𝑟𝑒𝑎  𝑖𝑛𝑡  𝑠𝑡𝑑 ൰   ×  ൬
[𝑖𝑛𝑡  𝑠𝑡𝑑]
[𝑛𝑒𝑢𝑡𝑟𝑎𝑙]൰ 
 
 
where Kx is the equilibrium constant for either the (R) or (S) enantiomer and int std is 
the internal standard. The total scans were divided into five separate groups to obtain a 
measure of the relative standard deviation (RSD) for the runs. The process was 
repeated for the (S) enantiomer (Figure 62), at which point the selectivity factor, KR/S, 
was calculated. This was re-run for a total of at least three separate days with fresh 
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Figure 61. Catalyst B after isolating the 65Cu isotope and allowing equilibrium with the chiral probe (R)-1-
phenylethanol) and the internal standard, d5-ring 1-phenylethanol. 
  
(1) 
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daily preps to minimize random variability. The average daily results for the three (or 
more) days were averaged and the standard deviation and percent RSD calculated.  
 The Gibbs free energy of binding may also be extracted from the data in a series 
of calculations, starting from the following equilibrium:  
 
 
 
whence:  
 
and:          'G°  =  -RT lnK 
The intensities (abundances) of both Cu-catalyst complexes are obtainable from 
Cat B new prep 080712 iso 359 2sec act time S phenylethanol #1-25 RT: 0.05-9.02 AV: 25 NL: 8.84E5
T: + p ESI Full ms2 359.00@cid0.00 [95.00-1000.00]
100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
A
bu
nd
an
ce
485.78
480.79
359.25
576.86
462.97
523.71 669.13376.08 748.77453.05 628.75 804.65 892.54 964.98707.92259.12 828.54353.33
Figure 62. Catalyst B after isolating the 65Cu isotope and allowing equilibrium with the chiral probe (S)-1-
phenylethanol) and the internal standard, d-ring 1-phenylethanol. 
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the mass spectra, but the concentration of the enantiomer must be calculated. This may 
be acquired by recalling equation (1) from Chapter 3: 
 
[𝑒𝑛𝑎𝑛𝑡𝑖𝑜𝑚𝑒𝑟]   =   𝑃ோ   =   𝑃ூ்  𝑥  
𝐹ோ
𝐹ு௘
  𝑥  
𝑑ோ
𝑀𝑊ோ
  𝑥  
(𝑀𝑊ோ)
4
ଵ/ଶ
 
 
 
where PIT is the pressure inside the trap when 3 psi of helium pressure is applied, FR, 
dR, and MWR are the flow rate, density, and molecular weight of the reagent, 
respectively, and FHe, is the flow rate of the helium (moles/min). Reactions with known 
rate constants are run, usually MeI and Br-, to calibrate the instrument (i.e., to obtain the 
ion-trap pressure correction).238 
 
5.6 – Synthesis of Ethers 
 
 
 Chiral ethers were not commercially available, so they were synthesized via the 
Williamson ether synthesis shown in Scheme 34. Chiral alcohols served as the staring 
materials for the ethers. The starting materials 
were added to the THF and cooled to 10 °C. The 
NaH, 0.9 equ. was slowly added (so as not to 
racemize the new chiral center), and allowed to sit 
for 20 minutes. The alkylating reagent was slowly 
added, so as not to exceed 30 °C, after which the 
reaction was allowed to sit at room temperature for 
3 hours. Water was added dropwise to quench any remaining NaH. KOH was added to 
remove unreacted starting material, followed by diethyl ether. The two layers were 
Scheme 34. Synthesis of the chiral ethers. 
ethers. 
(5) 
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separated and the aqueous layer extracted again with diethyl ether. The two organic 
layers were combined and dried over MgSO4. After decanting, the diethyl ether was 
removed on a rotary evaporator and the material placed in a vial. Column 
chromatography was attempted for 1-methoxyethylbenzene, but did not result in an 
improvement of the purity. The sample was used in this form and the data corrected 
based on chiral GC analysis. The 2-methoxyoctane was used without further purification 
and preliminary screening of the benzyl ether showed no binding to the copper catalyst, 
most likely due to the large bulk of the benzyl group. 
 
 
5.7 – Results 
 
 
5.7.1 – General Results 
 
 
Results for the bis-oxazolines are presented graphically in Figure 63 grouped by 
chiral probe, and in Figure 64, where they are grouped by catalyst. The black line 
represents the selectivity factor, KR/S (the ratio of the enantiomers equilibrium constants) 
of 1, or no selectivity. Values greater than 1 favor the (R) enantiomer, while values less 
than 1 favor the (S) enantiomer. Error bars are standard deviations for the averages.  
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Figure 63. Summary of results for the bis-oxazolines. Grouped by chiral probe. The line in black represents no selectivity. 
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Figure 64. Summary of results, grouped by catalysts. The black line represents no selectivity. 
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5.7.1.1 – Diastereomeric Excess 
 
 The selectivity factors may be converted to diastereomeric excess. Figure 65 and 
Figure 66 presents the data as the absolute value of the percent diastereomeric excess, 
which is easier to work with when absolute stereoexcess is not a concern. The DE 
range was from 0 - 34%. While not overly impressive for a condensed-phase 
transformation, 34% represents a very large number for a gas-phase complexation 
product, where the lack of solvent, counter-ion coordination, trigonal planar copper 
coordination, room temperature (excess energy), and lack of rigid transition-state all 
tend to reduce enantioselectivity.36, 287 
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Figure 65. Results presented as diastereomeric excess, grouped by catalyst. 
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Figure 66. Results as percent DE, grouped by chiral probe. 
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Not surprisingly, the larger the group, the more selectivity (in general) was 
observed. The trend follows 2-octanol < 1-phenylethanol < 1-phenyl-1-propanol < 1-
phenyl-2-propanol for the alcohols; propylene oxide < 1,2 epoxybutane < styrene oxide 
for the epoxides; and 2-methoxyoctane < 1-methoxyethylbenzene for the ethers (the 
benzyl ether was too big to coordinate). A phenyl group appears to be necessary to 
deliver good selectivity, either adding necessary bulk and/or possibly increasing 
stabilization factors such as S-cation interactions. It is notable that the R enantiomer 
was favored for most of the chiral reagents, with the exception being styrene oxide, 
where the S enantiomer was preferred. This switch from R to the S enantiomer is due to 
the change in priorities of the groups (Cahn-
Ingold-Prelog),288 and not a change in the 
orientation preference around the stereocenter of 
the catalyst (Figure 67). Catalyst G, also 
displayed a preference for the S enantiomer, 
however, this is expected due to the enantiomeric relationship between G and C (Figure 
68).  
 
 
 
 
Figure 67. Orientation of (R)-1-
phenylethanol and (S)-styrene oxide. 
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Modifications as small as an extra carbon, for example 1-phenyl-1-propanol and 
1-phenylethanol can have profound effects. Selectivity significantly increased when 
switching the alcohol group from the 1 position to 2 for all catalysts except B, where it 
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Figure 68. Catalysts G and C with 1-phenylethanol. The homo-couplings are similar as are the hetero-
couplings. 
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significantly decreased. Likewise, for the two results obtained for propylene oxide, 
where no selectivity was observed, adding an extra carbon (forming 1,2-epoxybutane), 
significantly increased selectivity. This is also observed in the etherification of 1-
phenyethanol, upon which the selectivity drastically improves for B, C, E, and G, while 
decreasing for D and F. Alkylation of 2-octanol to 2-methoxyoctane increased selectivity 
of the phenyl-bearing groups (catalysts C and G), while decreasing selectivity in others, 
specifically catalyst B, where selectivity disappeared.  
 
This effect can be observed in the catalyst as well, when the change occurs near 
the stereocenter. For example, catalyst A, with a benzyl group instead of a phenyl, was 
found not to coordinate to any of the chiral molecules. This is most likely due to the fact 
the extra CH2- group allows the 
phenyl ring the freedom to 
coordinate to the copper metal, 
blocking access to metal for the 
other chiral reagents (Figure 69). 
 
5.7.1.2 – Average Selectivity for Groups 
 
 The average selectivity factor for each probe was calculated by taking the natural 
log of each value, averaging the values, then converting back to the non-log value, via 
the natural exponential, e (Figure 70). The best chiral probe was the 1-phenyl-2-
propanol followed closely by styrene oxide, then 1-phenyl-propanol, and 1-
phenylethanol. The other, non-phenyl based probes displayed little selectivity.  
Figure 69. Structure of catalyst A.  
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It appears the 1-phenyl-1-propanol and 1-methoxyethylbenzene give the best 
selectivity over a range of catalysts. For example, these both displayed excellent 
selectivity with the t-Bu and Ph-bearing catalysts B, E C and G, while the 1-phenyl-2-
propanol and styrene oxide gave the best selectivity overall. It is noteworthy that while 
these gave the higher selectivity, not all catalysts were selective, for example catalyst B 
gave much lower selectivity for 1-phenyl-2-propanol than the similar catalyst E; styrene 
oxide also displayed lower selectivity for the phenyl bearing catalyst (C and G).  
Figure 70. Average selectivity factor for each chiral probe. 
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An average was also calculated for the catalyst groups and is shown below 
(Figure 71). Not surprisingly, the larger the group at the stereo-bearing center, the better 
the selectivity observed, with the t-Bu and Ph groups (B, E, C, and G) providing much 
better selectivity than the i-pro  catalysts  (D  and  F).  Catalyst  E’s  selectivity  is  somewhat  
surprising; given that the literature generally shows this to be inferior to the t-Bu and Ph 
bearing counterparts. 
 
  
Figure 71. Average selectivity factor for catalysts. 
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5.7.1.3 – Distal Modifications 
 
 Modifications at the methylene bridge, or distal modifications, do not have a 
significant effect on the stereoselectivity of cyclopropanation reactions in the condensed 
phase, and as such, should have no impact on the enantioselectivity observed in the 
gas-phase.287 Figure 72 shows this to be the case, as only 1-phenyl-2-propanol and 1,2 
epoxybutane displayed a significant change when shifting the bridging methylene 
substituents from a methyl (B) to a hydrogen (E) or a methyl to an ethyl (F). Counter-
intuitively, the smaller groups provided much better enantioselectivity than the larger 
groups with 1-phenyl-2-propanol and 1,2 epoxybutane. It is presumed that this change 
Figure 72. Distal modification to the bis-oxazoline scaffold and resultant effect on the selectivity. Only two  
results displayed significant differences, circled in red. 
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in the bridge may have altered the chiral environment of the catalyst and the 1-phenyl-2-
propanol molecule was more sensitive to this change than the other probes.  
 
5.7.1.4 – Gibbs Free Energy 
 
 Using equations 2-4, the Gibbs free energy of binding was calculated and 
tabulated in Table 8. The 'G was based on the most tightly-bound enantiomer. 
 
Table 8. Gibbs free energy of binding for the complexes (kcal/mol). 
 
In general, the larger the probe molecule, the higher the free energy of binding, most 
likely due to the greater polarizability. This is illustrated Figure 73 using the molecular 
weight as a general gauge of polarizability. 
 
 
 
 
 2-
octanol 
1-phenyl-
2-
propanol 
1-phenyl-
1-
propanol 
1-
phenyl
ethanol 
styrene 
oxide 
1,2 
epoxyb
utane 
propylene 
oxide 
2-
methoxyoctane 
1-methoxy 
ethylbenzene 
B -11.8 -12.4 -12.1 -11.6 -10.7 -7.7 -7.8 -11.5 -11.0 
C -12.4 -12.8 -12.1 -11.9 -10.9 -9.4  -12.2 -11.9 
D -12.3 -12.7 -11.9 -12.2 -10.9 -9.3 -9.0 -12.4 -11.5 
E -12.5 -12.5 -12.2 -11.6 -11.4 -10.1  -12.3 -13.4 
F -12.0 -12.2 -11.5 -11.8 -9.2 -11.4  -13.6 -13.0 
G -12.4 -12.7 -11.5 -11.7 -10.8 -9.5  -12.9 -12.9 
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Also evident was the decreased basicity of the epoxides, due to the reduced C-O-C 
bond angle, as they displayed significantly smaller 'G of binding than the alcohols and 
acyclic ethers. This is most clearly pronounced when comparing the 'G for styrene 
oxide and 1-phenylethanol. Both have similar molecular weights, 120 g/mol for styrene 
oxide versus 122 g/mol for 1-phenylethanol, but styrene oxide has significantly smaller 
binding energies.  
 
5.8 – System Checks and Variability 
 
  
Figure 73. Plot of Gibbs free energy versus chiral probe molecular weight. 
Molecular Weight of Chiral Probe 
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5.8.1 – RSD  
 
The relative standard deviation is a measure of the variability and scatter of the 
results and is found by dividing the standard error by the average of the results, and 
multiplying by 100. The RSDs of the data are presented below in Figure 74 and Figure 
75 grouped by the chiral probe and catalysts, respectively. 
 
Figure 74.  RSD grouped by probe. 
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 Overall, the results are excellent; with only 5 of the 50 readings displaying RSDs 
over 6%, half of them occurring with 1,2 epoxybutane. The high RSD observed there 
are most likely a result of the non-ideal ratio of the chiral reagent and internal standard. 
For example, the highest RSD observed was for catalyst C and 1,2-epoxybutane, at 
26%. Upon examination of the spectra, the catalyst exhibited very low coordination to 
the enantiomers (Figure 76).  
 
 
 
 
Figure 75. RSD grouped by catalyst. 
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Unfortunately, a universal internal standard cannot always be found. The ideal 
internal standard is a deuterium-labeled pseudo-enantiomer of the chiral probe. Most of 
these are not commercially available, so substitutes must be made. The next best 
internal standard would be the addition of the smallest possible group to the probe of 
interest, for example, the addition (or subtraction) of a methyl group. This too is not 
ideal, as the higher molecular weight analyte tends to preferentially bind to the catalyst, 
requiring a ratio significantly deviating from the ideal 1:1 ratio of analyte to internal 
standard. In addition, an internal standard that works well for one catalyst and probe 
may not work well with another. Thus, compromises were made.   
 
Box plots are an excellent way to present statistical data in a quick and easy-to 
read format; thus, the results are presented as box plots in Figure 77. 
S epoxybutane run 1 #1-25 RT: 0.27-7.52 AV: 25 NL: 1.37E5
T: + p ESI t Full ms2 399.50@cid0.00 [150.00-1000.00]
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
A
bu
nd
an
ce
398.95
443.18
468.86
Figure 76. Mass Spectrum of catalyst C and 1,2-epoxybutane with EtOH as the internal standard. 
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Figure 77. Box plots of all results for the bis-oxazolines. 
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5.8.2 – System Checks (ESI) 
 
 The ESI process was optimized for each catalyst by running the automatic tune 
feature.   The   probe   distance   from   inlet   was   set   to   3,   per   the   manufacture’s  
recommendation at flow rates used (1-5 PL min-1). After running for prolonged periods, 
the performance of the ESI spray progressively deteriorated. It was found that this was 
due to build up of material in the capillary tubing entering the ground junction of the 
instrument. This black material was probably copper precipitating out of solution (picture 
in Figure 78a). After periodically removing 1-2 inches of the capillary, the stability 
improved greatly as shown in (b) and (c) in Figure 78. 
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Figure 78. (a) Stability of the ESI spray before regular trimmings of the capillary tubing. Also shown a 
picture of the tubing. Black solid was observed at the entrance to the ground junction of the instrument. 
(b) and (c) examples of the stability after clipping of capillary tubing. 
 
 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) 
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 After introduction of the neutral reagent and syringe into the manifold, the time 
was measured to reach equilibrium, as evident from a stable ratio of analyte to internal 
standard ratio. From Figure 79, it is evident that it takes approximately 50-60 scans to 
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Figure 79. Time to equilibrate the manifold and ion-trap with the chiral probe. 
System Equilibration Time catalyst F and Phenyl-1-
Propanol 
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equilibrate. This corresponds to approximately 10 minutes, when scanning from 100-
1000m/z with a setting of 10 microscans. Thus, a period of 15 minutes was allowed to 
pass before collection of data.  
 
5.8.3 – Chiral and Achiral Controls 
 
 
 The  instrument’s  variability,  precision,  and  accuracy  were  tested  with  a  series  of  
experiments.  
 
5.8.3.1 – Instrument Variability and Accuracy 
 
 
 To   test   the   instrument   variability,   as   well   as   to   gauge   the   method’s   ability   to  
discriminate chirality, an achiral catalyst was used with a 
chiral neutral reagent. An Fe(III) tetraphenyl porphyrin 
(Figure 80) was tested with 2-octanol over a series of days. 
The same solutions of R/S 2-octanol were used for testing. 
They were stored in the freezer between uses. The control 
chart is shown in Figure 81.  
 
 
 
 
Figure 80. Fe(III) tetraphenyl 
porphyrin achiral catalyst. 
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The blue bar represents the daily selectivity value. The average over five days 
was 1.00 with an RSD of 0.72%. The daily RSD for the values (5 runs), represented by 
the red bar, was slightly higher but well within acceptable range of 3.3%. Thus, the 
instrument and method appears accurate and precise, over multiple days with an achiral 
catalyst.  
 
The next test was with a chiral catalyst known to display little selectivity. Catalyst 
B with 2-octanol was used as a control over the course of a week. Again, the same 
solution was used for the study and kept in the freezer when not in use. The results are 
shown in Figure 83. 
Date Run 
Figure 81. Achiral catalyst with 2-Octanol run over 5 days. 
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Figure 82. Catalyst B with 2-Octanol run over 5 days. 
 
  
The results again show excellent agreement between days, with an average of 
1.00 and an RSD of 1.46%, with daily RSD for 5 runs between 0.64-1.51% (green line).  
 
 
5.8.3.2 – Neutral Reagent Preparation 
 
 The sample prep variability was examined with catalyst B and 1-phenyethanol 
preps. This system displayed a selectivity of 1.49. With the high selectivity, and a 
deuterated internal standard, it offered a good candidate for the study, as any 
evaporation that occurred during the period between initial prep and final examination 
(one week), would have affected both the enantiomer and internal standard equally. To 
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minimize evaporation, the samples were kept in the freezer when not in use. The 
sample preps occurring between 8/7 – 8/16 were all run on 8/16/12. The ANOVA 
(analysis of variance) results are shown below in Table 9. 
 
 
 
 
 
 
 
 
 
 
The average selectivity obtained for the set of five was 1.52, with an RSD of 1.18. The 
ANOVA indicated there was a statistical significant difference at the 95% level, (p < 
0.05) for samples prepped on different days. A statistical analysis of the newly obtained 
data was run against the previously obtained data, comparing older prep date selectivity 
factors, to the results obtained on 8/16/12. These ANOVA results are shown in Table 
10: 
 
 
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance
8/15/12 5 7.511 1.502 7.957E-04
8/10/12 5 7.601 1.520 1.286E-04
8/7/12 5 7.489 1.498 2.511E-04
8/16/12 5 7.664 1.533 8.815E-04
8/8/12 5 7.689 1.538 1.484E-04
average 1.518 Min 1.498
std dev 0.0178 Max 1.538
ANOVA RSD 1.175 Range 0.040
Source of Variation SS df MS F P-value F crit
Between Groups 0.006360016 4 0.001590004 3.605019146 0.022766797 2.866081402
Within Groups 0.008821057 20 0.000441053
Total 0.015181072 24
Conclusion: P < 0.05, so reject the null hypothesis and accept alternative 
hypothesis that there is a difference between the preps.
Table 9. Result of ANOVA for sample preparation variability. 
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8/07/12 
prep run on 
8/16/12
8/07/12 
prep run on 
8/07/12 8/16/2012b 8/8/12
Mean 1.498 1.498 Mean 1.533 1.513
Variance 0.0002511 0.001986 Variance 0.000881519 0.000289907
Observations 5 5 Observations 5 5
Pooled 
Variance 0.0011185
Pooled 
Variance 0.000585713
Hypothesized 
Mean 
Difference
0
Hypothesized 
Mean 
Difference
0
df 8 df 8
t Stat -0.021644 t Stat 1.301288547
P(T<=t) two-
tail 0.9832619
P(T<=t) two-
tail 0.229383273
t Critical two-
tail 2.3060041
t Critical two-
tail 2.306004135
t-Test: Two-Sample Assuming Equal 
Variances
t-Test: Two-Sample Assuming Equal 
Variances
8/15/12 
prep run on 
8/16/12
8/15/12 
prep run on 
8/15/12 
8/10/12 
prep run on 
8/16/12
8/10/12 
prep run on 
8/10/12 
Mean 1.502 1.513 Mean 1.520 1.536
Variance 0.0007957 0.0005561 Variance 0.0001286 0.0005334
Observations 5 5 Observations 5 5
Pooled 
Variance 0.0006759 Pooled Variance 0.000331
Hypothesized 
Mean 
Difference
0
Hypothesized 
Mean 
Difference
0
df 8 df 8
t Stat -0.659842 t Stat -1.362965
P(T<=t) two-
tail 0.5278908
P(T<=t) two-
tail 0.2100168
t Critical two-
tail 2.3060041
t Critical two-
tail 2.3060041
t-Test: Two-Sample Assuming Equal 
Variances
t-Test: Two-Sample Assuming Equal 
Variances
Table 10. ANOVA results comparing data obtained on 8/16/12 to the previously obtained results. No 
statistical different was apparent. 
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No statistical differences were observed from the sample prepared on the older date, 
compared to the same sample run on 8/16/12; thus, the variability observed is due to 
sample preparation (no stability issues with the samples). 
 
 A separate experiment was run for sample prep variation with ligand B and 2-
octanol. It found that there is no difference in sample prep variation at the 95% 
confidence level (P = 0.0617), but did find a small difference in run-to-run variability, 
with a p-value of 1.09 x 10-4. 
 
Table 11. Variability in sample prep and run-to-run with catalyst B and 2-octanol. 
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5.8.3.3 – Propylene Oxide and Sample Preparation Variation 
 
The chiral probe propylene oxide was only tested for catalysts B and D. Due to 
the low selectivity exhibited, not surprising giving its small size, and the difficulty in the 
sample prep due to the extremely high volatility; it was only run for these two catalysts. 
Sample prep for this analyte required the use of headspace vials, pre-filled with solvent 
that were subsequently tared on the analytical balance. The sample was then 
introduced sub-surface via a gas-tight syringe and reweighed. The procedure was 
repeated for the internal standard, with a typical spectrum shown below, Figure 83. 
 
Figure 83. Spectrum of the t-Bu catalyst with propylene oxide and 1-octanol as the internal standard. 
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Due to the nature of the sample prep and very low abundance of the coordination 
complex between the catalyst and analyte, three sample preparations were made to 
examine the reproducibility. The RSD for three (S) enantiomer preps was 0.78 %; the 
RSD for two (R) preps was 4.1%, yielding greater confidence in the methodology and 
results.   
 
5.8.4 – Helium Pressure and Variability 
 
 
 The effect of helium pressure on the results was also examined by slightly 
adjusting the helium pressure from the tank to levels expected for day-to-day variance. 
Only the ratio between one prep of analyte and internal standard was measured, i.e., 
only the S enantiomer was examined (Table 12). 
 
Table 12. Effect of pressure on results. 
SUMMARY
Groups Count Sum Average Variance
Normalized P 
=17.49 4 3.330606185 0.832651546 3.15887E-05
Normalized P = 
17.36
5 4.044658803 0.808931761 2.93657E-05
Normalized P = 
17.15 5 4.087296337 0.817459267 2.36905E-05
Normalized P = 
17.53 5 4.01045932 0.802091864 0.000135544
Normalized P = 
17.81
5 4.006905922 0.801381184 3.22198E-05
average 0.813
std dev 0.012
ANOVA RSD 1.430
Source of 
Variation SS df MS F P-value F crit
Between Groups 0.00295397 4 0.000738493 14.34633443 1.4792E-05 2.895107308
Within Groups 0.000978045 19 5.1476E-05
Total 0.003932015 23 There is a difference in values with pressure
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A statistical difference was determined to exist between the different set values of 
helium pressure; however, this difference was not large, evident from the small RSD of 
1.4% between all sets of data. Nonetheless, pressure was kept as close to 17.5 psi as 
possible to minimize this effect. 
 
5.8.5 – Chiral Check 
 
 
 As mentioned in Chapter 1, one of the disadvantages of the chiral pool method, 
is the lack of availability of both enantiomers in the starting substrate. Thus, not all of 
the bis-oxazolines are commercially available in both enantiomers. This was the case 
for most of the bis-oxazolines utilized in this study, with the exception of PhBOX, 
(catalysts C and G). Since they are enantiomers, the opportunity exists for a chiral cross 
check. The selectivity factor, S, or KR/S, for each catalyst C and G when multiplied by 
one another should equal 1, or 
 
catalyst C KR/S x catalyst G KR/S  =  1 
 
Figure 84 displays the results for the chiral cross check. 
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All results were 1.0 within error, except 1-methoxyethylbenzene. It is not entirely 
clear why there is a large error in this case.  
 
Figure 84. Chiral cross check with catalysts C and G. 
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5.8.6 – Different Instruments 
 
 
 The lab was equipped with two different modified ion-traps, so catalyst B and 
phenylethanol was tested on each instrument. The results compare favorably. A plot of 
the scan activation times for the two instruments demonstrated excellent agreement 
(Figure 85). The selectivity factor for the alternate instrument was 1.49, compared to 
1.54 for the usual instrument. The ANOVA yielded a P-value of 0.016, so there is a 
statistical difference between the instruments, but no practical difference (Table 13). 
This yields greater confidence in the results and transferability or adaptability to/by other 
labs/instruments. 
Figure 85. Scan activation of catalyst B and phenylethanol on two different instruments. 
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5.9 – Chiral Amines 
 
 
 As part of the investigation into the catalyst template, chiral amines were initially 
thought to be promising probes, offering a different geometry around the central 
nitrogen than the oxygen-based probes. However, the strong Lewis-base nature of 
amines when coordinating with the catalyst did not allow for equilibrium to be achieved 
in the instrument. The upper-limit for trapping time is 10 seconds for the LCQ Deca, 
which was not enough time for equilibration.  
 
 Figure 86 demonstrates an achiral amine (butylamine) never reaching equilibrium 
(blue), while Figure 88 shows a chiral amine (sec-butyl) amine with an amine as the 
internal standard, again with no success. Thus, the class of amines was abandoned for 
use as chiral probes. 
Table 13. ANOVA comparing the results of catalyst 
B and phenylethanol on two different instruments.  
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Figure 87. Scan activation time study of butyl amine with octanol as the internal standard. The amine 
never reaches equilibrium. Inset – normalized ratio of the butylamine and octanol. 
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5.10 – Combinatorial Approach 
 
 
 A combinatorial approach was examined for the bis-oxazolines and compared to 
the single runs. That is, a mixture of catalyst was infused and multiple equilibrium were 
assessed from a single ESI solution. Due to the isobaric nature of the some of the bis-
oxazoline catalysts, only three could be run at the same time. Two mixes were created, 
mix one, consisting of catalyst B, E, and C; and mix two, consisting of catalysts D, F, 
and G.  No difference was observed between the single run samples and the 
combinatorial run mixes, when accounting for standard deviations, with the exception of 
catalyst E. This difference too, was small, 1.39 ± 0.04 for the single versus 1.47 ± 0.03 
for the mix shown in Table 14 and Figure 88. The single runs of catalyst E were run 
before the implementation of the dual syringe method, a possible source of error.   
Single Combinatorial Single Combinatorial
Cat B 1.49 1.43 0.03 0.03
Cat C 1.48 1.42 0.04 0.02
Cat D 1.13 1.13 0.04 0.02
Cat E 1.39 1.47 0.04 0.03
Cat F 1.04 1.04 0.03 0.04
Cat G 0.68 0.71 0.06 0.02
selectivity factor standard deviation
Table 14. Table of the single runs versus combinatorial mixes. 
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5.11 – Catalyst E Investigation 
  
 Initial investigations into the bis-oxazolines, particularly catalyst E, displayed odd 
isotope patterns in the MS (Figure ). Using a scan width of five and targeting 329m/z, 
Figure 88. Results of the single run versus combinatorial approach. 
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Figure 89.  (a) Catalyst E with the expected isotopic abundances. (b) Mass Spectrum of catalyst E. The 
major peak is minus one from expected. 
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enabled examination of all the isotopes. However, the expected pattern was not 
observed. When using fresh preps of the ligand and copper, an ion at 328 m/z, rather 
than 329 m/z, is observed as the base peak. Furthemore, the ratio changed with time, 
with an unknown at 327 m/z gradually appearing with time (Figure 90). 
 
5.11.1 – Ligand E Investigation 
 
 
To better understand the chemistry of the catalyst with copper, a study of the 
ligand by itself was performed. Fragmenting catalyst E (m/z = 267.3) resulted in a beta 
lactam as the major fragment, and a substituted oxazoline (Figure 91). Fragmenting 
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Figure 90. (a) Fresh prep of catalyst E. (b) Prep after nine days.  
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Figure 91. (a) Ligand only of catalyst E. (b) Fragmentation pattern for ligand E . 
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ions at 167 and 168 m/z ions resulted in one peak at 100 m/z, which resulted in a 
fragment at 83 m/z when performing another stage of MSn. The proposed structures 
and mechanisms for catalyst E ligand and transitions are shown in Figure 92. 
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The path in blue is a result of protonation at the oxygen, resulting in a stable 
beta-lactam. The path in red results in protonation at the nitrogen, resulting in the less 
stable nitrilium ion; however, upon further fragmentation, both result in the same 
fragment product(s), an aziridine, followed by a cyclopropane. With the normal isotope 
patterns and mechanistically reasonable fragment pathways, the conclusion is that the 
ligand behaves normally in the absence of copper. 
 
5.11.2 – Ligand E with Na 
 
 
Next, sodium was used a metal since it is relatively inert (no redox chemistry is 
likely) and has one natural isotope. The mass spectrum revealed the correct/expected 
isotopic distribution, with an ion at plus one m/z 
of approximately 17% (Figure 93). 
Fragmentation did not reveal any additional 
information. The typical fragmentation 
spectrum with sodium implicates copper in the 
unexpected pattern observed in the copper 
catalyst.   
 
5.11.3 – Fenton Chemistry 
 
 
The experiments with Na and the protonated ligand clearly demonstrate copper 
is playing a significant role in the chemistry of the ligand and the resultant MS spectra. 
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Figure 93. Ligand E with Na. 
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This implies a Fenton-like chemistry of the ligand, in which copper is oxidized to the plus 
two-state, most likely via oxygen, forming the superoxide anion, which subsequently 
reacts with the ligand (Figure 94).  
 
5.11.3.1 – Fragmentation of Catalyst E 
 
 
Fragmenting a fresh prep of catalyst E at 30 % collision energy results in peaks 
at 247 and 271 m/z. It was found these fragments are a result of two different species 
coordinating to the copper, the unaltered catalyst, and the M-1 (Fenton) molecule. This 
was found by a fragmentation study of catalyst E, taking advantage of the resonance 
excited CID available in QITs. The original peak displayed the odd isotopic pattern 
shown in (a) of Figure 95, with 328 (100%), 329 (60%), 330 (50%), and 331 (20%) m/z.  
Fragmenting at low energy (15%) results in the disappearance of 328 m/z peak and the 
appearance of 271 m/z. The peak at 329 m/z is still present ((b) in Figure 95). 
Increasing the fragmentation energy to 30% results in the complete disappearance of all 
peaks around 329 m/z ((d) Figure 95), and the appearance of a peak at 247 m/z ((b) in 
Figure 95).  
 
Figure 94. Fenton chemistry and the catalyst E. 
Exact mass = 328.1 
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This offers strong evidence for the case of two species in the mix, resulting from 
the unaltered catalyst E, and the species that underwent proposed Fenton chemistry.  
 
5.11.3.2 – Stability of Catalyst E 
 
Given more time, approximately one month, the catalyst again changes. Figure 
96 demonstrates the changes in binding to 2-octanol with catalyst E over time. Note a 
new species at m/z of 329 now appears, and it does not bind with the alcohols. 
Fragmentation of this new 329 m/z leads to a completely different fragmentation pattern 
than the original catalyst E, with a loss of water (311 m/z), followed by a loss of 32 (279 
m/z), followed by a loss of 100 (179 m/z).  
Figure 95. (a) Peak before fragmentation. (b) Peak with 15% collision energy applied, 271m/z appears, 
with 329m/z, still intact. (c) Increase to 30% energy. 247m/z now evident, with no evidence of 329m/z (d) 
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Any of these undesired species could alter the stereospecific binding of the 
catalyst with the chiral molecules, as previously demonstrated. Thus, the higher 
selectivity observed in catalyst E over t-BuBOX, which has generally been shown to 
deliver  higher  ee’s  in  the  literature, may be a result of the altered structure(s)/stability of 
catalyst E. It is also possible that over time the oxidation of Cu (I) to Cu(II) increases, 
which in turn increases the Lewis acid strength of the metal, which drives enolization of 
the catalyst to the 328 m/z unknown, in turn producing the unknown 327 m/z with time.  
 
5.11.4 – Minimizing Degradation and Fenton Chemistry 
 
As a result of these findings, a series of changes were implemented to minimize 
possible side-reactions by the ligand. The copper solution and the ligand solution were 
no longer mixed together; rather, a dual syringe system with a series of tees was 
applied to minimize the contact time together. To ensure efficient mixing of the two 
solutions before entrance into the ESI, an additional set of tees was applied to the 
configuration shown in Figure 97, however, this was found to be unnecessary. The set-
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Figure 96. The effect of time on the coordination of catalyst E and 2-octanol. 
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up as shown in Figure 97 allowed sufficient mixing of the copper and ligand solution to 
form the catalyst. 
 
 The dual syringe system was designed to minimize exposure of the catalyst to 
the redox active copper. By isolating 65Cu with a narrow isolation width, any undesired 
species resulting from hydrogen loss are ejected from the system. This simplified the 
integration of the spectra, and left only a small fraction of impurities containing the M – 1 
Fenton ligand with a carbon-13.  
 
5.12 – Integration Methods 
 
 
 Using catalyst B and phenylethanol, a study into the method of ion isolation and 
integration was performed. Different methods of isolating the catalyst peak along with 
different isolation widths for both isolating the catalyst and for calculations were 
examined. With data run on 6/12/12, using the previous conditions of isolating 358 m/z 
and an iso width of 4, and then summing all peaks (477-482 m/z for the enantiomer, and 
Figure 97. Design of the dual syringe and tees to minimize the ligand exposure to copper.  
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482-487 m/z for the internal standard), an R/S selectivity factor of 1.247 was obtained. 
This method of calculating the peaks is known as method 1, shown in Figure 98.  
 
 
 
 
 
 
 
 
 
 
 
An attempt to isolate only the isotope of interest in the presence of the other 
isotopes was investigated. Method 2, involved isolating 358 m/z with an iso width of 4 
for the reaction, but used an iso width of ± 1 for the calculations, thereby only summing 
the largest isotopic peak, 478.7 and 483.7 m/z ± 1 (Figure 99). Thus, all peaks were 
collected, but only the 63Cu were integrated (black arrows). This resulted in an R/S 
selectivity factor of 1.260. 
 
R phenylethanol #3-50 RT: 1.36-26.26 AV: 48 NL: 7.31E5
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Figure 98. Method 1 for integrating all peaks over isotopic range (black line – non-deuterated analyte, red 
line – deuterated internal standard). 
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An ANOVA comparing method 1 and 2 gave a P-value of 0.2743, thus there is no 
difference between the methods. 
 
 Method 3 was investigated in which a wide range of m/z were isolated, similar to 
the previous methods, but in this case, only the higher isotope peaks from 63Cu and 
65Cu (480.7 and 485.7 m/z) are integrated in the calculations (sum over 483.7 ± 0.5 and 
485.7 ± 0.5, the red arrow in Figure 99). An R/S selectivity factor of 1.506 is obtained 
using this method, significantly higher than the previous result.  
 
For comparison, method 4 was run which involved isolating the 65Cu isotope 
peak (359 m/z) with a narrow isolation band-width of 0.5 m/z and reacting with the R 
Figure 99. Method 2, isolating all peaks, but integrating only the 63Cu and 65Cu peaks. 
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and S enantiomers. Using an isolation width of 1 in the calculations, a selectivity factor, 
R/S, of 1.51 was obtained, similar to the result obtained by method 3. An ANOVA was 
run which did not show any difference between the methods 3 and 4.  
 
The new methods yield an R/S value significantly higher than the previous 
results. It is most likely the other species (356 and 358 m/z) are coordinating with the 
enantiomers with different selectivity and hence bring the R/S ratio down to 1.30. 
Evidence for this is observed in the different fragmentation patterns between the 356 / 
358 m/z (potential Fenton-species) and 357 / 359 m/z species. The 357 m/z species 
results in the usual fragmentation pathways, i.e., formation of the amide and nitrile 
fragments. 
 
The 357 m/z ion, corresponding to the correct molecule, was isolated with a narrow 
isolation window and fragmented at 30% collision energy and 30 msec activation time, 
resulting in the spectrum below in Figure 100. 
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Isolation of the 356 m/z ion, with a narrow isolation width, followed by 
fragmentation at 30% energy and 30 msec activation time yielded a peak at 300 m/z 
(Figure 101). This is most likely from Fenton-chemistry, with hydrogen abstraction of the 
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Figure 100. Isolation and fragmentation of 357m/z at 30% energy and 30 msec activation time. 
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t-butyl group, followed by an alkyl shift. Subsequent fragmentation leads to a loss of the 
t-Bu group, leaving 300 m/z (Figure 102). 
 
 
Isolation of the 356 m/z ion and subsequent reaction with 1-phenylethanol, yielded no 
coordination, potentially a result of oxidation of the copper and subsequent bond 
formation with the t-Bu group. Due to this investigation, the 65Cu isotope was isolated 
and reacted with the chiral reagents. This ensured the most accurate results possible, 
Cat B new prep 080712 iso 356 and frag #1-10 RT: 0.05-0.61 AV: 10 NL: 8.12E5
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Figure 101. Isolation of 356 m/z, followed by fragmentation at 30% energy and 30 msec activation time. 
Figure 102. Proposed mechanism of the formation of the 356 m/z ion, followed by fragmentation, leading 
to 300m/z.  
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while simplifying the integration and analysis. All results were obtained using this 
method. 
 
5.13 – Conclusion  
 
 
 A   new   method   for   determining   a   catalyst’s   stereo-environment has been 
developed utilizing a modified QIT and a series of chiral probes. Due to the importance 
of cyclopropanes in chemistry, the excellent ee afforded by copper bis-oxazolines in 
cyclopropanations, and their commercial availability, the bis-oxazolines offered an 
excellent starting point for development of the method. Using commercially purchased 
chiral alcohols and epoxides, and synthesizing chiral ethers, the bis-oxazoline catalysts 
were systematically probed to determine the selectivity of each catalyst. The 1-phenyl-
2-propanol, 2-methoxyethylbenzene, styrene oxide, and 1-phenyl-1-propanol proved to 
be the best chiral probes, ones that may be used to determine the asymmetric 
environment of unknown catalyst systems.  
 
 The data indicate that larger groups on the probe or the catalyst near the 
stereocenter afford better selectivity. The t-Bu and phenyl groups at the 4-position of the 
bis-oxazoline (B, C, E, G) yielded much better selectivity than the corresponding iso-
propyl groups (D and F), with the a benzyl moiety (A) proving too big to coordinate. In 
general, the stereoselectivity observed by a catalyst was in good agreement with the 
literature, with catalyst E displaying better selectivity in the gas-phase than would be 
expected based on literature. The R preference was observed for most of the probes, 
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with the noticeable difference being styrene oxide, which preferred the S enantiomer in 
the gas-phase, the opposite enantiomer preference from that experienced in the 
condensed-phase.  
 
 A series of investigations were made to the method to improve performance, 
chief among them was the isolation of the 65Cu isotope to improve the accuracy of the 
results. It was discovered that the presence of oxygen and copper combined to produce 
an environment conducive to redox chemistry, altering the structure of the ligand in the 
process. Multiple experiments were performed to determine the reproducibility of the 
method. Accuracy was determined based on achiral results, which yielded no 
preferential selectivity. Sample prep variability was minimal, and the precision was 
deemed excellent based on multiple days of analysis with the same preparation. The 
RSD for the results, at least three sample preps on three different days, was below 6% 
for 90% of the results, with the higher RSDs most likely due to imperfect internal 
standards which give low peak ratios. Nonetheless, the method appears capable of 
determining the asymmetric environment produced by the bis-oxazoline catalysts. 
 
 With a combinatorial approach proven successful, the possibility of the method 
for use as a rapid chiral catalyst-screening tool is apparent. The next chapter will further  
explore the use of this method for that purpose. 
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Chapter 6 – Di-Imines and the Combinatorial Approach 
 
 
 
 Since the previous work with the bis-oxazoline catalysts were run as single 
catalysts, the next step represented running catalysts in combination, using the mass 
spectrometer to filter and separate the catalysts. Di-imines were the natural choice for 
catalysts for use in development of a combinatorial method. The ease of synthesis 
from readily-available starting materials allows for a diverse array of ligands, with little 
effort.  
 
 Screening catalysts in a combinatorial fashion allows for a much simpler and 
faster process, by-passing many stages including purification, testing and analyzing, 
(Figure 103). A much more efficient process would consist of screening catalysts at the 
crude stage, via a combinatorial approach. The modified ion-trap mass spectrometer, 
affords the possibility of probing multiple chiral catalysts native environments at a much 
earlier stage in the catalyst development cycle, saving time, resources, and money in 
the process. 
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Figure 103. Catalyst Screening Process 
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The most common di-imine   is  Jacobsen’s  catalyst,  also   refered   to  as  a  Salen,  
used in asymmetric epoxidations; however, the metal used is Mn, not Cu.86 Like the 
bis-oxazolines, copper is commonly used with di-imines (not Salens) in asymmetric 
aziridinations,289 and cyclopropanations.253   
 
The following chapter details the development of a rapid chiral catalyst 
screening method, utilizing the modified QIT and the previous chiral probes, particularly 
1-phenyl-2-propanol, styrene oxide, and 1-methoxyethylbenzene.  
 
 
6.1 – Synthesis of Di-imines 
 
 
 Two general classes of di-imines were selected, with either an ethylene diamine 
or BINAM-based backbone. The following di-imines were synthesized starting from 
chiral amines and various aromatic benzaldehdyes with the scheme below (Scheme 
35).  
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 Table 15 displays the reagents and products used in the experiments. 
 
Table 15. Starting materials and products used in the di-imine study. 
 abbrev R enantiomer R1 R2 R3 R4 R1` R2` R3` R4` 
1a   S & R         
1b  Ph meso         
1c  1-napthalene S & R         
2a    H H H H     
2b    F H H F     
2c    Me H Me Me     
2d    H t-Bu H H     
2e    Cl H H Cl     
2f     OMe H H OMe     
2g    Br H H F     
3a Benz 1a S, R H H H H H H H H 
3b 2,6-diF 1a S, R F H H F F H H F 
3c Mesit 1a S, R Me H Me Me Me H Me Me 
3d t-Bu 1a S, R H t-Bu H H H t-Bu H H 
3e DiCl 1a S Cl H H Cl Cl H H Cl 
3f OMe 1a S OMe H H OMe OMe H H OMe 
3g 2Br,6F 1a S Br H H F Br H H F 
3h Imidaz 1a S         
3i 3,5-diF 1a S H F H H H F H H 
4a Ph Benz 1b meso H H H H H H H H 
4b Ph DiF 1b meso F H H F F H H F 
4c Ph Mes 1b meso Me H Me Me Me H Me Me 
4d Ph t-Bu 1b meso H t-Bu H H H t-Bu H H 
Scheme 35. Synthesis of di-imines. 
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6.1.1 – General Synthesis Procedure 
 
 
To an appropriate-sized round bottom flask (RBF), usually 25 mL, the chiral 
diamine was weighed and added to the RBF. Approximately 5 mL of ethanol was 
added, quantitatively transferring the diamine to the flask. Then 0.95 eq of the 
aldehyde was added to the RBF and stirred with a magnetic stir-bar. Reactions were 
conducted by either heating to reflux or by the addition of 50 mg of 4Å molecular 
sieves. Reaction times were 1-2 hours for refluxing, and 1-3 days for the molecular 
sieves. Toluene was added if the diamine did not readily dissolve.  
 
For reactions at reflux, the solution was allowed to cool to room temperature, 
after which the product precipitated. The product was then cooled to 0 °C and filtered. 
In some cases a 2nd crop was isolated. In the cases where molecular sieves were 
4e Ph DiCl 1b meso Cl H H Cl Cl H H Cl 
4f Ph OMe 1b meso OMe H H OMe OMe H H OMe 
4g Ph Br/F 1b meso Br H H F Br H H F 
4h Imidaz 1b meso         
4i 3,5-diF 1b meso H F H H H F H H 
5a Benz 1c S, R, racemic H H H H H H H H 
5b 3,5-diF 1c S H F H H H F H H 
5c Mes 1c S, R Me H Me Me Me H Me Me 
5d 3,5-di-t-Bu 1c S H t-Bu H H H t-Bu H H 
5e DiF2,6 1c S F H H F F H H F 
5f OMe 1c S OMe H H OMe OMe H H OMe 
5g DiCl2,6 1c S Cl H H Cl Cl H H Cl 
5h DiCl3,5 1c S H Cl H H H Cl H H 
5i 2Br,6F 1c S Br H H F Br H H F 
6a Mes/F 1c S Me H Me Me H F H H 
6b Benz/mes 1c S H H H H Me H Me Me 
6c Benz/t-Bu 1c S H H H H H t-Bu H H 
6d Benz/F 1c S H H H H H F H H 
6e Benz/BrF 1c S H H H H Br H H F 
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used, the solution was filtered to remove the molecular sieves, followed by washing 
with 1-3 mL of ethanol. The product was allowed to precipitate, then filtered and 
washed. For the BINAM cases, the solutions required rotary evaporation, followed by 
recrystallization in petroleum ether and hexanes. However, in most cases, this was 
unsuccessful and the crude product was utilized.  
 
For compounds 6a-e, 200 mg of diamine was mixed with approximately 1.3 
equivalents of the various benzaldehydes in a RBF. Approximately 20 mL of ethanol 
was used to dissolve the mix and 100 mg of 4Å molecular sieves was added. The 
solution was stirred with a magnetic stir bar for 1 day, after which the solution was 
evaporated via a rotary evaporator, followed by the quick addition of methanol to 
prevent oxidation. The crude solution was stored in the refrigerator when not in use. 
Specific procedures may be found in the appendix.  
 
Mass spectra were taken for all samples. In addition, collision-induced 
dissociation was used to generate fragmentation patterns. Selected samples were 
subjected to NMR analysis (see appendix).  
 
6.2 – Combinatorial Approach 
 
 
 As a first step, it was necessary to optimize conditions for simultaneously 
evaluating multiple catalysts in a single sample/solution. This is a significantly different 
strategy than the simpler approach with the bis-oxazolines, where a single catalyst was 
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present in each sample that was evaluated. After evaluating several copper salts and 
combination of salts, it was found that a mixture of CuI and CuCl gave the best results. 
This combination avoided counter-ion complexes observed with triflate salts and the 
CuI limited redox degradation of the ligand by Fenton chemistry. A spectrum for a 
solution containing multiple ligands and the CuCl/CuI mix is given in Figure 104.  
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The copper mix was run as a saturated solution, which gave the highest abundance of 
signal.  
Figure 104. Mix of catalysts with CuI:CuCl in approximately 1:1 ratio, with the structures and 
assignments. 
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 The role of the iodide anion was to reduce any Cu(II) back to Cu(I), forming 
iodine in the process. This was evident in a brownish color solution over time. 
Degassing the solvent minimized the presence of oxygen that initiated the reaction. A 
solution containing only CuI was tried, but no coordination with the ligand was 
observed (Figure 105). Since the ligands bearing coordinating substituents at the ortho 
position (e, f, g, an h) did not coordinate, they were not included in future mixes.  
 
 The ratio of the copper salts in the solution was critical. Much cleaner spectra 
were observed with a 1:1 CuI/CuCl mix (Figure 106a) compared to a 2:1 mix (Figure 
106b). 
 
Mix with CuI #1-10 RT: 0.00-0.17 AV: 10 NL: 1.68E6
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Figure 105. Ligand mix with CuI. No coordination evident. 
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 With the CuCl:CuI ratio fixed, stock ligands solutions of the ligands were made 
at approximately 1-2 mg of ligand per 1.5 mL of copper solution. A saturated solution of 
copper salt was made at time-of-use by mixing a 1:1 ratio of CuI:CuCl (approximately 
Figure 106. (a) – Catalyst mix with good ratio (1:1) of CuI:CuCl. (b) - Same ligand mix with a 2:1 ratio 
CuI:CuCl. 
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15-20 mg each) into 1.5 mL of degassed MeOH, and vortexing the solution to mix it. 
The solution was centrifuged and the supernatant was transferred into a clean vial. The 
stock ligand solutions were kept in the refrigerator when not in use. Approximately 50 
PL of each stock ligand solution was added to a vial and diluted to 1.5 mL with 
methanol. 200 PL of stock copper solution was added to a vial and diluted to 1.5 mL 
with degassed methanol. The dual syringe method was utilized for the mixing the 
copper solution and ligands and infused into the instrument at a rate of 1-5 PL per 
minute.  
 
6.3 – Trans-1,2-diaminocyclohexane-based Di-Imine Cu Catalysts 
 
 
Using a narrow isolation width of 1.0 m/z, each catalyst in the mixture was 
isolated with the 65Cu isotope in the ITMS and allowed to reach equilibrium with the 
chiral probe. The procedure was the same as in the bis-oxazoline work. Results for the 
combinatorial approach for the (1S,2S) cyclohexane di-imine are shown below, 
grouped by chiral probe (Figure 107) and catalyst (Figure 108). The results were also 
converted to diastereomeric excess and are shown in Figure 109, followed by the 
results displayed as box plots in Figure 110. 
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1"phenyl"2"propanol- 1"phenyl"1"propanol- 1"phenylethanol- styrene-oxide- 1,-2"epoxybutane- 2"methoxyoctane- 1"methoxyethyl-benzene-
benzaldehyde-(3a)- 1.47- 1.20- 1.15- 0.93- 0.98- 0.89- 1.38-
2,6"diF-(3b)- 2.15- 1.29- 1.16- 0.83- 1.06- 1.00- 1.71-
mesitaldehyde-(3c)- 1.34- 1.18- 1.10- 1.03- 0.97- 0.89- 0.94-
3,5"di"t"Bu-(3d)- 1.19- 1.03- 1.05- 1.16- 1.26-
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Figure 107. Results of the (1S,2S) cyclohexane di-imine catalysts. 
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benzaldehyde (3a) 2,6-diF (3b) mesitaldehyde (3c) 3,5-di-t-Bu (3d)
1-phenyl-2-propanol 1.47 2.15 1.34 1.19
1-phenyl-1-propanol 1.20 1.29 1.18 1.03
1-phenylethanol 1.15 1.16 1.10 1.05
styrene oxide 0.93 0.83 1.03 1.16
1, 2-epoxybutane 0.98 1.06 0.97 1.26
2-methoxyoctane 0.89 1.00 0.89
1-methoxyethyl benzene 1.38 1.71 0.94
0.00
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Figure 108. Results grouped by catalyst. 
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Figure 109. Results converting equilibrium ratios to diastereomeric excess. 
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Figure 110. Results presented as box plots. 
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6.3.1 – General Discussion 
 
 
 The selectivity was much lower than that observed for the bis-oxazolines. The 
chiral probe 1-phenyl-2-propanol had the highest average selectivity, followed by 1-
methoxyethylbenzene (Table 16). 
 
Table 16. Averages for the chiral probes with the (1S,2S) cyclohexane di-imines. 
 
1-phenyl- 
2-
propanol 
1-phenyl-
1- 
propanol 
1- 
phenylethanol 
styrene 
oxide 
1,2- 
expoxybutane 
2-
methoxy 
octane 
1-methoxy 
ethylbenzene  
 
Average 
KR/KS 1.50 1.17 1.12 0.98 1.06 0.93 1.30 
 
 
The probe styrene oxide displayed significantly lower selectivity than for the bis-
oxazolines, with the 2-methoxyoctane again displaying a slight preference for the S 
enantiomer (as with styrene oxide), in contrast with the others and an R preference.  
 
There appears to be a slight inverse relationship to the size of the substituent 
group and the observed selectivity. For example, when excluding the catalyst (3b) the 
1-phenyl-2-propanol probe displayed higher selectivity with the unsubstituted 
benzaldehyde, followed by the bulkier mesitaldehyde, and finally the much bulkier t-Bu 
substituted catalyst. Counter intuitively, the added steric bulk negatively affects the 
mechanism of stereoselectivity in these systems.  
 
This is also reflected in the binding energies of the complexes (Table 17). 
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Table 17. Free energy of binding for the trans cyclohexane di-imines (kcal/mol).  
 
Introduction of steric bulk generally decreases the binding energy, following the 
pattern observed earlier with decreasing selectivity with increasing bulk. For example, 
catalysts 3c and 3d display weaker binding than the unsubstituted 3a catalyst. Plotting 
the Gibbs free energy of binding versus selectivity factor, shows a weak correlation 
between the selectivity and binding energy for the phenyl-based alcohols, and 1- 
methoxyethylbenzene (Figure 111).  
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The data shows the DiF catalyst binds the strongest to the probes except 1,2-
epoxybutane and 2-methoxyoctane. The free energy of binding was plotted against the 
molecular weights of the chiral probes (Figure 112). Polarizability clearly drives the 
binding energy for the 3b catalyst, but for the others, the benefit of the larger molecular 
weight and polarizability is offset by the added steric interactions. 
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Figure 111. Plot of delta G versus selectivity factor. 
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 For example, the t-Bu catalyst (3d) displayed a flat line, indicating any benefit 
gained from the polarizability of the larger probe is negated by the steric interactions 
between the tert-butyl groups and the probe near the copper-coordinating site. The 
difference in Lewis basicity between the styrene oxide and 1-phenylethanol is not as 
pronounced as it was in the bis-oxazolines, with 3d and 3b displaying small differences, 
and the 3a and 3c displaying larger differences. 
 
The most common catalyst in the literature is the 2,6 dichloro-based catalyst 
(3e), which did not coordinate in the gas-phase here. The lone-pair electrons from an 
ortho chlorine can interact with the copper and prevent coordination of the probe. This 
Figure 112. Gibbs Free Energy of binding versus chiral probes molecular weight. 
Benzaldehyde (3a) 
2,6-diF (3b) 
mesitaldehyde (3c) 
3,5-di-t-Bu 
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the results were within error of the theoretical value 1. Only one sample prep was 
performed for the R enantiomers, so some of the error could also be due to the limited 
number of repeats.  
 
6.3.3 – Combinatorial versus Single Runs 
 
 
 To ensure there were no other isobaric species in the catalyst mixture that were 
affecting the selectivity results, the combinatorial runs were compared against the 
catalysts run by themselves. The results are shown in Figure 115. All the results were 
statistically the same between the single runs and the combinatorial experiment, except 
for the mesitaldehyde and 1-phenyl-1-propanol system.  
 
Figure 114. Chiral cross check of the di-imines. 
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the results were within error of the theoretical value 1. Only one sample prep was 
performed for the R enantiomers, so some of the error could also be due to the limited 
number of repeats.  
6.3.3 – Combinatorial versus Single Runs!
 
 
 To ensure there were no other isobaric species in the catalyst mixture that were 
affecting the selectivity results, the combinatorial runs were compared against the 
catalysts run by themselves. The results are shown in Figure 115. All the results were 
statistically the same between the single runs and the combinatorial experiment, except 
for the mesitaldehyde and 1-phenyl-1-propanol system.  
 
Figure 114. Chiral cross check of the di-imines. 
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 Fragmentation was performed on each catalyst run separately, and in a mixture 
of catalysts, to ensure there were no other isobaric species present. The fragmentation 
patterns were compared (Figure 116) to ensure there were no other m/z fragments 
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Figure 116. Fragmentation of the benzaldehyde catalyst (3a) isolated from a mixture (left) and from a 
pure solution (right).  
Figure 115. Single versus combinatorial runs. 
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arising from different species. The ratios may not have been exact due to the smaller 
signal (lower ion abundance) when run as a mixture, as well as variation in instrument 
performance. The other patterns are found in the appendix. 
 
 
6.3.4 – RSD 
 
 
 The RSD values were generally good, with the majority (85%) of the results for 
the multiple runs under 7% (Figure 117). Half of the styrene oxide runs had high 
deviations due to the weak coordination of the probe, and non-ideal internal 
standard/analyte ratios (Figure 118).  
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There was extreme variability observed with the fluorine-based catalyst 3b and 1-
phenyl-2-propanol. Part of this may be explained by the ratio of the internal standard 
and analyte being far from ideal (Figure 119); however, the mixing ratios were not too 
far from those used with styrene oxide, which while displaying high RSD itself, was not 
of the same magnitude observed for 1-phenyl-2-propanol. Thus, there may be other 
contributing factors to the high RSD values.  
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Figure 118. (S) Styrene oxide with internal standard and catalyst 3c. 
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 One possibility is a Lewis-acid catalyzed nucleophilic attack at the imine carbon 
(Figure 120). Even if this were a minor pathway it could significantly affect the ratios. 
 
 
 
 
 
 
 
 
6.4 – BINAM Di-Imine Catalysts 
 
 
Figure 120. Nucleophilic attack by alcohol on catalyst 3b. 
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Figure 119. 1-phenyl-2-propanol spectra. (S ) enantiomer on the left and (R ) enantiomer of the right. 
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 Due to the lack of conformational rigidity of the trans cyclohexane di-imines, a 
more  rigid  diamine  was  sought.  1,1’-binaphthyl-2.2’-diamine (BINAM) proved to be an 
excellent choice, as the selectivity was markedly improved, while also offering a simple 
synthesis and the opportunity to examine a seven-membered chelation ring instead of 
the previous 6 (bis-oxazolines) and 5 (trans-cyclohexane di-imines) membered rings 
formed with copper and the ligands. As with the previous trans-cyclohexane di-imines, 
the only ligand with an ortho substituent with lone pairs that coordinated with the 
probes was the DiF catalyst; catalysts 5e-5i did not coordinate, and readily oxidized in 
air if left as solids. 
 
6.4.1 – General Discussion 
 
 
 Results for the BINAM catalysts are shown as selectivity factors (Figure 121) 
and DE (Figure 122). 
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Figure 121. Results for the BINAM-based catalysts. 
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Figure 122. BINAM-based catalysts results as DE. 
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The selectivity observed was much greater than that in the trans-1,2-cyclohexane 
based di-imines, and close to that observed in the bis-oxazoline systems. The chiral 
probe 1-phenyl-2-propanol displayed behavior different from than that observed in the 
past. For example, two of the four catalysts displayed a preference for the S 
enantiomer, which was not previously observed for this probe. It also displayed 
enhanced selectivity with only one of the catalysts (5c), while the other phenyl-based 
alcohols displayed selectivity over the entire catalyst range, suggesting specific 
interactions (possibly H-bonding) are responsible for the selectivity. Overall though, the 
general trends were similar with a preference for the (R) enantiomer for the alcohols 
and 1-methoxyethylbenzene, and the (S) enantiomer for the epoxides and 2-
methoxyoctane.  
  
 When examining the averages for the chiral probes (Figure 123), the best 
probes for this system were the two ethers, 1-methoxyethylbenzene and 2-
methoxyoctane. The largest ether, 1-benzylethylbenzene, did not coordinate to the 
catalysts, presumably for steric reasons. The bulkier catalysts, 5c and 5d, did not 
coordinate with 2-methoxyoctane, again likely due to sterics. A new diastereomeric 
epoxide was also screened with these complexes, 1-phenyl-2-propylene oxide; 
however, as it will be shown later, the results obtained are unreliable.  
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Figure 123. Averages for the chiral probes. 
 
 When examining the averages for the catalysts, a trend of increasing selectivity 
is observed with increasing steric bulk (Figure 124); however, no such trend is observed 
within the individual probes. The DiF (5b) catalyst is different from that used in the 
previous trans-cyclohexane-based di-imines. The previous 2,6 disubstituted di-imine 
was too crowded to coordinate. By moving the substituents to the 3,5 position, more 
space was created and coordination was observed.    
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6.4.2 – Gibbs Free Energy 
 
 In order to detect the coordination complex between the BINAM-based catalysts 
and the chiral probes, the scan speed needed to be set higher, from the default 5,000 
amu/sec to 65,000 amu/sec (turbo scan). This is due to the fragile nature of the 
complexes and the method of ejection from the trap. Using the resonant ejection 
technique, the ion is tickled at its resonant frequency imparting a small amount of 
energy to the complex. This was enough to dissociate the complex during the scan. By 
speeding up the scan speed, the time was reduced, allowing for the detection of the 
complex.  
 
Figure 124. Average selectivity for the catalysts. 
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 This fragile nature of the complex is reflected in the binding energies (and the 
fact that only a few systems could be measured), which ranged from -9.5 – 11.8 
kcal/mol, significantly lower than previous systems (Table 18).  
 
Table 18. Binding energies of the BINAM-based complexes (kcal/mol). 
 
 1-phenylethanol 1-phenyl-1-propanol 
1-phenyl-
2-propanol 
styrene 
oxide 
1,2-
epoxybutane 
2-
methoxy 
octane 
1-methoxy 
ethylbenzene 
Benzaldehyde 
(5a) -10.5 -11.8 -11.5 -8.9  -10.7 -10.1 
3,5-diF (5b)     -11.3   
Mesitaldehyde 
(5c) -9.9 -9.7 -10.0 -9.5    
3,5-di-t-Bu 
(5d) -10.5 -10.9  -8.5    
 
 
 When plotting the values against the molecular weight of the chiral probe, the 
trend in polarizability is not as pronounced (Figure 125). This much weaker binding is a 
result of the much more rigid BINAM, offering little room for conformational freedom. 
The lower Lewis acid basicity of styrene oxide is evident, particularly for the t-Bu and 
benzaldehyde catalysts; for the mesital catalyst, it is not as pronounced, but still 
evident. 
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6.4.3 – Chiral Cross Check 
 
 Both enantiomers of the catalysts were synthesized for 5a and 5c catalysts. The 
R enantiomer for 5b (DiF) was synthesized, but oxidized before it could be run. The 
results are compared in Figure 126. A chiral cross check could also be performed with 
the data (Figure 127). Most of the results matched a value of one, within error, for the 
chiral cross check. For 1-phenyl-1-propylene oxide, an impurity was in one of the 
enantiomers of the probe. Resolution is decreased when the turbo scan is used, which 
caused the impurity to overlap with the probe, causing an error in the final analysis. 
The remaining deviations from the theoretical value of one may be attributed to a non-
ideal ratio between the probe and internal standard. 
Figure 125. Plot of Gibbs binding energy versus the chiral probe molecular weight. 
benzaldehyde (5a) 
mesitaldehyde(5c) 
3,5-di-t-Bu 
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Figure 126. Selectivity factors for both enantiomers of the BINAM-based catalysts. 
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6.4.4 – Combinatorial versus Single Runs 
 
 
 
When comparing the catalysts run in combination against the single-run 
catalysts, excellent agreement (within error) exists between the two values, indicating 
there were no impurities that interfered with the results in the combinatorial approach, 
giving further confidence in this method for use as a rapid chiral catalyst screening 
method. Figure 128 displays the results.  
 
 
Figure 127. Chiral cross check for the BINAM-based di-imines. 
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!
6.4.5 – RSD 
 
 A box plot of the results follows in Figure 129 followed by the RSD values 
grouped by chiral probe and catalyst (Figure 130). Approximately 22% of the results 
were under 7% RSD for the multi-prep, multi-day runs. While slightly higher than the 
results presented earlier, the variation is still acceptable, given the weak binding 
between the complex and chiral probe. In fact, only two cases were found where the 
RSD was unacceptably high, catalyst 5b and styrene oxide, and 5c and 1-
methoxyethylbenzne. For the case of styrene oxide, the internal ratio/analyte ratio was 
again 
Figure 128. The combinatorial approach versus single-run catalysts. 
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1-phenyl-1-propanol single runs 1.41 1.57 1.38 1.45
1-phenyl-1-propanol combinatorial 1.37 1.54 1.38 1.40
1-phenyl-2-propanol single runs 0.91 1.05 1.45 0.83
1-phenyl-2-propanol combinatorial 0.90 1.00 1.56 0.85
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again not ideal; however, no explanation can be given for the high RSD for the 1-
methoxyethylbenzene.  
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Figure 129. Box plot of the results for the (S) BINAM-based di-imines. 
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Figure 130. RSD for the (S) BINAM-based systems grouped by catalysts (top) and by chiral 
probe (bottom). 
 213 
6.4.6 – System Checks 
 
 
 As a further check of the system, a racemic BINAM catalyst based 
benzaldehyde (racemic 5a) was synthesized and run with some select chiral probes. 
The values are close to the expected theoretical value of one, further demonstrating 
the accuracy of the method. 
 
Table 19. Selectivity factors obtained with select chiral probes and a racemic BINAM-based catalyst 
(5a). 
 
Racemic Benz 
(5a) 
1-
methoxyethylbenzene 2-methoxyoctane 1-phenylethanol 
Selectivity factor 1.04 1.00 1.02 
RSD% 4.8 3.9 5.5 
 
   
6.4.6.1 – Linearity  
 
 
 Using the racemic catalyst, racemic 1-phenylethanol and d5-ring 1-
phenylethanol as an internal standard, a series of preps were made varying the ratio of 
standard and analyte. The ratio of the areas obtained were graphed versus the ratio of 
concentrations (Figure 131). The method displayed a wide range of linearity, from 0.2 – 
2 ratio of internal standard/analyte, with an excellent coefficient of determination, R2, of 
0.998.  
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The full regression analysis is shown in Table 20. 
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Figure 131. Linearity of the method with racemic benzaldehyde-BINAM and d5-ring 1-phenylethanol and 
1-phenylethanol. 
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6.5 – Mixed  2,2’-Diaminobinaphthyl System 
 
 
 As proof of concept, a series of aldehydes, benzaldehyde, 3,5- 
difluorobenzaldehyde, mesitalaldehyde, 3,5-di-tert-butylbenzaldehyde, and 2-bromo-6 -
fluorobenzaldehyde, were mixed with (S) 2,2’-diaminobinaphthyl to form mixed 
symmetrical and unsymmetrical, novel ligands. The use of these unsymmetrical ligands 
for enantioselectivity has precedence in the literature.291,292,293,294 The crude mixture 
was added to the CuI/CuCl mixture and run on the ITMS. A representative spectrum of 
the catalyst mixture is shown in Figure 132. 
Regression Statistics
R 0.9991
R Square 0.9983
Adjusted R Square 0.9979
S 0.04
Total number of observations 7
ANOVA
d.f. SS MS F p-level
Regression 1. 5.72 5.72 2,914.08 4.13E-08
Residual 5. 0.01 0.
Total 6. 5.73
Coefficients Standard Error LCL UCL t Stat p-level H0 (5%) rejected?
Intercept 0.12 0.03 0.05 0.19 4.61 0.01 Yes
8.14936244097188 0.79 0.01 0.75 0.82 53.98 0. Yes
T (5%) 2.57
Residuals
Observation Predicted Y Residual Standard Residuals
1 3.16 -0.02 -0.52
2 1.82 0. 0.
3 1.29 0.02 0.42
4 0.91 0.07 1.62
5 0.74 0.02 0.49
6 0.55 -0.02 -0.42
7 0.31 -0.06 -1.58
Linear Regression
LCL - Lower value of a reliable interval (LCL)
UCL - Upper value of a reliable interval (UCL)
Table 20. Regression analysis results. 
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6.5.1 – General Discussion 
 
 
 The results for the mixed catalysts are shown in Figure 133. The results are 
presented in DE, grouped by chiral probes (Figure 134) and by catalysts (Figure 135). 
In general, the unsymmetrical catalysts performance was equal to that of the 
symmetrical C2 counterparts, suggesting the general asymmetric environment near the 
coordinating center is driving  the  selectivity  versus  the  specific  details  of  the  catalyst’s  
substituent group.  
 
Figure 132. Representative spectra of the crude mixed BINAM catalysts. 
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Figure 133. Results of the crude mixed catalyst system. 
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Figure 134. Diastereomeric excess grouped by chiral probes. 
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Figure 135. Diastereomeric excess grouped by catalyst. 
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The differences in selectivity between previous C2-symmetric catalysts and the 
unsymmetrical catalysts are shown in Figures 136-138. Figure 136 displays the 
differences between the unsymmetrical catalyst 6d, composed of a benzaldehyde and 
3,5-difluorobenzaldehyde, to that of the C2-symmetric counterparts. The most obvious 
differences are displayed with the 1-methoxyethylbenzene probe, where the absence of 
a fluoro group results in a substantial decrease in selectivity, on par with the selectivity 
observed for the non-substituted catalyst (benzaldehyde). Interestingly, the removal of a 
single fluoro (3,5-DiF) substituted benzaldehyde on the catalyst resulted in no 
coordination for the 1-phenyl-2-propanol probe; alternatively, the addition of this group 
resulted 
Figure 136. Comparison of the mixed catalyst 6d (Benz & DiF) with the C2 counterparts 5a 
(benzaldehyde) and 5b (3,5-diF). 
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group resulted in coordination to the 1,2-epoxybutane probe, where it was only 
observed in the DiF substituted catalyst previously. 
 
 Moving to the benzaldehyde and mesitaldehyde catalyst 6b, the addition or 
subtraction of one of the benzaldehdyes can also affect the coordination and selectivity 
(Figure 137). For example, no coordination was observed in either of the C2-symmetric 
catalysts 5a or 5c with the 1,2-epoxybutane probe; however, the mixed catalyst (6b) 
displayed coordination, but no selectivity, to the probe, indicating two mesital units are 
too sterically demanding, while one unit provides some form of stabilization 
(polarizablity) 
Figure 137. Mixed catalyst 6b (Benz and Mesital) versus the C2-symmetric catalyts. 
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(polarizability), and that these forces strike a delicate balance in some systems. 
Another example of this balance is also observed in the 1-methoxyethylbenzene probe. 
The addition of the mesitaldehyde unit may also reverse the selectivity, as shown with 
1-phenyl-2-propanol, where addition of one or two mesitaldehyde units reversed the 
preference from the S enantiomer with the unsubstituted benzaldehyde, to the R 
enantiomer, and enhances selectivity in the process. 
  
 The balance between sterics and polarizability is also observed in the mixed 
catalyst 6a (DiF and mesital) and the 1,2-epoxybutane and 2-methoxyoctane probes, 
where the addition of two units of the mesitaldehyde proves too sterically demanding, 
overriding any additional stabilization from the extra bulk and polarizability (Figure 
138).  
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 A large difference in selectivity between the C1 and C2-symmetric catalysts was 
observed in only a couple of instances. For example with 1-phenyl-2-propanol, where at 
least one mesital substituent proves necessary for selectivity, an additional substituent 
actually decreases selectivity slightly. When moving to two mesital substituents in the 
case of 2-octanol, a complete reversal of the enantiomeric preference was observed, 
offering a drastic change in the local environment of the probe. 
 
 Finally, for catalyst 6c (Benz and t-Bu), the extra steric-hindrance provided by the 
tert-butyl group was too demanding for the chiral ethers (Figure 139). No 
ggggggggggggg 
Figure 138. Mixed catalyst 6a (DiF and mesitaldehyde) versus 5b (benz) and 5c (mesital). 
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coordination was observed for the bulkier 1-methoxyethylbenzene probe with any 
catalyst with a t-Bu substituent. Coordination was observed only between the singly t-Bu 
substituted 6c catalyst and 2-methoxyoctane. The addition of a singly substituted t-Bu 
group enhanced the selectivity in the case for 1-phenylethanol, where addition of a 
second substituted ring diminished the selectivity back to the level observed in the 
unsubstituted benzaldehyde catalyst.  
 
 When examining the average selectivity over the groups of chiral probes, a 
similar pattern to that of the C2-symmetric catalyst emerges (Figure 140). The chiral 
ethers were once again the most selective probes for these catalysts. The selectivity for 
the 1-phenyl-2-propanol probe also appears to have increased from approximately 1.00 
to 1.28. 
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Figure 139. Mixed catalyst 6c compared to the C2-symmetric catalysts.  
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When examining the averages for the mixed catalysts, the larger substituent in 
the mixed system yielded approximately the same selectivity as the larger C2-symmetric 
counterpart (Figure 141). For example, the average for the C2-symmetric mesital 
catalyst (5c) was 1.12, whereas here, the averages for the mesital-containing catalysts 
were 1.13 and 1.20.  There was no difference found upon addition of a t-Bu group when 
comparing against the unsubstituted benzaldehyde, however, the selectivity decreased 
when compared to the C2-symmetric t-Bu catalyst (1.12 vs. 1.02). 
 
 
Figure 140. Average selectivity for the chiral probes with the mixed catalysts. 
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6.5.2 – Gibbs Free Energy  
 
 
 The Gibbs free energy of binding was once again measured and is shown in 
Table 21. The balance between the negative impact of sterics and the positive effect of  
 
Table 21. Gibbs free energy for the mixed system (kcal/mol). 
 
 1-phenylethanol 
1-phenyl-
1-
propanol 
1-phenyl-
2-
propanol 
styrene 
oxide 
1,2- 
epoxybutane 
1-methoxy 
ethylbenzene 
2-
methoxy 
octane 
2-
octanol 
DiF &  
Mesital 
(6a) 
-10.6 -12.0 -12.2 -10.1 -9.6 -10.8 -10.9 -11.1 
Benz & 
mesital 
(6b) 
-10.7 -11.3 11.7 -9.9 -8.7  -10.7 -11.5 
Benz&t-
Bu (6c) -15.4 -10.3 -11.0 -8.4   -9.9  
Benz & 
DiF (6d) -15.3   -10.8 -9.7  -12.0 -12.9 
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Figure 141. Average selectivity factor for the catalysts. 
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polarizability can be shown in these results when comparing with those obtained for the 
C2-symmetric catalysts. For example, the binding energy of the C2-symmetric catalyst 
5d was -10.5 kcal mol-1. Upon removal of a t-Bu group, there is steric relief and a 
significant increase in binding energy (catalyst 6d) to -15.4 kcal mol-1, a 50% increase. 
Alternatively, removal of a fluoro substituent from the catalyst allows for the equilibrium 
to be measured (and hence the free energy to be calculated), whereas in the 
disubstituted catalyst, 5b, the equilibrium highly favors the products and the 'G could 
not be measured. 
 
 Figure 142 shows a plot of the binding energy versus the molecular weight. The 
t-Bu-containing catalyst displays a relatively flat line, with the exception of 1-
phenylethanol. The other catalysts also displayed less sensitivity to polarizability than 
the bis-oxazoline and the trans-cyclohexane di-imines. A dramatic difference is 
observed for the Lewis basicity of styrene oxide when compared to 1-phenylethanol, 
particularly for the t-Bu and DiF containing catalysts. This difference is not as stark for 
the other two catalysts (mesital and benz).  
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6.5.3 – RSD 
 
 
 A box plot of the results is shown in Figure 143, followed by a plot of the RSD 
grouped by chiral probe and catalysts (Figure 144). The RSD were close to those 
observed in the C2-symmetric BINAM-based catalysts, with 27% of the results 
displaying an RSD higher than 6%. 
Figure 142. Binding energy versus molecular weight of chiral probe. 
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Figure 143. Box plot of the results for the crude mixed catalyst system. 
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6.6 – Meso-1,2-Diphenylethylenediamine-based Di-Imines 
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Figure 144. RSD values for the mixed system. Grouped by chiral probe (top) and catalyst (bottom). 
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 Achiral meso-1,2-diphenylethylenediamine was condensed with various 
aldehydes to produce catalysts 4a-g. Due to the smaller signal in the ITMS, isolation of 
the 65Cu isotope and subsequent reaction with chiral probes, gave signals too low to be 
reliable, thus, a wider isolation range of 5 m/z was used to obtain a suitable signal. 
Again, with substituents bearing lone pair electrons, only the 2,6 difluoro substituted 
aldehyde displayed coordination. Being achiral, there should be no selectivity 
observed. Only the 1-phenyl-1-propanol probe displayed slight selectivity (Figure 145). 
It is unknown why this probe displayed this behavior, although the wider range of m/z 
selected may have isolated catalyst degradation species, and the 1-phenyl-1-propanol 
probe was more sensitive to these species than the other probes. 
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6.7 – Conclusion 
 
 
 Working with relatively unknown, or completely novel catalysts, as was the case 
for the mixed systems, a combinatorial approach was taken for examining the chiral 
environment induced by the catalysts via chiral probes. The previous bis-oxazoline 
studies allowed for the identification of probe reagents that could be used to determine 
the asymmetric environment of the catalyst. Up to eight different catalysts were mixed 
and separated in the ion-trap, however, due to non-coordination, a maximum of four 
hooo 
Figure 145. Selectivity for the meso-1,2-diphenylethylenediamine-based di-imines. 
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yielded results. This was due to lone-pair containing substituents interacting with the 
copper and effectively blocking access to the probe.  
 
The trans-1,2-diaminocyclohexane-based di-imines proved not to be rigid 
enough to yield satisfactory selectivity when compared to the previous bis-oxazoline 
systems, with the 1-phenyl-2-propanol and 1-methoxyethylbenzaldehyde probes 
showing the highest selectivity. A slight inverse correlation between selectivity and size 
is observed in the phenyl-based alcohols. Generally, there was less dependence on 
the polarizability than that observed in the bis-oxazoline system. 
 
The BINAM-based catalysts proved much more effective due to the more rigid 
nature of the BINAM and the imposed rotational barrier. This allowed for much better 
determination of the chiral environment around the copper and the coordinating probe. 
The overall strength of binding was lower for these catalysts, requiring the instrument 
to be run in turbo scan mode in order to detect the complexation. The 1-
methoxyethylbenzene was the best overall probe for the BINAM-based catalysts.  
 
As proof-of-concept, a crude mixture of novel chiral catalysts were synthesized 
and screened via the modified ITMS. These mixed C1-symmetric benzaldehyde 
catalysts displayed similar selectivity as their C2-symmetric counterparts, indicating the 
substituents have a limited effect on selectivity, but did display significant impact on 
binding energies.  
 234 
Multiple checks were performed, including chiral cross checks, comparison of 
single run catalysts and combinatorial, and achiral catalyst runs. In most cases, the 
data indicated excellent accuracy and precision, except for the case of the meso-
diphenylethylenediamine-based catalysts with the chiral probe, 1-phenyl-1-propanol. 
Overall, however, the ability to rapidly screen chiral catalysts and the asymmetric 
environment induced by them with the modified ITMS has been shown herein to be 
accurate, reproducible, and transferable.   
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Chapter 7 – Conclusions 
 
 
 
 Due to the chirality found throughout nature, there exists a large market for chiral 
technologies, estimated to be $5.1 billion by 2017.20 The trend towards single 
enantiomer drugs, sparked by the thalidomide tragedy, has brought a need for better 
methodologies for asymmetric synthesis, such as chiral catalysts. The extremely small 
differences in transition state energies between diastereomeric complexes, which is 
responsible for enantioselectivity, imposes difficulty in theoretically designing and tuning 
chiral catalysts; thus, the C2-symmetric class of ligands is often the first line of catalysts 
used for new transformations. These catalysts, however, may not bring the desired 
selectivity, thus, combinatorial chemistry has been applied to find a desired chiral 
catalyst. This in turn imparts a need for a rapid chiral catalyst screening method to 
measure the effectiveness of catalysts in the large libraries that are created. 
 
 Current chiral catalyst screening methods are long processes. A reaction must 
be performed to gauge the effectiveness of the catalysts. This is usually done after 
purification of the crude catalysts and is a time-consuming process. Mass spectrometry, 
usually not a tool associated with chiral measurements, has recently been adopted for 
the study and quantitation of enantiomeric excess. When applied to chiral catalysts, it 
allows for the study of the catalysts at a much earlier stage in the screening process, 
since the MS can act as a filter, selecting only pure catalysts (assuming no other 
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isobaric species). It also affords the ability to study intermediates not possible in the 
condensed-phase, free from solvation and ion-pairing effects. Using a modified ion-trap 
mass spectrometer, a neutral reagent can be introduced and allowed to react with the 
ion, introduced via ESI.  
 
 Using the modified ion trap mass spectrometer and methodology, intermediates 
in catalytic cycles have been deduced,295 kinetics of reactions studied,198 proton 
affinities and bond strengths measured,175, 203, 296 and competitions between elimination 
and substitution reaction studied,297 as well as many other uses.199 Herein, we used it to 
determine a chiral catalysts inherent stereoselective preference, by introducing a chiral 
probe and allowed it to react with a chiral catalyst. Using an internal standard, and 
allowing the reaction to proceed to equilibrium, the chiral preference was determined. 
The   catalyst’s   binding   energy  was   also   be   determined.  Utilizing   the   ITMS  as  a  mass  
filter, multiple catalysts were screened from a crude synthetic mixture and assessed for 
their chiral discriminating ability. 
 
The C2-symmetric bis-oxazoline catalysts are readily available from Aldrich. 
These   catalysts   offer   excellent   ee’s   for   a   wide-range of transformations, particularly 
cyclopropanations, and thus offered an excellent catalyst to begin studies towards the 
development of a mass spectrometry-based chiral screening method. As expected, the 
(S,S) catalysts displayed excellent discrimination with a preference for the R enantiomer 
in most cases. The selectivity was generally greater with larger substituents such as t-
Bu, and phenyl. The bridging moiety did not have an impact on selectivity, save for a 
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few select cases, indicating the selectivity is determined/derived close to the metal 
center. 
 
The 1-methoxyethylbenzene, 1-phenyl-2-propanol, styrene oxide, and 1-phenyl-
1-propanol chiral probes proved to be the best chiral probes for determining the 
asymmetric environment of the catalyst. A large steric bulk near the coordinating atom 
was necessary for selectivity. This also contributed to the enhancement of the binding 
energy as the greater polarizability of the larger molecular weight probes displayed 
much higher binding energies. The lower Lewis bascitiy of styrene oxide when 
compared to a similar weight probe, 1-phenylethanol, was also evident in the weaker 
free energies of binding.  
 
Many improvements were made to the method. For example, by utilizing a tee 
and mixing the copper solution and ligands before entry to the ESI probe, in conjunction 
with isolating the higher molecular weight isotope of copper in the ion trap, potential 
interference from Fenton chemistry could be minimized. Multiple checks were run and 
the method displayed good accuracy and precision. 
 
The work with the bis-oxazolines allowed for the discovery of suitable chiral 
probes that could be used to probe other catalysts. These probes were then used on 
the trans-1,2-diaminocyclohexane-based di-imines in a combinatorial approach. 
Unfortunately, these displayed only moderate selectivity when compared to the bis-
oxazoline system, with the 1-methoxyethylbenzene and 1-phenyl-2-propanol proving to 
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be the best probes. A slight inverse relationship between size and selectivity was 
observed for the phenyl-based alcohols, with less dependence on polarizability for 
binding energy. Again, the R enantiomer was favored for the majority of the (S,S) 
catalysts. 
 
Due to the lack of selectivity displayed in the cyclohexane-based system, a more 
rigid catalyst was desired  and  found  in  the  2,2’binaphthyl-based catalyst. The selectivity 
was much higher than the cyclohexane-based systems, but slightly lower than that 
observed in the bis-oxazoline catalysts. The weak binding displayed by the catalysts 
necessitated the use of a faster scan speed (turbo scan) to minimize fragmentation 
during the MS scan. The fragile nature of these complexes was confirmed by the low 
binding energies observed in this system.  
 
This system displayed slightly different behavior than the others, with 1-phenyl-2-
propanol displaying less selectivity and with the (S) catalysts having preference for 
either the R or S enantiomer depending on the probe. The 1-methoxyethylbenzene  
probe displayed the best selectivity, as for the other systems. Conversely, the 
previously excellent chiral probe, 1-phenyl-2-propanol, displayed little selectivity in this 
system. The (S) catalyst’s   preference   for   (S) enantiomer of 2-methoxyoctane is more 
pronounced in this system.   
 
As a proof-of-concept, a novel mixed aldehyde system of BINAM-based catalysts 
were synthesized and run as a crude mixture. These C1-symmetric catalysts displayed 
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similar selectivity as the C2-symmetric counterparts, indicating the general chiral 
environment around the metal center, rather than substituent-specific features drives 
selectivity. Removal of one large group from the C2-symmetric catalyst, such as t-Bu, 
relived steric strain, and resulted in a large increase in binding energy (up to 50%) 
driven by the greater polarization of the added substituent when compared to 
benzaldehyde-based catalyst.    
 
  
 Again, multiple checks were run to ensure the accuracy of the results. These 
included chiral cross checks, checks with racemic and achiral catalysts, multiple sample 
preps for variability, and running the catalysts singly and in combination. The majority of 
these checks returned results indicating the method is sound. In cases where there 
were questionable results, most can be attributed to a non-ideal internal standard to 
analyte ratio.  
 
While direct comparisons to the condensed phase are difficult due to the complex 
mechanisms involved, previous work with the Mn-Salen system provide potential insight 
for comparison. The gas-phase Mn-salens  gave  DE’s  between  12-20% in our system.298 
These   catalysts  were   found   to   yield  EE’s   greater   than  90%   in   the   condensed   phase.  
This demonstrates that the methodology developed herein, despite exhibiting modest 
DE’s  can  identify  excellent condensed phase chiral catalyst with the appropriate set of 
chiral probes.299  
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Appendix 
 
8.1 –  (1S, 2S)-diaminocyclohexane-based di-imines  
 
Mass Spectrometer tune conditions 
Tune file: benzaldehydes 090313.LCQTune 
 
Infusion rate – 1 Pl/min 
Positive Ion Mode 
Source type – ESI 
Spray Voltage (kV) – 5  
Spray current (PA) – 0.1  
Capillary heat (°C) – 165  
Probe position – 1 
Sheath flow (arb) – 20 
Capillary (V) – 120 
Octapole 1 offest (V) – -3.75 
Octapole 2 offest (V) – -8.5 
Tube lens offset (V) – 55  
Trap offset (V) – -10  
Multiplier – -1310 
Pscan – 10  
AGC – Off 
Ion Gauge – 2.69 x 10-5 torr 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 275 
Tune file – benzaldehydes 090313.LCQTune 
Isolate 353.2 m/z  
isolation window 5.0 m/z 
Fragmentation energy – 35%  
Activation time – 50 msec 
  
 
 
 
 
 
full scan with Cu cl and ligand mix iso frag 354 #2-20 RT: 0.05-1.01 AV: 19 NL: 9.05E4
T: + p ESI Full ms2 354.00@cid35.00 [95.00-1000.00]
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double syringe pump ligand add cu iso and frag 353 #1 RT: 0.00 AV: 1 NL: 8.85E4
T: + p ESI Full ms2 353.00@cid35.00 [95.00-1000.00]
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Figure 146. Catalyst 3a in mixture of catalysts 3 b-d-g (top) and as single solution (bottom). 
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Tune file – benzaldehydes 090313.LCQTune 
Isolate – 425.1 m/z 
Isolation width – 5.0 m/z 
Fragmentation energy – 35% 
Activation time – 50 msec  
 
 
 
 
Dif only iso and frag #1-15 RT: 0.03-1.01 AV: 15 NL: 6.51E4
T: + p ESI Full ms2 426.00@cid30.00 [115.00-1000.00]
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double syringe pump ligand and cu iso 425 and frag #1-25 RT: 0.04-1.17 AV: 25 NL: 6.70E4
T: + p ESI Full ms2 425.20@cid35.00 [115.00-1000.00]
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Figure 147. Catalyst 3b in mixture of catalysts 3 a, c, & d-g (top) and as single solution (bottom). 
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Tune file – benzaldehydes 090313.LCQTune 
Isolate 437.2 m/z (top) and 439.2 m/z (bottom) 
Isolation width 5.0 m/z (top) and 1.3 m/z (bottom) 
Fragmentation energy – 45% 
Activation time – 50 msec 
 
Figure 148. Catalyst 3c in mixture of catalysts 3 a, b, & d-g (top) and as single solution (bottom). 
 
 
 
 
 
Day 1 stability mesitaldehdye iso and frag 437 #1-20 RT: 0.03-1.05 AV: 20 NL: 1.49E5
T: + p ESI Full ms2 437.20@cid45.00 [120.00-1000.00]
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after s run iso 439 and frag run 2 #1-15 RT: 0.02-0.89 AV: 15 NL: 6.51E4
T: + p ESI Full ms2 439.00@cid40.00 [120.00-1000.00]
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Tune file – benzaldehydes 090313.LCQTune 
Isolate 577.4 m/z (top)  
Isolation width 5.0 m/z (top) 
Fragmentation energy – 40% 
Activation time – 50 msec 
 
 
 
 
 
 
 
 
full scan with copper chloride iso 577 frag  #1-20 RT: 0.02-1.01 AV: 20 NL: 6.81E4
T: + p ESI Full ms2 577.60@cid40.00 [155.00-1000.00]
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full scan with Cu cl and ligand mix iso frag 578 #1-20 RT: 0.03-0.96 AV: 20 NL: 3.96E4
T: + p ESI Full ms2 578.00@cid40.00 [155.00-1000.00]
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Figure 149. Catalyst 3d in mixture of catalysts 3 a – c, and e-g (top) and as single solution (bottom). 
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Tune file – benzaldehydes 090313.LCQTune 
Isolate 491.0 m/z (top), weak signal (bottom) 
Isolation width 5.0 m/z (top) 
Fragmentation energy – 40% 
Activation time – 50 msec 
 
 
 
 
 
stock dicl S cyclohexane cu solution iso 491 and frag more energy #10 RT: 0.42 AV: 1 NL: 7.86E4
T: + p ESI Full ms2 491.00@cid40.00 [135.00-1000.00]
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full scan with Cu cl and ligand mix iso frag 492 #1-20 RT: 0.03-0.91 AV: 20 NL: 8.86E4
T: + p ESI Full ms2 492. 0@cid35. 0 [135.00-1000.00]
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Figure 150. Catalyst 3e in mixture of catalysts 3 a – d, f, and g (top) and as single solution (bottom). 
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Tune file – benzaldehydes 090313.LCQTune 
Isolate 473.2 m/z (top) 
Isolation width 5.0 m/z (top) 
Fragmentation energy – 35% 
Activation time – 50 msec 
 
 
 
Tune file – benzaldehydes 090313.LCQTune 
 
full scan ligand add cu iso and frag 474 #1-20 RT: 0.01-0.87 AV: 20 NL: 9.73E4
T: + p ESI Full ms2 474.00@cid35.00 [130.00-1000.00]
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all ligand mix ISO 473 methoxy #1-10 RT: 0.07-0.84 AV: 10 NL: 7.13E4
T: + p ESI Full ms2 474.00@cid40.00 [130.00-1000.00]
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Figure 151. Catalyst 3f in mixture of catalysts 3 a – e, and g (top) and as single solution (bottom). 
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Isolate 546.9 m/z (top) 
Isolation width 5.0 m/z (top) 
Fragmentation energy – 35% 
Activation time – 50 msec 
 
   
 
 
Day 1 iso 547 and frag #1-20 RT: 0.04-1.33 AV: 20 NL: 1.17E5
T: + p ESI Full ms2 547.30@cid35.00 [150.00-1000.00]
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full scan with Cu cl and ligand mix iso frag 548 #1-20 RT: 0.04-1.20 AV: 20 NL: 1.46E5
T: + p ESI Full ms2 548.00@cid35.00 [150.00-1000.00]
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Figure 152. Catalyst 3g in mixture of catalysts 3 a – f (top) and as single solution (bottom). 
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8.2 – BINAM-based Di-imines 
 
Mass Spectrometer tune conditions for BINAM-based di-imines 
Tune file: BINAM Benz.LCQTune 
 
Infusion rate – 1 Pl/min 
Positive Ion Mode 
Source type – ESI 
Spray Voltage (kV) – 4.5  
Spray current (PA) – 0.1  
Capillary heat (°C) – 160 
Probe position – 1 
Sheath flow (arb) – 10 
Capillary (V) – 37 
Octapole 1 offest (V) – -4.5 
Octapole 2 offest (V) – -8.5 
Tube lens offset (V) – 55  
Trap offset (V) – -10  
Multiplier – -1310 
Pscan – 10  
AGC – Off 
Ion Gauge – 2.69 x 10-5 torr 
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Tune file – BINAM Benz 
Isolate 525.2 m/z (top) 
Isolation width 1.7 m/z (top) 
Fragmentation energy – 35% 
Activation time – 50 msec 
 
8.2 – 1,1’-binaphthyl-2.2’-diamine (BINAM) 
 
Figure 153. Catalyst 5a in a mixture of catalysts 5b-d (top) and single solution (bottom). 
Benz BINAM with Cu iso and frag 524 #1-10 RT: 0.01-0.42 AV: 10 NL: 5.76E4
T: + p ESI Full ms2 524.20@cid45.00 [200.00-1000.00]
250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
A
bu
nd
an
ce
459.20
445.13
523.20
465.07
381.27356.40
492.80
Racemic BINAM iso 24pt5 frag at 50 and 50 #1-4 RT: .00-0.14 AV: 4 NL: 1.65E5
T: + p ESI Full ms2 524.50@cid50.00 [140.00-1000.00]
150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
A
bu
nd
an
ce
459.27
445.27
523.07
381.33
356.47
435.93
418.47
 284 
Tune file – BINAM Benz 
Isolate 597.1 m/z (top) 
Isolation width 1.5 m/z (top) 
Fragmentation energy – 35% 
Activation time – 50 msec 
 
 
 
Figure 154. Catalyst 5b in a mixture of catalysts 5a, c, and d (top) and single solution (bottom). 
 
ligand currently being recrystrallized with Cu iso 597 pt8 width frag 40 and 50 #1-10 RT: 0.03-0.44 AV: 10 NL: 1.08E5
T: + p ESI Full ms2 597.30@cid40.00 [160.00-1000.00]
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Ligand mix stability iso 597 frag #1-12 RT: 0.04-0.54 AV: 12 NL: 1.03E
T: + p ESI Full ms2 597.30@cid40.00 [160.00-1000.00]
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Tune file – BINAM Benz 
Isolate 609.2 m/z (top) 
Isolation width 1.5 m/z (top) 
Fragmentation energy – 35% 
Activation time – 50 msec 
 
 
 
Mesital BINAM with Cu iso high cu 65 isotope and frag  #1-14 RT: 0.06-1.07 AV: 14 NL: 6.86E4
T: + p ESI Full ms2 609.40@cid45.00 [165.00-2000.00]
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fresh ligand mix iso mesital and frag increase to 45 energy  #9 RT: 0.42 AV: 1 NL: 6.28E4
T: + p ESI Full ms2 609.30@cid45.00 [165.00-1000.00]
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Figure 155. Catalyst 5c in a mixture of catalysts 5a, b, and d (top) and single solution (bottom). 
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Tune file – BINAM Benz 
Isolate 747.3 m/z (top) 
Isolation width 1.5 m/z (top) 
Fragmentation energy – 35% 
Activation time – 50 msec 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3,5 Ditert butyl iso 748 frag #1-5 RT: 0.01-0.25 AV: 5 NL: 4.38E4
T: + p ESI Full ms2 748.30@cid45.00 [205.00-1500.00]
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Figure 156. Catalyst 3d in mixture of catalysts a-c. No spectra was recorded for the single catalyst 
solution. 
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8.3 – Diphenylethylene-based di-imines 
 
Mass Spectrometer tune conditions for Diphenyl-based di-imines 
Tune file: BINAM Benz.LCQTune 
 
Infusion rate – 1 Pl/min 
Positive Ion Mode 
Source type – ESI 
Spray Voltage (kV) – 5  
Spray current (PA) – 0.1  
Capillary heat (°C) – 165 
Probe position – 1 
Sheath flow (arb) – 10 
Capillary (V) – 60 
Octapole 1 offest (V) – -5.0 
Octapole 2 offest (V) – -8.0 
Tube lens offset (V) – 25  
Trap offset (V) – -10  
Multiplier – -1310 
Pscan – 10  
AGC – Off 
Ion Gauge – 2.69 x 10-5 torr 
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8.4 – Bis-Oxazolines 
 
Mass Spectrometer tune conditions for Bisoxazolines 
Tune file: BINAM Benz.LCQTune 
 
Infusion rate – 1 Pl/min 
Positive Ion Mode 
Source type – ESI 
Spray Voltage (kV) – 3.5  
Spray current (PA) – 0.1  
Capillary heat (°C) – 150 
Probe position – 1 
Sheath flow (arb) – 10 
Capillary (V) – 50 
Octapole 1 offest (V) – -6.5 
Octapole 2 offest (V) – -9.5 
Tube lens offset (V) – 55  
Trap offset (V) – -10  
Multiplier – -1310 
Pscan – 10  
AGC – Off 
Ion Gauge – 2.69 x 10-5 torr 
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8.5 – NMR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1S,2S)-N,N dibenzylidenecyclohexane-1,2-diamine 
1H NMR (300MHz ,CHLOROFORM-d) δ = 8.20 (s, 2 H), 7.58 (dd, J = 2.1, 5.6 Hz, 4 H), 7.31 (dd, J = 2.1, 4.7 Hz, 6 H), 
3.41 (dd, J = 4.7, 5.9 Hz, 2 H), 1.92 - 1.81 (m, 6 H), 1.50 (d, J = 10.3 Hz, 2 H) 
 
 
Figure 157. Proton NMR Catalyst 3a 
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(1S,2S)-N,N-bis(2,6-dichlorobenzylidene)cyclohexane-1,2-diamine 
1H NMR (300MHz ,CHLOROFORM-d) δ = 8.46 (s, 2 H), 7.29 (d, J = 1.2 Hz, 2 H), 7.26 (br. s, 2 H), 7.20 - 7.12 (m, 2 H), 
3.74 - 3.51 (m, 2 H), 2.01 - 1.73 (m, 6 H), 1.55 - 1.45 (m, 2 H). 
 
Figure 158. Proton NMR of catalyst 3e. 
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(1S,2S)-N,N-bis(2,6-diflourobenzylidene)cyclohexane-1,2-diamine 
1H NMR (300MHz ,CHLOROFORM-d) δ = 8.39 (s, 2 H), 7.33 - 7.14 (m, 3 H), 6.84 (t, J = 8.2 Hz, 3 H), 3.63 - 3.34 (m, 2 
H), 1.89 (br. s., 6 H), 1.50 (br. s., 2 H). 
Figure 159. Proton NMR of catalyst 3b. 
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(1S,2S)-N,N-bis(2-bromo-6-flourobenzylidene)cyclohexane-1,2-diamine 
1H NMR (300MHz ,CHLOROFORM-d) δ = 8.37 (s, 2 H), 7.33 (d, J = 7.9 Hz, 2 H), 7.14 (dt, J = 5.3, 8.1 Hz, 2 H), 7.05 - 
6.95 (m, 2 H), 3.59 - 3.48 (m, 2 H), 1.90 (br. s., 6 H), 1.51 (br. s., 1 H), 1.25 (s, 1 H). 
 
 
 
Figure 160. Proton NMR catalyst 3g. 
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(1S,2S)-N,N-bis(2,4,6-trimethylbenzylidene)cyclohexane-1,2-diamine 
1H NMR (300MHz ,CHLOROFORM-d) δ = 8.54 (s, 2 H), 6.77 (s, 2 H), 3.49 - 3.37 (m, 2 H), 2.32 - 2.17 (m, 18 H), 1.82 (s, 
8 H), 1.25 (s, 2 H). 
Figure 161. Proton NMR catalyst 3c. 
D 
F 
C 
E 
wa
te
r 
CD
Cl
3 
A/B 
 294 
 
Figure 162. Proton NMR of Catalyst 3e with Cu(I) trifluormethanesulfonate. Indicates oxidation of Cu (I) to Cu(II) which is paramagnetic and 
hence the lack /broadness of NMR peaks.  
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(1S,2S)-N,N-bis(2-bromo-6-flourobenzylidene)cyclohexane-1,2-diamine 
1H NMR (300MHz ,CHLOROFORM-d) δ = 8.37 (s, 2 H), 7.33 (d, J = 7.9 Hz, 2 H), 7.14 (dt, J = 5.3, 8.1 Hz, 2 H), 7.05 - 
6.95 (m, 2 H), 3.59 - 3.48 (m, 2 H), 1.90 (br. s., 5 H), 1.51 (br. s., 1 H), 1.25 (s, 1 H). 
 
Figure 163. Proton NMR of catalyst 5i. 
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(S)-N2,N2'-dibenzylidene-[1,1'-binaphthalene]-2,2'-diamine 
1H NMR (300MHz ,CHLOROFORM-d)  = 7.86 - 7.74 (m, 5 H), 7.31 - 7.03 (m, 19 H), 3.48 (q, J = 7.0 Hz, 2 H), 1.63 (br. 
s., 5 H), 1.21 (t, J = 7.0 Hz, 3 H). 
 
 
 
Figure 164. Proton NMR of catalyst 5a. 
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(R) 2-
methoxyoctane 
1H NMR (300 MHz, Chloroform-d)  δ  3.35  – 3.16 (m, 4H), 1.43 – 1.22 (m, 10H), 1.15 – 1.08 (m, 3H), 0.86 (q, J = 8.0, 7.3 
Hz, 3H). 
 
 
 
Figure 165. Expanded proton NMR of (R) 2-methoxyoctane. 
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(S) 2-
methoxyoctane 
1H NMR (300 MHz, Chloroform-d)  δ  3.42  – 3.18 (m, 4H), 1.35 – 1.22 (m, 10H), 1.15 – 1.08 (m, 3H), 0.92 – 0.83 (m, 3H). 
 
 
Figure 166. Expanded proton NMR of (S) 2-methoxyoctane. 
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(S) 1-methoxyethylbenzene 
1H NMR (300 MHz, Chloroform-d)  δ  7.38  (t,  J = 1.5 Hz, 1H), 7.36 (q, J = 1.2 Hz, 1H), 7.34 – 7.31 (m, 2H), 7.30 (q, J = 1.5 
Hz, 1H), 4.30 (q, J = 6.5 Hz, 1H), 3.27 – 3.19 (m, 3H), 1.46 – 1.41 (m, 3H). 
Figure 167. Proton NMR of (S)-2-methoxyethylbenzene. 
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(R) 1-methoxyethylbenzene 
1H NMR (300 MHz, Chloroform-d)  δ  7.38  (d,  J = 1.3 Hz, 1H), 7.37 – 7.35 (m, 1H), 7.35 – 7.32 (m, 2H), 7.30 (p, J = 2.1 Hz, 
1H), 4.30 (q, J = 6.5 Hz, 1H), 3.28 – 3.19 (m, 3H), 1.47 – 1.40 (m, 3H). 
Figure 168. Expanded proton NMR (R)-2-methoxyethylbenzene. 
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Figure 169. Proton NMR of catalyst 5b. 
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Figure 170. Extracted mineral oil from NaH. 
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Figure 171. Proton NMR of racemic [1-(Benzyloxy)ethyl]benzene (too big to coordinate). 
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8.6 – Synthesis of catalysts 
 
8.6.1 – Meso-1,2-diphenylethylenediamine 
 
 
General procedure: weigh diamine into a 25 or 50 mL round bottom flask (RBF) and 
add solvent. Add benzaldehyde, stir and heat to reflux. Material was crystallized and/or 
recrystallized, washed with cold methanol, and dried in an oven at 105 °C overnight. 
 
DiPhenyl Benzaldehyde (catalyst 4a) 
Add 100.63 mg meso-1,2-diphenylethylenediamine, 10 mL ethanol (anhydrous 200 
proof), 125 PL benzaldehyde, and 10 mL toluene to a 50 mL RBF. Reflux for 1 hour. 
Distill until approximately 10 mL is left and let crystallize. Cool in ice bath, filter, wash 
with 10 mL cold methanol and dry in oven at 105 °C overnight. Yield 80%. 
 
Mesitaldehyde diphenyl (catalyst 4c) 
Add 100.6 mg of meso-1,2-diphenylethylenediamine, 4.5 mL of toluene, 5.5 mL ethanol 
(anhydrous, 200 proof), and 140 PL mesitaldehyde to a 50 mL RBF. Reflux for 1 hour. 
Distill until approximately 5 mL left. Allow to crystallize. Filter and wash with cold 
methanol.  Recrystallize in 5.5 mL toluene. Filter and wash with 10 mL cold methanol. 
Dry in oven at 105 °C overnight. Yield 51%. 
  
2,6-DiCl diphenyl (catalyst 4e) 
Add 100 mg meso-1,2-diphenylethylenediamine, 175 mg of 2,6-dichlorobenzaldehyde, 
5 mL toluene, 5 mL anhydrous ethanol (200 proof), into 25 mL RBF. Reflux for 1hr, 
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filter and recrystallize in 10 mL of anhydrous ethanol and 5 mL of toluene. Filter, wash 
with 10 mL cold methanol, and dry at 105 °C overnight. Yield 74%. 
 
3,5-di-tert-butyl benzaldehyde (catalyst 4d) 
Add 104.32 mg of meso-1,2-diphenylethylenediamine, 223 mg of di-tert-butyl 
benzaldehdye, 4 mL of toluene into a 50 mL RBF. Reflux for 1 hour. Let cool to allow 
for crystallization. Filter and wash with cold 10 mL methanol. Dry at 105 °C overnight. 
Yield 47%. 
 
3,5-di-tert-butyl benzaldehyde (catalyst 4d)  
Weigh 101 mg of meso-1,2-diphenylethylenediamine and 219.9 mg of 3,5-di-tert-
butylbenzaldehyde into a 50 mL RBF. Add 125 mg 4Å molecular sieves (MS). Stir 
overnight. Filter and wash with 10 mL cold methanol. Dry at 105 °C overnight. Yield 
24%.  
 
2,6-dimethoxy (catalyst 4f) 
Add 100.03 mg of meso-1,2-diphenylethylenediamine, 160.94 mg of 2,6-
dimethoxybenzaldehdye, 3 mL of toluene, 2.5 mL of anhydrous ethanol into a 25 mL 
RBF. Reflux for 1 hr. Let cool to crystallize, then filter and wash with 7 mL of cold 
methanol. Evaporate solvent with rotary evaporator. Dry at 105 °C overnight. Yield 
42%. 
 
2Br,6F (catalyst 4g) 
 306 
Add 100.3 mg meso-1,2-diphenylethylenediamine, 198.92 mg of 2-bromo,6-
fluorbenzaldehdye, 7 mL of toluene, and 3 mL of anhydrous ethanol into a 25 mL RBF. 
Reflux for 1 hour. Allow to cool to crystallize, and then filter and wash with 5 mL cold 
methanol. Dry at 105 °C overnight. 
 
2,6-DiF (catalyst 4b) 
Weigh 100.1 mg of meso-1,2-diphenylethylenediamine and pipet 104 P  of 2,6-
difluorobenzaldehyde into a 25 mL RBF. Add 3 mL of toluene, and 3 mL of anhydrous 
ethanol. Allow to reflux for 1 hour. Allow to cool to crystallize, then filter and wash with 
7 mL of cold methanol. Dry at 105 °C overnight. 
 
Imidazole-2-carboxaldehyde (catalyst 4h) 
Weigh 99.6 mg of meso-1,2-diphenylethylenediamine and 91.64 mg of 2-
imidazolecarboxaldyhde into a 50 mL RBF. Add 10 mL toluene and reflux for 1 hour, 
cool, and filter. Wash with 15 mL cold methanol. Recrystallize in approximately 7 mL 
toluene and 2 mL heptane. Filter and dry overnight at 105 °C. Yield 28%. 
 
Meso-3,5-DiF (catalyst 4i) 
Add 103 mg of meso-1,2-diphenylethylenediamine, 149.35 mg 3,5-
diflurobenzaldehyde, 4 mL methanol, and 5 mL toluene into a 25 mL RBF. Reflux for 1 
hour with 4Å MS. Cool and filter, and wash with 7 mL cold methanol. Yield 71%.  
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8.6.2 – BINAM-based Di-imines 
 
 
General procedure: Weigh BINAM into a 25 or 50 mL RBF. Add solvent, then 
benzaldehyde. Add stir bar and 4 Å MS. Allow to stir for 24-36 hours. Filter solution and 
use the rotary evaporator to remove solvent. Recrystallize with petroleum ether and 
hexanes. Store in solvent to prevent oxidation. 
 
Benzaldehyde (catalyst 5a)  
Add 100 mg of (S) BINAM and 77 PL of benzaldehyde, 5 mL of toluene, 5 mL of 
anhydrous ethanol, and 150 mg of 4 Å MS. Allow to stir for 1 day. Remove solvent via 
rotary evaporation, and recrystallize with petroleum ether and hexanes (50/50 v/v). 
Filter and wash with 10 mL of cold methanol. Redissolve in methanol. Yield 39%. 
 
Mesitaldehyde (catalyst 5b)   
Weigh 99.78 mg of (S) BINAM and 110 PL of mesitaldehyde into a 25 mL RBF. Add 4 
mL of anhydrous ethanol, 5 mL of toluene, and 150 mg of 4 Å MS. Stir overnight. 
Proceed as in general procedure. Yield 45%. 
 
2,6-DiF (catalyst 5e) 
Add 100.33 mg of (S) BINAM, 83 PL of 2,6-difluorobenzaldehyde to a 50 mL RBF. Add 
5mL of toluene, 4mL of anhydrous ethanol, and 100 mg of 4 Å MS. Stir overnight. 
Remove solvent with rotary evaporator. and redissolve in methanol. Yield 20%. 
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3,5-di-tert-butyl benzaldehyde (catalyst 5d) 
Weigh 99.72 mg of (S) BINAM and 166 mg of di-tert-butylbenzaldehyde to a 25 mL 
RBF. Add 5 mL of toluene, 4 mL of anhydrous ethanol, and 125 mg of 4 Å MS. Stir 
overnight. Remove solvent via rotary evaporator and redissolve in methanol. Yield 
50%. 
 
3,5-difluoro (catalyst 5b) 
Add 99.34 mg of (S) BINAM, 4 mL each toluene and anhydrous ethanol, 100 P  3,5-
difluorobenzaldehdye, 200 mg 4 Å MS to a 50 mL RBF. Remove solvent with rotary 
evaporator and redissolve in methanol. Yield 38%. 
 
3,5-DiCl (catalyst 5e) 
Add 99.5 mg of (S) BINAM, 190.65 mg 3,5-dichlorobenzaldhyde. Add 4 mL each of 
toluene and anhydrous ethanol, to a 25 mL RBF. Add 250 mg of 4 Å MS and stir 
overnight.  Remove solvent (rotary evaporator) and redissolve in methanol. Yield 22%. 
 
3,5-di-tert-butyl (catalyst 5d) 
Add 99.8 mg of (S) BINAM, 147.97 mg 3,5-di-tert-butylbenzaldehyde, 3 mL toluene, 4 
mL ethanol, and 170 mg Å MS. Add additional 2 mL toluene and 2 mL of anhydrous 
ethanol. Heat to reflux for 4 hours. Allow to cool and then filter. Wash with 15 mL of 
cold methanol. Redissolve in methanol. Yield 43%. 
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2,6-DiCl (catalyst 5g) 
Add 104.5 mg of (S) BINAM, 145 mg of 2,6-dichlorobenzaldehyde, 255 mg of 4 Å MS,  
and 3 mL each of toluene and anhydrous ethanol to a 50 mL RBF. Stir overnight and 
remove solvent via rotary evaporation. Redissolve in methanol. 
 
2,6-dimethoxy (catalyst 5f) 
Add 50.8 mg of (S) BINAM, 66 mg of 2,6-dimethoxybenzaldehyde, 3 mL each of 
toluene and anhydrous ethanol, and 200 mg of 4 Å MS into 50 mL RBF. Stir over 
weekend, and remove solvent. Redissolve in methanol. 
 
2Br,6F (catalyst 5i) 
Weigh 99.89 mg of (S) BINAM and 165.2 mg of 2-bromo,6-fluorobenzaldehyde into a 
50 mL RBF. Add 4 mL each of toluene and anhydrous ethanol, and 200 mg of 4 Å MS. 
Stir for 48 hours. Remove solvent. Redissolve in methanol. Yield 33%. 
 
3,5 DiCl (catalyst 5h) 
Add 99.17 mg of (S) BINAM, 139 mg 3,5-dichlorobenzaldehyde, 4 mL each of toluene 
and anhydrous ethanol, and 150 mg of 4 Å MS to a 50 mL RBF. Stir for 48 hours. 
Remove solvent. Redissolve in methanol. Yield 27%. 
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(R) BINAM diamines 
 
Benzaldehyde (catalyst 5a) 
Weigh 100.8 mg of (R) BINAM into a 25 mL RBF. Add 8 mL toluene and 73 PL 
benzaldehyde. Add 100 mg of 4 Å MS and stir overnight. Remove solvent and 
redissolve in methanol. 
 
Mestaldehyde (catalyst 5c) 
Weigh 99.88 mg of (R) BINAM into a 50 mL RBF. Add 8 mL of toluene, 110 PL of 
mesitaldehyde, and 125 mg of 4 Å MS. Stir overnight. Remove solvent and redissolve 
in methanol. 
 
3,5-DiF (catalyst 5b) 
Weigh 99.4 mg of (R) BINAM into a 50 mL RBF. Add 10 mL of toluene, 110 PL 3,5-
difluorobenzaldehyde, and 100 mg 4 Å MS. Monitor reaction via TLC. Add 30 PL 
additional 3,5-difluorbenzaldehyde after 6 hours. Add additional 125 mg of 4 Å MS. Stir 
overnight and remove solvent.  
 
2,6-DiF (catalyst 5e) 
Add 99.9 mg of (R) BINAM, 86.5 PL of 2,6-difluorobenzaldehyde, 4 mL each toluene 
and anhydrous ethanol, and 250 mg of 4 Å MS into 50 mL RBF. Stir overnight and 
remove solvent. Redissolve in methanol.  
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8.6.3 – 1,2-diaminocyclohexane-based Ligands 
 
General procedure: Weigh diamine into a 25 or 50 mL RBF. Add solvent(s) and 
benzaldehyde. Procedure A - add molecular sieves (MS) and stir for specified time. 
Filter and wash with cold methanol. Recrystallize with methanol or ethanol. Cool, filter 
and wash with cold methanol. Allow to dry overnight at 105 °C. Procedure B - heat to 
reflux for specified time. Allow to cool and crystallize.   
 
8.6.3.1 – trans-(1S, 2S)-diaminocyclohexane di-imines 
 
3,5-DiF (catalyst 3i)  
Add 103 mg of trans-(1S, 2S)-diaminocyclohexane (diamine) into a 25 mL RBF. Add 7 
mL of ethanol and 300 PL of 3,5-difluorobenzaldehyde, and 125 mg of 4 Å MS. Follow 
procedure A in general procedure. Stir overnight. Recrystallize in methanol. Yield 66%. 
 
Benzaldehyde (catalyst 3a) 
Add 100.17 mg of diamine, 170 PL of benzaldehyde, and 5 mL of anhydrous ethanol, 
to a 50 mL RBF and reflux for 1 hour. Follow procedure B in general procedure. 
Product crystallized as it cooled. Yield 85%.  
 
Mesitaldehyde (catalyst 3c)  
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Weigh 104.74 mg of diamine into a 50 mL RBF. Add 125 PL of mesitaldehyde and 6 
mL of anhydrous ethanol. Reflux for 1 hour. Follow procedure B in general procedure. 
Yield 74%.  
 
2, 6-dichlorobenzaldehyde (catalyst 3e) 
Add 103.22 mg of diamine, 348.89 mg of 2,6-dichlorobenzaldehyde, and 5 mL of 
anhydrous ethanol into 25 mL RBF. Heat to reflux for 1 hour. Isolate via procedure B. 
Yield 63%. 
 
2-bromo,6-fluorobenzaldehyde (catalyst 3g) 
Weigh 101.31 mg of diamine and 446.39 mg of 2-bromo-6-fluorobenzaldehyde into a 
25 mL RBF. Add 5 mL of anhydrous ethanol.  Reflux for 1 hour. Follow procedure B in 
general procedure. Yield 83%. 
 
2,6-dimethoxybenzaldehdye (catalyst 3f) 
Add 100.3 mg of diamine, 347 mg of 2,6-diethoxybenzaldehyde, and 5 mL of 
anhydrous ethanol to a 25 mL RBF. Reflux for 1 hour. Follow procedure B in general 
procedure. Yield 49%. 
 
Imidazole-2-carboxaldehyde (catalyst 3h) 
Add 100 mg of diamine, 187.21 mg imiadazole-2-carboxaldehyde, 170 mg of 4Å MS, 
and 10 mL of anhydrous ethanol to a 25 mL RBF and stir for 3 days. Follow procedure 
A in general procedure. Yield 20%. 
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2,6-difluorobenzaldehyde (catalyst 3b) 
Add 101.1 mg of diamine and 95 PL of 2,6-difluorobenzaldehyde to a 50 mL RBF. Add 
7 mL of anhydrous ethanol and heat to reflux. Follow procedure B in general 
procedure. Yield 78%. 
 
3,5-di-tert-butyl benzaldehyde (catalyst 3d) 
Add 100.65 mg of diamine, 228.5 mg of 3,5-di-tert-butylbenzaldehyde, 10 mL of 
anhydrous ethanol, and 150 mg of 4 Å MS to a 50 mL RBF. Stir over weekend. Follow 
procedure B in general procedure. 
 
Trans-(1R, 2R)-diaminocyclohexane 
 
2,6-difluorobenzaldehyde (catalyst 3b) 
Add 100.4 mg of diamine, 92 PL of 2,6-difluorobenzaldehyde, 5 mL of anhydrous 
ethanol, and 200 mg of 4Å MS to a 50 mL RBF. Follow procedure A in general 
procedure.  
 
3,5-di-tert-butylbenzaldehyde (catalyst 3d) 
Weigh 102.0 mg of diamine and 370.4 mg of 3,5-di-tert-butylbenzaldehyde into a 50 
mL RBF. Add 6 mL of anhydrous ethanol and 260 mg of 4Å MS. Stir for 48 hours. 
Follow procedure A in general procedure. Yield 67%. 
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Benzaldehyde (catalyst 3a) 
Add 100.5 mg of diamine, 170 PL of benzaldehyde, and 10 mL of anhydrous ethanol to 
a 50 mL RBF. Heat to reflux for 1 hour. Follow procedure B in general procedure. Yield 
77%. 
 
Mesitaldehye (catalyst 3c) 
Weigh 101.3 mg of diamine into a 50 mL RBF. Add 125 PL of mesitaldehdye and 6 mL 
of anhydrous ethanol. Reflux for 1 hour. Follow procedure B in general procedure. 
 
8.7 – Synthesis of Ethers 
 
General procedure: Add anhydrous THF to a RBF, previously flame-dried and flushed 
with nitrogen. Place under ice bath to cool. Add NaH and stir for 10 minutes. Add the 
chiral alcohol drop-wise, not exceeding 10 °C during the addition and stir for 30 
minutes. Add the alkylating reagent drop-wise, not exceeding 30 °C during the addition. 
Stir at room temperature for 1 hour and quench remaining NaH with methanol. Extract 
twice with 10 mL water and 10 mL diethyl ether. Combine organic layers and dry with 
either sodium sulfate or magnesium sulfate. Decant and evaporate the solvent. Store in 
amber vial. 
 
(S)-1-methoxyethylbenzene 
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Add 10 mL anhydrous THF and 401.0 mg NaH (60%), at 10 °C under N2 to a 50 mL 
RBF. Add 1.2 mL (S)-phenylethanol drop-wise, not exceeding 8 °C in the process. Add 
600 PL of MeI, not exceeding 25 °C. Follow general procedure. Yield 84%. 
 
(R)-1-methoxyethylbenzene  
Add 10 mL of anhydrous THF and 400.1 mg NaH, at 10 °C under N2, to a 50 mL RBF. 
Add 1.2 mL (R)-phenylethanol drop-wise, not exceeding 10 °C in the process. Add 600 
PL of MeI, not exceeding 25 °C during the addition. Follow general procedure. Yield 
86%. 
 
1-methoxyethylbenzene with n-butyl lithium as base 
Add 7 mL anhydrous hexane and 4 mL n-butyl lithium to a 50 mL RBF, previously 
flame-dried. Add 1-phenylethanol (1.2 mL), not exceeding 12 °C during the addition. 
Allow to stir for 30 minutes. Add 0.8 mL of methyliodide over 30 minutes, not exceeding 
25 °C during the addition. Follow extraction procedure in general procedure.  
 
[1-(Benzyloxy)ethyl]benzene 
Add 10 mL anhydrous THF and 400.1 mg NaH (60%) to a 50 mL RBF. Add 1.2 mL of 
(R) phenylethanol. Let mixture stir for 20 minutes with ice bath at ~10 °C. Add 950 PL 
of benzylbromide and stir for 3 hours at room temperature. Quench with methanol and 
follow general procedure to extract. Yield 84%. 
 
(R)-1-methoxyethylbenzene 
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Add 440 mg of 60% NaH to anhydrous THF (10 mL) in a 50 mL RBF. Stir for 30 
minutes under ice bath at 10 °C. Add 1.2 mL of (R) phenylethanol . Slowly add 630 PL 
of MeI. Stir 3 hours at room temperature. Quench reaction with methanol and follow 
general procedure. Yield 89%. 
 
d8-methoxyethylbenzene 
Add 450 mg of 60% NaH to anhydrous THF (10 mL) in a 50 mL RBF. Add 1 mL of d5-
ring phenylethanol and stir for 30 minutes with ice bath. Add 800 PL of d3-MeI. Stir for 1 
hour, quench with methanol, and follow general procedure to extract. Yield 81%. 
 
(R)-2-methoxyoctane 
Add 334 mg of 60% NaH into 10 mL of anhydrous THF in a 50 mL RBF.  Add 1 mL 
(R)- 2-octanol and 800 PL of MeI. Stir at room temperature for 4 hours. Add methanol 
to quench reaction followed by 10 mL of water and 10 mL of diethyl ether to extract. 
Wash with 1N KOH (repeat extraction). Combine the aqueous layers and the organic 
layers. Follow general procedure to dry and isolate product. Yield 88%. 
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8.6 - Chiral GC Analysis of Ethers 
 
Column – E-DEX 120 dimensions: 30 m x 0.25 mm  
GC Instrument conditions: 
Initial oven temperature (°C): 6 
Hold time (min): 1:00 
Ramp 1 rate (°C/min): 2.5 
Temperature 2 (°C): 220 
Hold Time (min): 5:00 
Maximum Temperature (°C): 230 
Pre-Run Timeout (min): 5:00 
Equilibration Time (min): 1:00 
Oven run Time (min): 70 
Inlet Temperature (°C): 220 
Split Flow (mL/min): 50 
Split Ratio: 50 
Constant Flow 
Flow Rate (mL/min): 1.0 
Gas Saver: Enabled 
Gas Saver Flow (mL/min): 20 
Time (min): 0.2  
Detector temperature (°C): 220 
Ignition Threshold (pA): 0.5 
Detector gases 
Air: On 
H2: On 
Make-up: On 
Sample Volume (PL): 2 
Plunger Strokes: 1 
Viscous Sample: No 
Sampling Depth in Vial: Bottom 
Pre-Injection Solvent: A 
Cycles: 2 
Sample Rinses: 1 
Post Injection Solvent: A 
Cycles: 2 
Injection Depth: Minimum 
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(R)-1-methoxyethylbenzene 
 
 
Compound Retention Time (min) Area Percent 
(R)-1-methoxyethylbenzene 18.272 85.35 
(R)-1-Phenylethanol 30.237 14.13 
Unknown 53.4 0.35 
 
 
 
 
 
 
 
Figure 172. (R)-1-methoxyethylbenzene chiral GC analysis. 
Solvent 
MeOH 
(R)-1-
methoxyethyl
benzene 
(R)-1-
phenylethanol 
(starting 
material) Unknown 
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(S)-1-methoxyethylbenzene 
 
Compound Retention Time (min) Area Percent 
(S)-1-methoxyethylbenzene 18.379 82.12 
(S)-1-Phenylethanol 30.815 12.08 
Unknown 53.4 5.80 
 
 
 
 
 
 
Figure 173. (S)-1-methoxyethylbenzene chiral GC analysis. 
(S)-1-
methoxyethyl
benzene 
(S)-1-
phenylethanol 
Solvent 
(MeOH) 
Unknown 
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Racemic Phenylethanol 
Compound Retention Time (min) Area Percent 
(R)-1-Phenylethanol 30.218 50.44 
(S)-1-Phenylethanol 30.755 49.56 
 
 
 
 
 
 
 
 
Figure 174. Racemic phenylethanol GC analysis. 
Solvent 
MeOH 
(R)-1-
Phenylethanol 
(S)-1-
Phenylethanol 
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(S)-2-methoxyoctane 
Compound Retention Time (min) Area Percent 
Unknown 1 5.45 2.52 
(S)-2-Methoxyoctane 25.73 95.38 
Unknown 2 77.93 1.51 
Unknown 3 78.90 0.58 
 
 
 
 
 
 
 
 
Figure 175. (S)-2-methoxyocatne chiral GC analysis. 
Solvent 
MeOH 
(S)-2-
methoxyoctane 
Unknown 1 
Unknown 2 and 3 
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(R)-2-methoxyoctane 
Compound Retention Time (min) Area Percent 
Unknown 1 5.45 1.14 
(R)-2-Methoxyoctane 25.86 98.15 
Unknown 2 77.93 0.72 
 
 
 
 
 
 
 
 
Figure 176. (R)-2-methoxyoctane chiral GC analysis. 
Solvent 
MeOH 
(R)-2-
methoxyoctane 
Unknown 2 
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(R)-2-octanol (for retention time) 
Compound Retention Time (min) Area Percent 
MeOH 2.57 92.54 
(R)-2-Octanol 43.54 7.38 
 
 
 
 
 
 
 
 
 
Figure 177. (R)-2-octanol chiral GC analysis. 
MeOH 
(R)-2-Octanol 
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(S)-2-octanol (for retention time) 
Compound Retention Time (min) Area Percent 
(S)-2-Octanol 44.07 98.06 
 
 
 
 
  
Figure 178. (S)-2-2octanol chiral GC analysis. 
MeOH 
(S)-2-Octanol 
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pharmaceutical industry. Rapidly promoted through the technical ranks of the Quality 
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Lead team of scientists to develop and validate analytical methods for the analysis of 
small  molecule  API’s.  Project leader for qualification of analytical methods at new CMO 
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analysis reports that detailed each step of the process and the corresponding 
safety hazards; investigation and technical reports; SOPs and training manuals. 
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full current Good Manufacturing Practices (cGMP) conditions. 
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validated a UV spectroscopy method that correlated the products final color to 
its pre-isolation solution color. This allowed the plant to know, with a high degree 
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money. 
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specifications and test methods for products/intermediates/starting materials for 
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Analytical Chemist I, II, and III, Quality Control 
Ensure consumer safety and product quality of APIs, intermediates, and raw materials 
by testing products in accordance to internal specifications, SOPs, and cGMP 
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x Developed and validated new gas chromatography methods with internal 
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employee morale. 
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